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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and safety of workers exposed to an 
ever-increasing number of potential hazards at their workplace. The 
National Institute for Occupational Safety and Health has projected a 
formal system of research, with priorities determined on the basis of 
specified Indices, to provide relevant data from which valid criteria for 
effective standards can be derived. Recommended standards for occupational 
exposure, which are the result of this work, are based on the health 
effects of exposure. The Secretary of Labor will weigh these recommen­
dations along with other considerations such as feasibility and means of
implementation in developing regulatory standards.
It is Intended to present successive reports as research and epide­
miologic studies are completed and as sampling and analytical methods are 
developed. Criteria and standards will be reviewed periodically to ensure 
continuing protection of the worker.
I am pleased to acknowledge the contributions to this report on
polychlorinated biphenyls by members of the NIOSH staff and the valuable,
constructive comments by the Review Consultants on polychlorinated 
biphenyls, by the ad hoc committees of the Society for Occupational and 
Environmental Health and the American Occupational Medical Association, and
ill
by Robert B. O'Connor, M.D., NIOSH consultant in occupational medicine. 
The NIOSH recommendations for standards are not necessarily a consensus of 
all the consultants and professional societies that reviewed this criteria 
document on polychlorinated biphenyls. A list of Review Consultants 
appears on page vl.
rohi^P. Flnklea, M.D.
Director, National Institute for 
Occupational Safety and Health
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The Division of Criteria Documentation and Standards 
Development (DCDSD), National Institute for Occupational 
Safety and Health, had primary responsibility for the 
development of the criteria and recommended standard for 
polychlorinated biphenyls. From DCDSD, John M. Fajen served 
as criteria manager and developed the basic information with 
the assistance of John A. Wass, Ph.D. Personnel from other 
NIOSH Divisions that assisted in the development of this 
document were Robert H. Hill Jr., Ph.D., Alan K. Gudeman, 
and Dennis M. O'Brien (Division of Physical Sciences and 
Engineering); Mark W. Jones (Division of Surveillance, 
Hazard Evaluations and Field Studies); and Trent R. Lewis, 
Ph.D. (Division of Biomedical and Behavioral Science).
The DCDSD review of this document was provided by Richard A. 
Rhoden, Ph.D., Chairman; J. Henry Wills, Ph.D.; and Howard 
L. McMartln, M.D., with A. Blair Smith, M.D. (Division of 
Surveillance, Hazard Evaluations and Field Studies), and 
James H. Sterner, M.D.
The views expressed in this document, the conclusions 
reached, and the recommendations for a standard are those of 
NIOSH after review of the evidence and consideration of the 
comments of reviewers. These views and conclusions are not 
necessarily those of the consultants, other federal 
agencies, and professional societies that reviewed the 
document.
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I. RECOMMENDATIONS FOR A POLYCHLORINATED BIPHENYLS (PCBs) STANDARD
The National Institute for Occupational Safety and Health (NIOSH) 
recommends that employee exposure to polychlorinated biphenyls (PCBs) in 
the workplace be controlled by adherence to the following sections. The 
standard is designed to protect the health and provide for the safety of 
employees for up to a 10-hour workday, 40-hour workweek, over a normal 
working lifetime. The standard is measurable by techniques that are valid, 
reproducible, and available to Industry and governmental agencies. 
Compliance with the standard should substantially reduce any risk of 
reproductive or tumorigenic effects of PCBs and prevent other adverse 
effects of exposure in the workplace. Employees should regard the 
recommended workplace environmental limit as the upper boundary for exposure 
and make every effort to keep exposure as low as possible.
Evidence indicates adverse reproductive and tumorigenic effects In 
experimental animals exposed to certain commercial PCB preparations. 
Currently available information is not adequate to demonstrate that other 
commercial PCB preparations do not have these effects. Should sufficient 
information become available to indicate that the standard offers greater 
or lesser protection from some chlorobiphenyl isomers or commercial 
preparations than is needed, it will be considered for revision.
The Toxic Substances Control Act of 1976 (Public Law 94-469) required
the US Environmental Protection Agency (EPA) to prescribe marking and
disposal regulations for PCBs by July 1, 1977 (Federal Register 42:26563-
77, May 24, 1977). By this Act, the manufacture, processing, distribution
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in comerce, or use of PCBs in any but totally enclosed systems is to be 
banned» effective 1 year after the date of its enactment, October 11, 1976. 
Two years after the enactment date PCB manufacture is to be banned, and 
processing and distribution in commerce are to be banned 2.5 years from 
that date. However, the Act allows the Administrator of EPA to rule 
otherwise if he finds that manufacture, processing, distribution in 
commerce, or use In other than totally enclosed systems will not present an 
unreasonable risk of Injury to health or to the environment. The Act does 
not affect use of equipment already containing PCBs In totally enclosed 
systems, so that a potential for occupational exposure to PCBs will 
continue to exist for many years as a consequence of their transportation, 
Installation, use, and disposal. The part of the Act specific for PCBs Is 
presented In Figure I-1.
"PCBs" are defined for this recommended standard as commercial 
preparations of chlorinated biphenyl compounds, Including those 
preparations which may be described as single isomers or classes of 
Isomers, such as Decachlorodlphenyl. Biphenyl and Its monochlorinated 
derivatives occurring in commercial preparations of PCBs shall be measured 
along with the polychlorinated derivatives, and shall be treated in thle 
standard as the polychlorinated components of the preparations. 
"Occupational exposure to PCBs," Is defined as working with PCBs or with 
equipment containing PCBs that can become airborne or that can spill or 
splash on the skin or Into the eyes, or the handling of any solid products 
that may result in exposure to PCBs by skin contact or by inhalation. The 
term "PCB work area" Is defined as an area where there is occupational 
expoeure to PCBs. In areas where no occupational exposure to PCBs occurs,
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but «hers PCB« are present In equipment In the workplace, adherence is 
required only to Section 8(a).
Section 1 - Environmental (Workplace Air)
(a) Concentration
Occupational exposure to polychlorinated biphenyls (PCBs) shall be 
controlled so that no worker Is exposed to PCBs at a concentretlon greater 
than 1.0 mlcrogram total PCBs per cubic meter of air (1.0 jig/cu m), 
determined as a time-weighted average (TWA) concentration, for up to a 10- 
hour workday, 40-hour workweek.
(b) Sampling and Analysis
The recommended TWA occupational exposure limit for PCBs hae been 
determined to be the lowest reliably detectable limit by the sampling and 
analytical methods recommended In this document. Environmental samples 
shall be collected and analyzed as described in Appendices I and II, or by 
any methods shown to be at least equivalent in accuracy, precision, and 
seneltivity to the methods specified.
Section 2 - Medical
Medical surveillance shall be made available to all employees subject 
to occupational exposure to PCBs.
(a) Preplacement or Initial medical examinations for workers shall
Include:
(1) Comprehensive medical and work histories with special 
emphasis on hepatic function, skin condition, and reproductive history.
(2) Comprehensive physical examination with particular 
attention to the skin and to hepatic function including determinations of 
serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamic-pyruvic 
transaminase (SGPT) activities. The responsible physician may also wish to 
obtain measurements of serum triglyceride concentrations or of other 
indices of fat metabolism.
(3) A judgment of the employee's ability to use positive 
pressure respirators.
(b) During examinations, applicants or employees having medical 
conditions that could be directly or indirectly aggravated by exposure to 
polychlorinated biphenyls or formulations containing polychlorinated 
biphenyls shall be counseled on the increased risk of impairment of their 
health that might result from working with these substances.
(c) Women in the work force who are of child-bearing age shall be 
advised of the potential adverse effects of PCBs on the unborn child. 
Those who bear children while working with PCBs shall be counseled 
concerning the advisability of nursing their babies.
(d) Initial medical examinations shall be made available to all 
workers as soon as practicable after promulgation of a standard based on 
these recommendations.
(e) Periodic examinations shall be made available at least 
annually and includes (1) interim medical and work histories, and (2) 
physical examinations as outlined in paragraphs (a)(1) and (a)(2) of this 
section.
(f) If evidence of adverse effects of exposure to PCBs is 
suspected or confirmed, appropriate medical care shall be made available to 
the affected worker(s).
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(g) Pertinent medical records shall be maintained for all
employees exposed to PCBs in the workplace. Such medical records shall be 
maintained for the period of employment plus 30 years. These records shall 
be made available to the designated medical representatives of the 
Secretary of Health, Education, and Welfare, of the Secretary of Labor, of 
the employer, and of the employee or former employee.
Section 3 - Labeling and Posting
All labels and warning signs shall be printed both in English and in 
the predominant language of non-English-reading workers. Illiterate 
workers and workers reading languages other than those used on labels and 
posted signs shall be otherwise informed regarding hazardous areas and 
shall be Informed of the Instructions printed on labels and signs.
(a) Labeling
The following warning label shall be affixed in a readily visible




DANGER! CONTAINS POLYCHLORINATED BIPHENYLS 
CANCER SUSPECT AGENT
Use only with adequate ventilation.
Do not get in eyes, or on skin or clothing.
Fjrst Aid: In case of skin or eye contact, flush with running water.
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(b) Posting
Warning placards shall be affixed in readily vieible locations in or 
near PCB work areas. The information contained thereon shall be arranged 




CANCER SUSPECT AGENT 
AUTHORIZED PERSONNEL ONLY
Do not enter unless area is adequately ventilated.
Do not get in eyes, or on skin or clothing.
First Aid: In case of skin or eye contact, flush with running water.
Section 4 - Personal Protective Equipment and Clothing
(a) Protective Clothing
In any operation where workers may come into direct contact with 
PCBs, protective clothing Impervious to PCBs shall be worn. Gloves, boots, 
overshoes, and bib-type aprons that cover boot tops shall be provided when 
necessary. Protective apparel shall be made of materials which most 
effectively prevent ekln contact with PCBs where it is most likely to 
occur. Employers shall ensure that all personal protective clothing is 
inspected regularly for defects and that It is In a clean and satisfactory 
condition.
(b) Eye Protection
Chemical safety goggles, face shields (8-inch minimum) with goggles, 
or safety glasses with side shields shall be provided by employers and 
shall be worn during any operation In which PCBs are present. If liquid or
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solid PCBs contact the eyee( the eyes shall be Irrigated Immediately with 
large quantities of water and then examined by a physician or other
responsible medical personnel. (A drop of vegetable oil on the eye has 
been found to reduce the resultant irritation.) Eye protection shall be in 
accordance with 29 CFR 1910.133 and ANSI Z 87.1-1968.
(c) Respiratory Protection
(1) Engineering controls shall be used when needed to keep 
concentrations of airborne PCBs at or below the recommended TWA 
occupational exposure limit. The only conditions under which compliance 
with the permissible exposure limit may be achieved by the use of 
respirators are:
(A) During the time necessary to install or test the 
required engineering controls.
(B) For nonroutine maintenance or repair activities.
(C) During emergencies when concentrations of 
airborne PCBs may exceed the permissible limit.
(2) When the use of respirators Is permitted by paragraph 
c(l) of this section, respirators shall be selected and used in accordance 
with the following requirements:
(A) The employer shall establish and enforce a 
respiratory protection program meeting the requirements of 29 CFR 1910.134.
(B) The employer shall provide respirators In
accordance with Table 1-1 and shall ensure that employees properly uee the 
respirators provided. The respirators shall be those approved by NIOSH or
the Mining Enforcement and Safety Administration. The standard for
approval is specified in 30 CFR 11. The employer shall ensure that
7





Respirator Type Approved under 
Provisions of 30 CFR 11
Greater than 1.0 jig/cu m 
or Emergency (entry into 
area of unknown concentra­
tion)
(1) Self-contained breathing apparatus 
with full facepiece operated in 
pressure-demand or other positive 
pressure mode.
(2) Combination Type C supplied-air 
respirator with full facepiece 
operated in pressure-demand or other 
positive pressure mode and an 
auxiliary self-contained breathing 
apparatus operated in pressure demand 
or other positive pressure mode.
Section 5 - Informing Employees of Hazards from PCBs
(a) All new and present employees in any area in which PCBs are 
used shall be informed of the hazards, relevant symptoms, and effects of 
overexposure to PCBs, and the precautions to be observed for safe use and 
handling of these materials.
(b) All employees involved with the manufacture, use, transport, 
or storage of PCBs shall be informed that PCBs have been found to Induce 
tumors in experimental animals after repeated oral ingestion and that 
because of these findings it is concluded that PCBs are potential human 
carcinogens; employees shall also be informed that adverse reproductive
8
effects nay result from occupational exposure to PCBs.
(c) The employer shall Institute a continuing education program, 
conducted by Instructors qualified by experience or training, to ensure 
that all employees occupationally exposed to PCBs have current knowledge of 
job hazards, proper maintenance and cleanup methods, and proper use of 
protective clothing and equipment, including respirators. The instructions 
shall include a general description of the medical surveillance program and 
of the advantages to the employee of participation. Special attention 
shall be given to women in the workplace. They shall be made aware of the 
potential adverse effects of PCBs on the unborn child, and of the known 
transport of PCBs to breast milk. Elements of the program shall also 
Include:
Emergency procedures and drills;
Instruction In handling spills and leaks;
Decontamination procedures ;
Firefighting equipment location and use;
First-aid procedures, equipment location, and use;
Rescue procedures;
Confined space entry procedures;
Low warning (odor) properties of PCBs.
(d) The Information explaining the hazards of working with PCBs 
shall be kept on file and be readily accessible to workers at all places of 
employment where PCBs are manufactured, used, stored, or transported. 
Required information shall be recorded on the "Material Safety Data Sheet" 
shown in Appendix III, or similar form approved by the Occupational Safety 
and Health Administration, US Department of Labor.
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Section 6 - Work Practices and Engineering Controls
(a) Regulated Areas
Access to PCB work areas shall be regulated and limited to authorized 
persons. A dally roster shall be kept of persons entering such areas.
(b) Handling of PCBs and General Work Practices
(1) Operating Instructions shall be formulated and posted 
where PCBs are handled or used.
(2) Transportation and use of PCBs shall comply with all 
applicable local, state, and federal regulations.
(3) PCBs shall be stored in tightly closed containers in 
well-ventilated areas.
(4) When PCB storage containers are being moved, or when
they are not In use and are disconnected, valve protection covers shall be
In place. Containers shall be moved only with the proper equipment and
shall be secured to prevent dropping or loss of control during transport.
(5) Storage facilities shall be designed to contain spills
completely within surrounding dikes and to prevent contamination of
workroom air.
(6) Ventilation switches and emergency respiratory 
equipment shall be located outside storage areas In readily accessible 
locations which will remain minimally contaminated with PCBs in an 
emergency.
(7) Process valves and pumps shall be readily accessible 
and shall not be located in pits or congested areas.
(8) Containers and systems shall be handled and opened with 
care. Approved protective clothing as specified in Section 4 shall be worn
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by employees engaged In opening, connecting, and disconnecting PC6 
containers and systems. Adequate ventilation shall be provided to minimize 
exposures of such employees to airborne PCBs.
(9) PCB-operatlng and storage equipment and systems shall 
be Inspected dally for signs of leaks. All equipment, Including valves, 
fittings, and connections shall be checked for leaks Immediately after PCBs 
are Introduced therein.
(10) When a leak Is found, It shall be repaired or otherwise
corrected Immediately. Work shall resume normally only after necessary
repair or replacement has been completed, the area has been ventilated, and 
the concentration of PCBs has been determined by monitoring to be at or 
below the recommended TWA concentration limit.
(c) Control of Airborne PCBs
(1) Suitable engineering controls, designed to maintain
exposure to airborne 'PCBs at or below the limit prescribed in Section 1(a),
shall be used. Complete enclosure of processes is the recommended method 
for control of PCB exposure. Local exhaust ventilation may also be 
effective, used alone or in combination with process enclosure. When a 
local exhaust ventilation system is used, it shall be so designed and 
operated as to prevent accumulation or recirculation of airborne PCBs in 
the workplace environment and to effectively remove PCBs from the breathing 
zones of employees. Exhaust ventilation systems discharging to outside air 
must conform to applicable local, state, and federal regulations and must 
not constitute a hazard to employees or to the general population. Before 
maintenance work on control equipment begins, the generation of airborne 
PCBs shall be eliminated to the extent feasible.
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Enclosures, exhaust hoods, and ductwork shall be kept in good repair 
so that designed airflows are maintained. Airflow at each hood shall be 
measured at least semiannually and preferably monthly. Continuous airflow 
indicators are recommended, such as water or oil manometers properly 
mounted at the juncture of fume hood and duct throat (marked to indicate 
acceptable airflow). A log shall be kept showing design airflow and the 
results of semiannual airflow measurements.
(2) Forced-draft ventilation systems shall be equipped with 
remote manual controls and shall be designed to shut off automatically in 
the event of a fire in the PCB work area.
(d) Special Work Areas
(1) PCB Hazard Areas
A hazard area shall be considered as any space having physical 
characteristics and containing sources of PCBs, such as transformers, that 
could result in PCB concentrations in excess of the recommended airborne 
PCB exposure limit. Exits shall be plainly marked, conveniently located, 
and open outwardly into areas which will remain minimally contaminated in 
an emergency.
(2) Confined or Enclosed Spaces
Entry into confined or enclosed spaces, such as tanks, pits, 
process vessels, and tank cars where there is limited egress, shall be 
controlled by a permit system. Permits shall be signed by an authorized 
representative of the employer and shall certify that appropriate measures 
have been taken to prevent adverse effects on the worker's health as a 
result of his or her entry into such space.
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Confined or enclosed spaces which have contained PCBs shall be 
thoroughly ventilated to assure an adequate supply of oxygen, tested for 
PCBs and other contaminants, and inspected for compliance with these 
requirements prior to each entry. Adequate ventilation shall be maintained 
while workers are In such spaces. Leakage of PCBs into such confined or 
enclosed spaces while work is in progress shall be prevented by 
disconnecting and blanking the PCB supply lines. Each individual entering 
such confined or enclosed space shall be furnished with appropriate 
personal protective equipment and clothing and be connected by a lifeline 
harness to a standby worker stationed outside of the space. The standby 
worker shall also be equipped for entry with approved personal protective 
equipment and clothing and have contact with a third person. The standby 
person shall maintain communication (visual, voice, signal line, telephone, 
radio, or other suitable means) with the employee inside the confined or 
enclosed space.
(e) Emergency Procedures
For all PCB work areas where there is a potential for the occurrence 
of emergencies, employers shall take all necessary steps to ensure that 
employees are instructed in, and follow, the procedures specified below as 
well as any others appropriate to the specific operation or process.
(1) If PCBs leak or are spilled, the following steps shall
be taken:
(A) All nonessential personnel shall be evacuated 
from the leak or spill area.
(B) The area of the leak of spill shall be 
adequately ventilated to prevent the accumulation of vapors.
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(C) If the PCBs are in liquid form, they shall be 
collected for reclamation or sorbed in vermiculite, dry sand, earth, or 
similar nonreactive material.
(2) Personnel entering the spill or leak area shall be
furnished with appropriate personal protective equipment and clothing. All 
other personnel shall be prohibited from entering the area.
(3) Only personnel trained in the emergency procedures and 
protected against the attendant hazards shall shut off sources of PCBs, 
clean up spills, control and repair leaks, and fight fires, in areas where 
PCBs are used.
(4) All wastes and residues containing PCBs shall be 
collected in PCB-reslstant containers and appropriately disposed of 
(Federal Register 42:26563-77, May 24, 1977).
(5) Safety showers, eyewash fountains, and washroom
facilities shall be provided, maintained in working condition, and located
so as to be readily accessible to workers in all areas where the occurrence 
of skin or eye contact with PCBs is likely. If liquid or solid PCBs are 
splashed or spilled on an employee, contaminated clothing shall be removed 
promptly and the skin washed thoroughly with soap and water for at least 15 
minutes. Eyes shall be irrigated immediately with copious quantities of 
running water for at least 15 minutes if liquid or solid PCBs get into 
them. A drop of vegetable oil may be applied to the eye to relieve the 
Irritating effect of PCBs.
Section 7 - Sanitation Practices
(a) Employees occupationally exposed to PCBs shall be provided
14
with separate lockers or other storage facilities for street clothes and 
for work clothes.
(b) Employees occupationally exposed to PCBs shall not wear work
clothing away from their place of employment.
(c) Employees occupationally exposed to PCBs shall be provided
clean work clothing dally, and cleaning establishments shall be informed as 
to the hazards of handling PCBs and proper disposal procedures for PCB- 
contaminated waste water.
(d) Facilities for shower baths shall be provided for employees 
occupationally exposed to PCBs. Workers should shower before changing into 
street clothes.
(e) Employees exposed to PCBs shall be advised to wash their hands
and expoeed skin before eating, drinking, smoking or using toilet 
facilities during the work shift.
(f) Food, drink, or smoking materials shall not be permitted in 
areas where PCBs are handled, processed, or stored.
Section 8 - Monitoring and Recordkeeping Requirements
(a) Monitoring
(1) As soon as practicable after the promulgation of a 
standard based on these recommendations, each employer who manufactures, 
processes, handles, stores or otherwise uses PCBs shall determine by an 
Industrial hygiene survey whether occupational exposure to PCBs may occur. 
Surveys shall be repeated at least once every year and within 30 days of 
any process change likely to result in occupational exposure to PCBs. 
Records of these surveys, including the basis for any conclusion that there
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may be no occupational exposure to PCBs, shall be retained until the next 
survey has been completed.
(2) If occupational exposure to PCBs is determined to be 
possible, a program of personal monitoring shall be instituted to measure 
or permit calculation of the exposures of all employees.
(A) In all personal monitoring, samples 
representative of the employees' breathing zones shall be collected.
(B) For each TWA concentration determination, a 
sufficient number of samples shall be taken to characterize each employee's 
exposure during each work shift. Variations in work and production 
schedules and In employees' locations and job functions shall be considered 
in choosing sampling times, locations, and frequencies.
(C) Each operation in each work area shall be 
sampled at least once every 3 months.
(3) If an employee Is found to be exposed to PCBs in excess 
of the recommended TWA concentration limit, control measures shall be 
initiated, the employee shall be notified of the exposure and of the 
control measures being implemented to correct the situation, and the 
employee shall be monitored every 30 days. Such monitoring shall continue 
until two such consecutive determinations indicate that the employee's 
exposure no longer exceeds the recommended TWA concentration limit. 
Routine monitoring may then be resumed.
(b) Recordkeeping
Environmental monitoring records shall be maintained for at least 30 
years after the employee’s last occupational exposure to PCBs. These 
records shall Include the dates and times of measurements, job function and
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location of employees within the worksite, methods of sampling and analysis 
used, types of respiratory protection In use at the time of sampling, TWA 
concentrations found, and Identification of exposed employees. Each 
employee shall be able to obtain Information on his or her own 
environmental exposures. Dally rosters of authorized persons who enter 
regulated areas shall be retained for 30 years. Environmental monitoring 
records and entry rosters shall be made available to designated 
representatives of the Secretary of Labor and of the Secretary of Health, 
Education, and Welfare.
Pertinent medical records for each employee shall be retained for 30 
years after the employee's last occupational exposure to PCBs. Records of 
environmental exposures applicable to an employee should be Included In 
that employee'8 medical records. These medical records shall be made 
available to the designated medical representatives of the Secretary of 
Labor, of the Secretary of Health, Education, and Welfare, of the employer, 
and of the employee or former employee.
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PUBLIC LAW 94-469—OCT. 11, 1976 90 STAT. 2025
( e )  P o l y c h l o r i n a t e d  B i p h e n y l s . — ( 1 )  W ithin six months after 
t h e  effective date of this Act the Administrator shall promulgate 
r u l e s  to—(A ) prescribe methods for the disposal of polychlorinated biphenyls, and(B ) require polychlorinated biphenyls to be marked with clear ana adequate warnings, and instructions with respect to their processing, distribution in commerce, use, or disposal or with 
respect to any combination of such activities.Requirements prescribed by rules under this paragraph shall be con­sistent with the requirements o f paragraphs (2) and (3).(2) (A ) Except as provided under subparagraph (B ), effective one year after the effective date of this Act no person may manufacture, process, or distribute in commerce or use any polychlorinated biphenyl 
in any manner other than in a totally enclosed manner.(B ) The Administrator may by rule authorize the manufacture, processing, distribution in commerce or use (or any combination of such activities) o f any polycldorinated biphenyl in a manner other than 
in a totally enclosed manner i f  the Administrator finds that such manu­facture, processing, distribution in commerce, or Use (or combination of such activities) will not present an unreasonable risk of injury to 
health or the environment.(C) For the purposes of this paragraph, the term “totally enclosed manner'’ means any manner which will ensure that any exposure of 
human beings or the environment to a polychlorinated biphenyl will be insignificant as determined by the Administrator by rule.(3) (A ) Except as provided in subparagraphs (B ) and (C) —(i) no person may manufacture any polychlorinated biphenyl 
after two years after the effective date o f this Act, and(ii)  no person may process or distribute in commerce any poly­chlorinated biphenyl after two and one-half years after such date.(B ) Any person may petition the Administrator for an exemption from the requirements of subparagraph (A ), and the Administrator may grant by rule such an exemption if  the Administrator finds that— (i) an unreasonable risk o f injury to health or environment would not result, and(ii)  good faith efforts have been made to develop a chemical substance which does not present an unreasonable risk of injury to health or the environment and which may be substituted for such polychlorinated biphenyl.An exemption granted under this subparagraph shall be subject to such terms and conditions as the Administrator may prescribe and shall be in effect for such period (but not more than one year from  the date it is granted) as the Administrator may prescribe.(C) Subparagraph (A ) shall not apply to the distribution in com­merce o f any polychlorinated biphenyl if  such polychlorinated biphenyl was sold for purposes other than resale before two and one half years after the date o f enactment o f this Act.(4) Any rule under paragraph (1 ), ( 2 ) ( B ) ,  or (3 )(B )  shall be promulgated in accordance with paragraphs (2 ), (3 ), and (4) of sub­
section (c).(5) This subsection does not limit the authority of the Adminis­trator, under any other provision of this Act or any other Federal law, 








FIGURE 1-1. SECTION 6(e) OF THE TOXIC SUBSTANCES CONTROL ACT
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II. INTRODUCTION
This report presents the criteria and the recommended standard based 
thereon which were prepared to meet the need for preventing occupational
disease and injury arising from workplace exposure to PCBs. The criteria
document fulfills the responsibility of the Secretary of Health, Education, 
and Welfare, under Section 20(a)(3) of the Occupational Safety and Health 
Act of 1970, to "...develop criteria dealing with toxic materials and 
harmful physical agents and substances which will describe...exposure 
levels' at which no employee will suffer Impaired health or functional 
capacities or diminished life expectancy as a result of his work 
experience."
The National Institute for Occupational Safety and Health (NIOSH), 
after a review of data’and consultations with others, formalized a system 
for the development of criteria upon which standards can be established to 
protect the health and to provide for the safety of employees exposed to 
hazardous chemical and physical agents. Criteria and recommended standards 
should enable management and labor to develop better engineering controls 
resulting in more healthful work environments. Mere compliance with the 
recommended standard should not be used as a final goal.
These criteria for a standard for PCBs are part of a continuing
series of criteria developed by NIOSH. The recommended standard applies to 
the processing, manufacture, and handling of PCBs as applicable under the 
Occupational Safety and Health Act of 1970. The standard was not designed 
for the population-at-large, and any application to situations other than 
occupational exposures is not warranted. It is intended to (1) protect
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against acute and chronic PCB poisoning, (2) be measurable by techniques 
that are available to industry and official agencies, and (3) be attainable 
with existing technology.
The standard is designed to substantially reduce the risk of 
development of carcinogenic, adverse reproductive, hepatotoxic, and 
dermatologic effects. Since 1970, PCBs have been one of the more 
thoroughly investigated environmental and occupational hazards. 
Nevertheless, there are important gaps in the knowledge of chronic exposure 
effects In man at low concentrations of PCBs. Important research needs 
Include studies on the reproductive histories of women who have been 
exposed to PCBs, and quantitation of the dermal and respiratory absorption 
of different mixtures of PCBs. A better understanding Is needed of the 
contaminants in commercial PCB preparations, particularly studies to 
determine the extent to which any chlorinated dibenzofurans in tissues of 
PCB-exposed American workers result from direct absorption or are derived 
from PCBs in the body. Another need is for an assessment of the hazards 
associated with the mobilization, during fasting or in other abnormal 
physiologic states, of PCBs stored in the body.
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III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure
Biphenyl (C 12H 10), diagrammed In Figure III-l, can be chlorinated 
by replacing any or all of Its hydrogen atoms with chlorine [1],
3 2 6' 5'
5 2' 3'
Figure III-l. BIPHENYL MOLECULE AND RING NUMBERING SYSTEM
Specific chloroblphenyl molecules are designated by reference to the 
positions of the chlorine atoms according to the numbering scheme depicted 
in Figure III-l. The lowest possible numbers are assigned, and the phenyl 
moiety with the fewest chlorine atoms is assigned prime numbers [1,2]. 
Examples of the nomenclature used here are shown In Figure IÏI-2.
C1 C1 C1
3-chloroblphenyl 2,2',3,41,5-pentachlorobipheny1
Figure III-2. EXAMPLES OF NOMENCLATURE SYSTEM OF CHLOROBIPHENYL COMPOUNDS
There are three monochloroblphenyl compounds, 2-, 3-, and 4-
chlorobiphenyl. The 5- and 6-monochloroblphenyls are identical to 3- and 
2-monochlorobiphenyl, respectively.^ There are 18 dlchloroblphenyl
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compounds. The number of possible chloroblphenyl Isomers and the 
corresponding welght-percents of chlorine are presented In Table III-l.
TABLE III-1
NUMBER OF ISOMERS AND PERCENT CHLORINE 







mono C 12H9C1 3 18.79
dl C 12H8C1 2 12 31.77
tri C 12H7C1 3 24 41.30
tetra C 12H6C1 4 42 48.56
penta C 12H5C1 5 46 54.30
hexa C 12H4C1 6 42 58.93
hepta C 12H3C1 7 24 62.77
octa C 12H2C1 8 12 65.98
nona C 12HC1 9 3 68.73
deca C 10C1 10 1 71.18
Adapted from reference 1
In the commercial synthesis of chloroblphenyls, biphenyl Is 
catalytlcally chlorinated with anhydrous chlorine; either Iron filings or 
ferric chloride may be used as the catalyst [1]. The commercial 
preparations, commonly referred to as "PCBs," are Isomeric mixtures. The 
weight-percent chlorine In commercial mixtures has generally varied between 
21 and 68% and has been used to designate grades of commercial products. 
Commercial PCB products manufactured In the US, Great Britain, and Japan 
have been marketed under the trade name "Aroclor" [1-3]. Several grades of 
Aroclor have been designated by numbers such as 1221, 1242, 1254, and 1260, 
where the last two digits represent the percent by weight of chlorine In
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the mixtures. Another grade of Aroclor, 1016, made primarily of tri- and 
tetrachlorobiphenyl compounds and containing 41% chlorine by weight, was 
introduced in 1971 to replace Aroclor 1242 [2,4,5], Other PCB products 
manufactured in Japan were marketed as "Santotherm" [1], and "Kanechlors" 
300, 400, 500, and 600, containing approximately 42%, 48%, 54%, and 60%
chlorine, respectively [6], In Germany, products marketed as "Clophens" 
A50 and A60 contained 54 and 60% chlorine, respectively [7], In France, 
PCBs were marketed as "Phenoclors" and "Pyralenes;" Phenoclor DP6 contains 
60% chlorine [8]. Other countries reported to have produced PCBs are 
Italy, Spain, Czechoslovakia, Poland, Argentina, Brazil, the USSR, and 
India [1,9,10],
The chlorobiphenyl constituents of several commercial PCB products 
have been studied [6-8,11-16], Some data, both qualitative and 
quantitative, are presented in Table XII-2. About half the 209 possible 
chlorobiphenyls do not occur in any of the commercial preparations. Among 
those compounds which do not occur, or which occur in trace amounts only, 
are 3-chloroblphenyl, all of the tri- to pentachloro compounds that are 
chlorinated In only one ring, the penta-, hexa-, and heptachloro compounds 
that are completely chlorinated in one ring, and the penta- and hexachloro 
compounds that are chlorinated In four positions in one ring.
Commercial PCBs are Insoluble in water, but are soluble In oil and 
many organic solvents. Some other physical and chemical properties of 
certain Aroclor products are presented in Table XII-1 [1],
In addition to chlorinated biphenyls, the commercial mixtures with 
20-40% chlorine contained biphenyl from about 11% to traces, respectively, 
by weight. Many commercial PCB products also contain chlorinated
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dibenzofurans [17-23] and naphthalenes [18,19]. Concentrations of 
chlorinated dibenzofurans In various commercial PCB products are presented 
In Table III-2.
TABLE III-2
CHLORODIBENZOFURAN TYPES AND CONCENTRATIONS Gig/g) 
IN COMMERICAL PCB PREPARATIONS
Mixture* di tri
Chlorodibenzofurans 
tetra penta hexa hepta Total Ref.
(1) 1016 0.5 0.5 **
(1) 1016 <0.001 <0.001 <0.001 21
(1) 1248 0.5 1.2 0.3 2.0 21
(1) 1254 0.1 0.2 1.4 1.7 21
(1) 1254 0.2 0.4 0.9 1.5 21
(1) 1260 0.1 0.4 0.5 1.0 21
(1) 1260 0.2 0.3 0.3 0.8 21
(2) A-60 1.4 5.0 2.2 8.4 21
(3) DP-6 0.7 10.0 2.9 13.6 21
(4) K300 (a) (a) 1-1.5 20
(4) K400 (c)*** (e) (e) (c) 17-18 20
(4) K500 (a) (c) (a) 2.5-4 20
(4) K600 (a) (a) (b) (b) 3-5 20
*(1) Aroclor, (2) Clophen, (3) Phenoclor, (4) Kanechlor
**(I Pomerantz, written communication, January 1977)
*** (a), (b), (c), (d), (e) represent relative amounts In Increasing order
Some commercial preparations that were marketed under the trade name 
Aroclor contained chlorinated terphenyls In addition to chlorinated 
biphenyls. Aroclors 2565 and 4465 contained 75% and 60% chlorinated 
biphenyl compounds and 25% and 40% chlorinated terphenyl compounds, 
respectively. Both mixtures contained 65% chlorine [1].
A broad class of nonflammable synthetic chlorinated hydrocarbon 
Insulating liquids used In electrical capacitors, transformers, nuclear
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reactors, and accessory equipment is designated by the generic tern 
"askarel" [4,5,24,25]. PCBs have been najor components of most askarels 
used in the US since 1932. Two general classes of PCB-containing askarels 
are "capacitor"-grade and "transformer"-grade [4,5], Aroclor 1242 was the 
major capacitor imprégnant In the US before 1971; subsequently, Aroclor 
1016 has been used mainly for this purpose [4]. Transformer-grade askarels 
manufactured in the US Include those marketed under trade names including 
"Asbestol," "Chlorextol," "Inerteen," "No-Flamol," "Pyranol," and "Saf-T- 
Kuhl" [4]. Transformer-grade askarels are usually mixtures of 
trichlorobenzene and more highly chlorinated (42-60%) biphenyls [5,24], 
Some typical compositions are: 100% Aroclor 1242; 70% Aroclor 1254 and 30% 
trichlorobenzene; 60% hexachloroblphenyl and 40% trichlorobenzene; 45% 
hexachloroblphenyl and 55% trichlorobenzene; and 70% pentachloroblphenyl 
and 30% trichlorobenzene. Another type of transformer-grade askarel 
contains 45% polychlorinated biphenyl (54% chlorine) and 55% of a mixture 
of trl- and tetrachlorobenzenes. Transformer-grade askarels also contain 
stabilizers such as glycidyl phenyl ether and 3,4-epoxycyclohexylmethyl-3,
4-epoxycyclohexane carboxylate [24],
Exposure to conmerclal preparations of PCBs in the work environment 
may Involve many different chlorinated biphenyl compounds, and also 
substantial âmounts of biphenyl, tri- and tetrachlorobenzenes, and small 
amounts of many different chlorinated dibenzofurans, chlorinated 
naphthalenes and in special uses, chlorinated terphenyls.
Commercial production of PCBs in the US began in 1929 and reached 85 
million pounds in 1970 when the major producer began selling PCBs only for 
use in "closed" systems. Since 1972, only those Aroclors designated 1016,
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1221, 1242, and 1254 have been produced in the US, and total annual 
production has been around 40 million pounds [26],
Imported PCBs amounted to about a half-million pounds in 1972 and 
1973 [26,27], A decachlorobiphenyl produced in Italy and imported by one 
company for use in investment casting waxes accounted for 80-90% of the 
total PCB imports [26], The other 10-20% was imported from France for use 
in semiclosed heat transfer applications [27], Occupational exposure to 
decachlorobiphenyl could occur in the manufacture of the Investment casting 
waxes as well as in the preparation of the investment casting molds in the 
25 US foundries which use the decachlorobiphenyl wax [26],
Most of the PCBs produced in the US since 1971 have been used In 
electrical capacitors (70%) and transformers (30%). About 95% of the 100 
million capacitors produced annually in the US contain PCBs [27], There is 
potential occupational exposure to PCBs in the plants of the 17 reported 
companies that manufacture capacitors in the US. Capacitors are generally 
classified into two categories for disposal purposes. "Small" capacitors 
contain less than 2 pounds of PCBs; those Incorporated into electrical 
equipment such as television sets, home air conditioners, and light 
fixtures contain 2-340 ml of PCBs and have service lives of at least 10 
years [26,28], "Large" capacitors may contain about 25 liters of PCBs [26] 
and have a' service life of 15-20 years [26,27], Potential occupational 
exposures exist in the servicing of appliances and in the disposal of used 
capacitors or equipment.
Transformers that contain PCBs are used mainly in or near inhabited 
buildings where fire hazards from cheaper oil-filled transformers are 
greatest. The estimated 135,000 PCB-containing transformers represent
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about 5X of all- transformers in the US [27]. Occupational exposure to 
various askarels used for transformers may occur in their manufacture, 
servicing, and transportation, or as a result of leaks [29].
Other potential occupational exposures to PCBs exist through losses 
in storage [30], shipment [29], manufacture and use of heat exchange units
[27.31], and in use of previously manufactured items which contain PCBs, 
such as hydraulic systems, vacuum pumps, and gas transmission turbines
[30.31]. The past use of PCBs In carbonless copying papers may result in 
exposure of workers currently engaged in paper reclamation [30]. Workers 
in plants that previously used PCBs may have current exposure in their 
working environments because PCBs have been shown to remain In the 
workplace air and on surfaces for years after PCB use has been discontinued 
[32,33]. Several occupations that may have involved exposure to PCBs were 
tabulated in a 1966 publication [34]. NIOSH estimates that 12,000 workers 
have potential occupational exposure as a result of current uses of PCBs in 
their working environments [35].
In addition to their occupational exposures, PCB workers may be 
exposed to PCBs carried into their homes from the workplace [36], from 
general contamination of the ambient air [26,37,38] and water [26,37], and 
to PCBs and their metabolites in their diets [39-46].
Metabolism and Mechanism of Action
A study of the metabolism of 4-chlorobiphenyl was reported in 1959 by 
Block and Cornish [47]. In this experiment, 1 gram of 4-chlorobiphenyl was 
fed to rabbits in a single dose and 4*-chloro-4-biphenylol and Its
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glucuroniside wete recovered from the urine in amounts that accounted for 
24 and 50%, respectively, of the administered dose.
Subsequently, a substantial number of metabolic studies of Individual 
chlorobiphenyl compounds [41-43,48-84], mixtures [85,86], and metabolites 
[48,49,87] were reported, and a comprehensive review was published in 1976 
[88]. These reports collectively demonstrate through many study methods 
that some aspects of metabolism are of special significance to the toxicity 
of PCBs and that some Isomers are more toxic, or have different effects, 
than others [89-94].
Chlorinated biphenyl compounds are readily absorbed from the
digestive tract, regardless of the degree or pattern of chlorine
substitution [50,51,95,96]. It seems likely that similar absorptive
characteristics apply to the respiratory system since chlorobiphenyl 
mixtures in air are rapidly absorbed [97], as is decachloroblphenyl 
[98,99]. Varying amounts of chloroblphenyls, depending on degree and
pattern of chlorination, are excreted in the feces [42,50,53-56,100], milk 
[41-44,51,101], and hair [102] of animals, but no more than trace amounts 
are excreted in the urine [42,51-55,57-62,103-105].
Metabolites of chlorobiphenyl compounds have been found in the urine 
of mammals including mice [52], rats [48,53-56,58-60,63,64,66,71,85], 
rabbits [65,67-69], monkeys [51,61,74,75], swine [72], goats [73], and cows 
[41,73], as well as in feces [48,50-54,56,58-65,76-80], and milk [41]. The 
metabolites excreted in urine [53,54,58,59,61,63,64,66,67], bile
[50,51,53,81], feces [52—54,58,63,76], and milk [41] are, to varying 
degrees, conjugated with glucuronic or sulfuric acids. Differences in 
metabolism of PCBs among the aforementioned species are more quantitative
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than qualitative [51,73]; however, metabolism in birds and fish may differ 
qualitatively from that in mammals [55,77]. Among mammals there are also 
quantitative differences in PCB metabolism and in effects related to age 
and sex [50,93,106]. Metabolites identified in mammals include mono- to 
polyhydroxylated derivatives [41,48,49,51-56,58-81,85], and methoxy
[59,60], hydroxymethoxy [64,65,68,70,76,87], dihydrodihydroxy
[51,53,54,69,74,75,81], hydroxydihydrodihydroxy [51,74], and dechlorinated 
derivatives [48,65,70,77].
The lower-chlorinated biphenyl compounds are more readily metabolized 
than are the more highly chlorinated ones [41,50,51,55,61-64,66,82- 
84,96,107-109], with no metabolism having been demonstrated for 
decachloroblphenyl [66]. As a consequence, some of the more highly 
chlorinated compounds persist in the tissues for years after intake has
been discontinued [51,83,103,110].
The presence of at least two adjacent, unsubstituted hydrogen atoms, 
particularly In positions 3, 4, and 5, or 3’, 4', and 5', is required for 
rapid metabolism of chlorobiphenyls [79,83,84]. All mono- dl-, and 
trlchloroblphenyls, and all tetrachlorobiphenyls except 3,3',5,5'-
tetrachloroblphenyl meet this requirement. The latter compound, 3,3',5,5’- 
tetrachloroblphenyl, was found to be particularly toxic to monkeys, and It 
was suggested that the chlorinated dibenzofuran derivative may have been 
involved [94]. While dibenzofuran derivatives have not been demonstrated 
to exist as mammalian metabolites, they may have been identified as PCB 
metabolites in chickens [111] and Curley et al [22] reported the excretion 
of dlbenzofurans In urine of rats. In the latter case, however, 
dibenzofurans were also identified In the administered PCB [22].
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Dibenzofurans are of concern because they may be many times more toxic than 
PCBs [19,112].
Metabolites found in urine [48,51,53,56,60,61,64,66-74,85], bile 
[81], feces [51-53,56,58,60,61,64,66,76,79,80,113], and milk [41] include 
hydroxy derivatives. Such compounds have been demonstrated to be more 
toxic than their respective parent chlorobiphenyl [41,114] and their 
presence in milk [41] is of special concern.
Hydroxylation may be direct through hydroxylating enzyme systems, or 
through formation of arene oxide intermediates [48,51,53,68,75,81,87,115]. 
This latter process is of particular concern because of potential
carcinogenesis and mutagenesis as a result of covalent binding of arene
oxides to nuclear components of the cell [51,68,74,82,86,116]. Such 
binding has been demonstrated both in vivo [51,86] and in vitro
[51,82,86,116,117]. Additional evidence of hydroxylation through arene
oxide intermediates included findings of metabolites in which chlorine, 
dueterium, or tritium were at different molecular locations than In the 
administered compound [68,115,116,118], and transdlhydrodiols as mammalian 
metabolites [51,69,74,75,81].
Although adjacent unsubstituted hydrogen atoms are necessary for 
rapid metabolism of chlorinated biphenyls, It has been demonstrated that 
2,2',4,4',5,5'-hexachloroblphenyl, which does not have this characteristic, 
can be hydroxylated [70,79], and oxidatively dechlorinated [65,70]. It has 
been proposed that the metabolism of this compound may also Involve arene 
oxide formation [65], and chronic exposure to potential carcinogenic 
activity of resulting arene oxides [86] may result from the metabolism of 
thle and similar compounds [75].
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Historical Reports
Smyth [119], in a paper read October 28, 1930, presented the results 
of his studies with biphenyl, 2- and 4-chlorobiphenyl, and two unidentified 
polychlorobiphenyl mixtures. He reported the oral minimum lethal doses for 
rabbits and guinea pigs as 4+, 2.5, 3.5, 4+, and 4+ g/kg, respectively.
Health problems associated with the manufacture of PCBs were the 
subject of a report by Jones and Alden [120] In 1936. The case history was 
presented of a man whose employment, from April 1930 to the end of 1933, 
involved the distillation of chlorobiphenyl. In May 1933 he developed 
chloracne, a specific type of acne known to be caused by some chlorinated 
hydrocarbon compounds [121,122]. Jones and Alden [120] stated that the 
manufacturing process was not enclosed, that a different source of benzene 
(a starting ingredient) had been used from the summer of 1932 through 
October 1933, and that from March to October 1933, the dielectric qualities 
of the PCBs produced had been substandard. Of 2A men working in the 
manufacturing process during the period beginning in the summer of 1932, 23 
developed chloracne. The first indication of chloracne in the workers 
appeared in January 1933. Following another change in the source of 
benzene, enclosure of the distillation apparatus and installation of 
ventilation fans, a gradual Improvement in the acnelform eruptions was 
noted.
In 1936, Schwartz [123] reported digestive disturbances, burning of 
the eyes, and impotence in men working with chloroblphenyls. He also noted 
that nonachlorobiphenyl was used as an Insulator for automobile electric 
wires. In capacitors, and as a delusterer of rayon.
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An early use of PCBs was for incorporation along with 
chloronaphthalenes into synthetic waxes [124-128], These waxes contained 
10-20% PCBs [124-126] and were used to insulate electrical wire and cable. 
There were several reports that chloracne [125-128] developed in workers 
Involved in the manufacture and use of these waxes * which were associated 
with at least one fatality in 1936 [125,127],
The fatal case was described by Drinker et al [125] in 1937, The 
patient, who had been exposed to low concentrations of tetra- and 
pentachloronaphthalenes (90%) and chlorinated biphenyls (10%) developed 
chloracne, followed by jaundice. He was hospitalized with abdominal pain 
and distention. At autopsy, cirrhosis of the liver with superimposed acute 
yellow atrophy was found. Two other fatal cases were described where the 
exposures had been to mixtures of penta- and hexachloronaphthalenes [125], 
According to the authors, no similar cases had been reported in the 
literature. As a result of these fatalities, estimates of the airborne 
concentrations of chlorinated hydrocarbons in 30 different factories were 
made and animal experiments were performed to study the effects of exposure 
at such concentrations.
Rats were exposed 16 hours/day, 6 days/week to trichloronaphthalenes 
at 1.31 mg/cu m, to a mixture of penta- and hexachloronaphthalenes at 1.16 
mg/cu m, to a mixture of penta- and hexachloronaphthalenes (90%) and 
chlorinated biphenyls (10%) at 1.37. mg/cu m, and to a chlorinated biphenyl 
mixture containing 64% chlorine at 0.57 mg/cu m. The authors [125] stated 
that higher concentrations had frequently been found In the factories, and 
that except for trichloronaphthalenes, they did not consider that It would 
be safe to expose workers to any of the mixtures at the concentrations
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studied [125]. Further details of the animal experiment were reported by 
Bennett et al [129] In 1938. These Investigators [129] found morphologic 
changes In the livers of two groups of rats exposed at the 0.57-mg/cu m 
concentration and also at 0.93 mg/cu m for 8 hours/day. These animal 
experiments reported by Drinker et al [125] and by Bennett et al [129] have 
continued to be erroneously cited [130,131] even though Drinker [132] 
reported In 1939 that the "chlorinated biphenyl" was actually a mixture of 
chlorinated biphenyls and chlorinated terphenyls. Drinker [132] stated 
that a followup inhalation experiment with chlorinated biphenyls containing 
68% chlorine showed them to be of low toxicity and he recommended
permissible limits for workroom air of 0.5 mg/cu m for mixtures of
chlorinated biphenyls and terphenyls and 10 mg/cu m for chlorinated
biphenyls.
The first indication in the literature that PCBs might be embryotoxic 
or have teratogenic effects was the report by McLaughlin et al [133] in 
1963, 5 years prior to the recognition of PCBs as an environmental
pollutant. The authors evaluated the toxicity of Aroclor 1242 by injecting 
it into the yolk sac of fertilized eggs prior to incubation, and then 
observing the effects on embryonic development. None of the eggs hatched 
after injection with 25 mg of PCBs/egg; with injection of 10 mg/egg, one 
chick hatched'out of 20 injected eggs, but it died 2 days later. Some of 
the embryos examined showed beak deformities, edema, and retarded growth.
Effects on Humans
(a) Effects from General Environmental Contamination
In the United States, PCBs are present in ambient air [26,37,38],
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water [26,37], and in many foods [39,45,46], A common dietary intake of 
10-20 /xg/day has been estimated for teenage males in the US [46]. PCBs 
frequently have been found in various tissues and body fluids of the US 
population, eg, at ppm concentrations In adipose tissue [7,36,134-136], ppb 
concentrations in blood [137,138,140,141], and in milk [143,144] at ppm or 
ppb concentrations in the milk fat or whole milk, respectively.
The Environmental Protection Agency's Human Monitoring Survey has 
analyzed human adipose tissue samples collected since late 1968 for PCB 
content [134], According to this 1972 report, 637 samples had been 
analyzed, and 198 of these contained more than 1 ppm of PCBs. Positive 
findings were made in tissues from each of the 18 participating states.
A detailed analysis of two samples collected in the Human Monitoring 
Survey was made by gas-liquid chromatography (GLC) and mass spectrometry 
(MS) and reported by Biros et al [135] In 1970. The samples contained at 
least 14 isomers ranging from penta- to decachlorobiphenyls. Price and 
Welch [36] stated that of more than 4,000 human adipose tissue samples 
examined by the Michigan State Department of Health Pesticides, none had 
chromatograms that exactly matched those of standard Aroclor solutions. 
Their data show relative accumulation In adipose tissue of the more highly 
chlorinated compounds, and relative dilution or absence of the less highly 
chlorinated compounds originally present in Aroclors 1254 and 1260. They 
[36] described the analyses of tissue samples at autopsy of a 77-year-old 
man in which PCB concentrations of 100-250 ppm (fat basis) were found The 
highest PCB concentration was in the liver. The authors [36] found about 
55% of adipose tissue samples in the general population contained PCBs at 
<1.0 ppm, about 36% at 1-2 ppm, and the remainder at more than 2 ppm.
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During July 1972 through June 1974, 2,324 fat samples were analyzed 
by the Human Monitoring Survey, 1,277 In the first year and 1,047 In the 
second [136]. In the 2 years, respectively, PCBs were not detected In 24.5 
and 9.1%, were present at <1 ppm In 40.2 and 50.6%, were present at >2 ppm 
In 5.5 and 4.9%, and were present at 1-2 ppm In the remainder of the 
samples. Penta-, hexa-, and heptachloroblphenyl were the PCBs most 
frequently present.
A complete analysis of PCB compounds In a composite sample of adipose 
tissues from patients at the University Hospital In Lund, Sweden, was 
reported by Jensen and Sundstrom [7] In 1974. Forty-five compounds, 
accounting for the total PCB content of the adipose tissues, were found and 
Identified by comparison with known PCB Isomers. The biphenyl compounds 
Included three tetrachloro Isomers, many penta-, hexa-, hepta-, octa-, and 
nonachloro Isomers, and decachloroblphenyl. By comparison with Clophens 
A50 and A60, which had compositions similar to Aroclors 1254 and 1260, 
respectively, the authors [7] found the relative concentration of several 
compounds with chlorine substitution In the 4,4' positions of the biphenyl 
ring to have occurred, as did many compounds without vicinal, unsubstituted 
positions. Most of the compounds which underwent relative dilution to the 
greatest extent had either vicinal, unsubstituted 3,4-positions or two 
pairs of vicinal, unsubstituted positions.
Blood sera of 616 residents of urban and rural areas of South 
Carolina were analyzed for PCBs and the results were presented by Flnklea 
et al [137] in 1972. Analysis was accomplished by GLC with a Ni-63 
electron capture detector after basic dehydrochlorlnatlon. The amounts of 
PCBs present were estimated by Integration of five peak areas associated
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with Aroclors 1254-and 1260. PCBs were not present In samples from all 
Individuals In quantities measurable by the technique used (Table III-3). 
Analysis of the data Indicated-that measurable serum PCB concentrations 
were not related to the age «5 to >60 years) or sex (305 females, 311 
males) of the donor, but that the concentrations associated with race and 
residence (Table III-3) were statistically different.
TABLE II1-3
PCB CONCENTRATIONS IN BLOOD SERUM BY RACE AND RESIDENCE 
Race and No. In PCBs Measureable In PCB Concentrations




Rural black 107 5 4,67 9.45 20.6
Urban black 151 57 37.75 5.22 29.0
Rural white 192 119 61.98 5.12 16.6
Urban white 166 89 53.61 4.38 22.0
¿Average of measureable concentrations 
Adapted from reference 137
Maternal and cord blood samples collected In Tokyo, Japan from 
December 1973 through February 1974 were reported in 1975 by Akiyama et al 
[138] to contain PCBs at mean concentrations of 2.8 and 1.1 ppb, 
respectively (on a whole blood basis). The maximum concentrations found 
were 7.6 ppb in maternal blood and 3.3 ppb in cord blood. Quantitatively, 
significant correlations of PCB concentrations In 21 pairs of maternal and 
cord blood samples were not found. Qualitatively, pairs of maternal and 
cord bloods had identical PCB patterns resembling those of Kanechlors 500
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and 600. The data suggested nonselective In utero transfer of PCB 
compounds from mother to fetus. Concentrations of PCBs in human embryonic 
and fetal tissues were reported by Shiota et al [139] in 1973 to not exceed 
those found in postnatal individuals who died accidentally. The 
concentrations, found in 19 embryos 5-8 weeks old, were reported as <2 ppb. 
The concentrations found in 5 second trimester and 2 third trimester 
fetuses are presented In Table III-4, expressed on the bases of both whole 
tissue and on the fat content of the tissue.
TABLE III-4
CONCENTRATIONS (ppb) OF PCBs IN TISSUES OF HUMAN FETUSES





2nd trimester Whole 2-23 2-33 6-20 17-83
Fat 150-60 230-800 60-1,900 550-1,300
3rd trimester Whole 2* 25-90 6-10 48-769
Fat 270* 1,000-1,30C1 420-470 880-1,400
*0ne sample
Adapted from reference 139
PCB concentrations In the venous blood of nine patients hospitalized 
with severe wasting diseases were reported by Hesselberg and Scherr [140] 
in 1974. The Investigators were concerned with the release of stored 
organo-hallde pesticides and PCBs during mobilization of body fat. They 
were unable to detect any PCBs in the blood of 15 apparently healthy
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control subjects. PCB concentrations found In the patients' blood 
(uncorrected for efficiency of recovery) ranged from 10 to 100 ppb. 
Information was not presented on the patients' occupations etc prior to 
their having become 111.
PCB concentrations In blood plasma and In adipose tissue samples 
obtained from 28 people during routine abdominal sections had a correlation 
coefficient of 0.74 according to Inoue et al [141]. The average 
concentration of PCBs was 6.1±3.52 ppb In blood plasma, and In the adipose 
tissue (fat basis) It was 2.6±1.9 ppm. These Investigators [141] also 
evaluated the effect of emaciation on PCB concentrations In blood plasma of 
these and other patients; they found an average of 8.414.26 ppb In 19 
emaciated patients and 4.7±2.17 ppb In 30 unemaclated patients.
Hair samples collected from a college barber shop were reported by 
Matthews et al [102] In 1976 to contain PCBs at 0.34-0.76 ppm. The samples 
were composites from five or more Individuals collected on two occasions, 4 
months apart. Hair was collected from the barber shop aprons, and care was 
taken to avoid possible contamination. Five commercial preparations of
hair sprays, shampoos, and hair clipper lubricating oil were negative for 
PCBs. Blood samples were not collected for comparison.
PCBs were reported In 1966 to have been found In hair samples from
three members of a Swedish family [142], but no concentration data were
given. It was speculated that one of the family members, a 5-year-old 
girl, had acquired PCBs from her mother's milk.
A correlation was found between the quantities and compositions of 
PCBs In samples of adipose tissue collected from four women during 
Caesarean deliveries and in milk samples collected 3-5 days later [143].
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There were differences in chromatographic patterns between individuals, but 
for each individual the chromatographic patterns for the adipose tissue and 
the milk were qualitatively the same. PCBs in all samples contained 
principally 4-8 chlorine substitutions. Although the basis (fat or whole 
milk) for expressing the concentration of PCBs in the milk was not stated, 
comparisons with PCB concentrations found in adipose tissue and milk by 
other Investigators indicate that the whole milk basis was used [136,144] 
(EP Savage, written communication, February 1977). Concentration data are 
summarized in Table III-5.
TABLE III-5










Adapted fron reference 143
Concentrations of PCBs measured in milk samples from 39 women living 
in two small cities in Colorado were presented by Savage et al [144] in 
1973. Two samples contained PCBs at concentrations of 0.05 and 0.1 ppm. 
Six other samples contained PCBs at 0.04 ppm, the lower limit of detection 
for the analytical method, or less. The time postpartum at which the 
samples were collected and the basis (fat or whole milk) for expressing the 
concentrations were not mentioned. (Comparison with data in the following
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paragraph suggests that the whole milk basis was used.)
Results of analyses of 384 human milk samples from 40 states for PCBs 
were presented In a written communication by EP Savage in February 1977. 
All positive samples that contained PCBs at less than 50 ppb on a whole 
milk basis were recorded as a "trace." Samples with 50 ppb or more of PCBs 
were reported as ppm In milk fat on the basis of 2.8% milk fat. Only five
samples were not positive for PCBs, and 112 samples from 27 states
contained measurable amounts (up to 12.6 ppm on a fat basis). Of the total 
number of samples, 141 were analyzed during December 1976 and January 1977. 
The time postpartum when the samples were collected was not stated.
While no adverse effects have been associated with PCBs at the
concentrations found in adipose tissue, blood, or milk of individuals whose 
only known exposures were from general environmental contamination
[7,36,102,136-144], knowledge of these concentrations is important to the 
evaluation of reports on occupational exposures. That is, the data provide 
a basis for evaluating body burdens of PCBs added by occupational exposure 
and Indicate that workers may have substantial body burdens before the 
added Insult of occupational exposure.
(b) Effects from Consuming PCB Contaminated Rice Bran Oil
An episode of poisoning associated with PCB Ingestion occurred in 
Japan in 1968, and was the subject of a special issue of the journal 
Fukuoka Acta Medlca in June 1969 [145-159], These reports dealt primarily 
with the situation in Fukuoka prefecture where 325 poisoning cases had been 
identified through January 20, 1969, The episode resulted from consumption 
of a particular brand of rice bran oil [160] and ultimately involved 
persons in 22 prefectures [161], About equal numbers of cases
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(approximately 450 each) were registered in Fukuoka and Nagasaki 
prefectures as of September 1973 [161], In the prefectures of Hiroshima, 
Kochi, and Yamaguchi, there were 80, 45, and 40 cases, respectively, at 
that time. In each of the other 17 prefectures there were 1-25 registered 
cases. The total number of cases registered by March 1970 was 1,015; by 
September 1973, the number had increased to 1,200, and by May 1975 to 1,291
[161.162]. The disease became known as "Yusho," or rice oil disease
[145.163]. The outstanding signs of the poisoning were acnelform eruptions 
and eye discharges (a peculiar secretion from the meibomian glands) [146]. 
Chloracne was suspected [164]. Hyperpigmentation of the skin, nails, and 
mucous membranes, swelling of the upper eyelids, and hyperemia of the 
conjunctlvae were other common signs [146,165].
Studies of the rice oils consumed by the patients indicated that the 
oil associated with Yusho was produced mainly during February 1968 
[147,148]. The source of the contamination was determined to be a heat 
exchange unit containing PCBs that leaked through tiny holes when rice bran 
oil was heated at low pressure to remove odorous constituents [163,165], 
By Intensive chemical analyses, including Infrared spectrophotometry and 
GLC, the major contaminant in the rice bran oil was found to be Kanechlor 
400 [147], PCB concentrations in the oil varied, depending on the date of 
production or shipment. The highest concentration of PCBs, based on the 
chlorine content of the oil, was about 3,000 ppm which was found in canned 
oil shipped on February 5. GLC data were not quantitated. In oils shipped 
thereafter, PCB concentrations decreased rapidly, and only traces were 
found in oils produced after February 19, 1968 [147,148], Minor
contaminants in the rice oil included polychlorinated dlbenzofurans at
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about 1/200 of the PCB concentration [20,160], traces of chlorinated 
naphthalenes, and bromine at about 2% of the chlorine content [147], 
Recent analyses of some of the oil samples indicate that there may have 
been other chlorinated organic contaminants (F Cordle, written 
communication, November 1976).
In one study [148], the contaminated rice bran oil was found to have 
been used largely for frying food (which may have altered the 
constituents). The oil was consumed for various periods during the spring 
through October 1968 [148]; the first reported clinical examination of a 
Yusho patient had occurred on June 7, 1968 [163], Studies through January 
1969 of patients in Fukuoka prefecture indicated that onsets of Yusho began 
as early as February and as late as December 1968, and first involved the 
eyes [146], Onset occurred in most patients in June, July, and August 
[146].
Some attempts were made to estimate the amounts of rice oil and PCBs 
consumed by the patients [166,167]. Maximum consumption of oil was 
estimated at 4.4 liters [166]. Isono and Fujiwara [167] estimated that two 
Yusho cases may have resulted from the ingestion of PCBs at a dally rate of 
67 ¿¿s/kg body weight for 3 months. For 146 Yusho patients who lived in 
homes known to have used oil shipped on February 5-6, the estimated average 
total oil consumption was 800 ml, a volume that contained an estimated 2 g 
of PCBs [166]. It was estimated that the maximum volume of oil consumed by 
an individual was 2.7 liters. Of 21 patients who had consumed more than 
1,400 ml (3-4 g of PCBs), 18 were considered to have had major signs of 
Yusho. Among 80 patients estimated to have consumed less than 720 ml of 
the oil, 31 were thought to have had major signs of Yusho. From the same
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data, the minimum PCB ingestion among the 146 patients was estimated at 0.5 
g [165]. Estimates of the amount of contaminated oil consumed by 13 
pregnant women during the ingestion period ranged from 300 to 2,600 mg
[167], but estimates of their PCB consumption were not made. Of the 13
babies born to these women, 8 had jaundice, 3 had marked dermal chromopexy,
and 9 had excess secretion of tears [167].
Several studies of PCBs in the tissues and body fluids of Yusho 
patients were made at various Intervals after Ingestion of the contaminated 
oil [146,147]. The samples taken closest to the time of ingestion were 
collected in October and November 1968 [146,147]. Samples from discharges
of the acnelform eruptions of two patients contained PCBs at 32 and 45 ppm,
and samples of subcutaneous fat from the face and abdomen of an 18-year-old 
man contained PCBs at about 75 and 13 ppm, respectively. PCBs with GLC 
patterns similar to those of the contaminated oil were found in these 
samples as well as in placental and fetal tissues [147]. Preserved tissues 
from a baby that had been stillborn in October 1968 were later analyzed and 
PCB concentrations of 1,8, 1.2, and 0.1 ppm in fat were found in the liver, 
skin, and fat, respectively [168]. The baby's mother had been classified 
as a severe case of Yusho with onset about mid-June, but the amount of oil 
consumed, the period of pregnancy during which it was consumed, and the 
body burden of the mother were not reported [149]. PCBs were found in all 
sputum samples from 13 patients collected between December 1969 and May 
1970 [169,170], PCB concentrations were highest in December and detection
was less common by May.
Other data on concentrations of PCBs were obtained from body fat and 
other tissues taken from five Yusho patients at autopsy [168,171], The
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dates of death were between July 1969 and May 1972. Cause of death was 
heart failure In four cases and a ruptured liver In another case [171], 
Estimates of contaminated oil consumed by two of the dead patients were 
about 0.3 g and 1.6 g, respectively [171], One PCB, probably a hexa- or 
heptachloroblphenyl from the contaminated oil, was especially concentrated 
In the tissues. The peaks associated with tetrachloroblphenyls were very 
low by comparison, suggesting that total PCBs In the body had been 
substantially decreased within a year after the end of exposure. The 
mesenteric fat contained PCBs at 0.9-15.1 ppm, and the liver contained 1.3- 
10.4 ppm in its fat. PCB concentrations in fatty tissues obtained during 
11 control autopsies averaged 2.6 ppm. Of the organs examined (liver, 
heart, kidney, brain, and skin), the liver and heart usually contained the 
highest concentrations of PCBs [168,171].
In an additional case, the subcutaneous fat obtained on autopsy of a 
woman who died In ' September 1972 (about 2 years after consuming 
contaminated oil) contained PCBs at 2.9 ppm [168],
Polychlorinated dibenzofurans (PCDFs), mainly penta- and hexachloro 
compounds, were found in tissues obtained on autopsy of two Yusho patients 
who died in 1969 and of one who died in 1972 [160], No chlorinated 
dibenzofurans were found in tissues obtained on autopsy of two controls, 
although PCB concentrations of about 1-1.5 ppm were found in adipose tissue 











1969 3.4 4.7 0.03 2.3
1969 8.5 5.6 0.04 1.1
1972 2.1 3.5 0.01 0.3
Adapted from reference 160
The ratio of PCBs to PCDFs In the rice bran oil was about 200, as In 
the adipose tissues obtained at autopsy. However, In the liver, ratios of 
2, 5, and 12 Indicate that considerable concentration of PCDFs had
occurred.
Information on PCBs [146,147,168,171] and PCDFs [160] In tissues 
Indicates some shifts In concentrations during the 3 years after Ingestion 
of the contaminated oil was discontinued. Masuda et al [168] reported that 
a year after Ingestion stopped, the concentrations of tetrachloroblphenyl 
components had decreased and were near those found In persons who had not 
Ingested the contaminated oil. The more highly chlorinated PCB compounds 
were still retained In the fatty tissue 4 years after Ingestion had stopped
[168].
Blood from Yusho patients was first examined for PCBs 5 years after 
Ingestion of the contaminated oil ceased. Three distinct GLC patterns were 
found among blood samples from 49 patients [172-175]. Two patterns (A and 
B) were peculiar to the Yusho patients, and the third pattern (C) was
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similar to that of controls. Patterns A and B were characterized by peaks 
corresponding to those of certain penta- and hexachlorobiphenyl compounds 
that were present in the contaminated rice bran oil. Patterns A and B 
differed, however, as to the relative amounts of these compounds [172,173]. 
These patterns became diagnostic for Yusho [161]. The average
concentrations of PCBs in the blood serum were 9, 4, and 2 ppb for patients
with patterns A, B, and C, respectively, and 3 ppb for 27 control subjects
[173]. The maximum blood serum PCB concentration found among 72 Yusho 
patients examined between April 1973 and March 1974 was 26 ppb [174]. Of 
these patients, 43 had pattern A, 26 had pattern B, and 3 had pattern C.
Similar patterns were reported In 1975 by Abe et al [176] in a 1974 
study of 18 female Yusho patients and their 30 children. Concentrations of 
PCBs in blood samples from mothers ranged from 3 to 33 ppb during 1974;
PCBs in samples from their children ranged from 1 to 20 ppb, and In samples
from 14 control children, from 1 to 8 ppb. PCB concentrations tended to be
higher in the blood samples from children nursed by Yusho mothers. A 
sample of milk from a Yusho mother was reported In 1974 to contain PCBs
with a GLC pattern similar to those in samples of fatty tissue from other
Yusho patients [168]. Concentrations of PCBs in the mother's milk were
0.06 ppm on postpartum days 0-2, 0.04 ppm on days 3 and 4, and 0.03 ppm on 
day 5. The respective concentrations In the milk fat were 4.5, 3.0, and 
2.6 ppm.
In addition to the skin and eye conditions manifested by most people 
who consumed the contaminated rice bran oil [146,151-153,162], there was 
pigmentation of the nails [146] and of the oral mucosa [154]. A 
substantial array of clinical and laboratory findings were published on
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patients with Yusho [150,152,155,156,177-180], including slight increases 
in activity of serum alkaline phosphatase, reduced serum iron 
concentrations [155], changes in the microanatomy of liver cells that were 
considered indicative of microsomal enzyme stimulation [156], symptomatic 
and functional changes indicative of neuropathy [150,177], respiratory 
involvement [170,178], a decreased concentration of bilirubin in the serum 
[179], and, in many patients, an elevation of the concentration of 
triglycerides in the serum [155,157,158,175,179-181],
Babies born to women with Yusho, both during and after the period of 
ingestion of the contaminated rice bran oil, were the subject of several 
Investigations [149,159,176,182,183]. Babies of mothers who had Ingested 
the contaminated oil became known as "black" or "cola" babies because of 
the abnormal skin pigmentation that tended to persist for several months 
after their birth [176,182,183]. Infants born up to 5 years after their 
mothers’ last ingestion of contaminated rice oil were still affected to 
some extent [182]. In one study of four babies, other clinical and 
anatomical abnormalities (retarded intrauterine growth in three, edematous 
face and exophthalmic eyes In three, dentition in two, calcification on 
skull and wide, open sagltal suture of skull in three) were seen at birth 
[183]. These were not permanent, and postnatal body and mental development 
appeared normal in these and other Yusho children [160,176,183]. In at 
leaBt one case, an investigator concluded that a baby had developed Yusho 
from nursing [182].
The period of Ingestion of contaminated rice bran oil was only a few 
months, but the effects have persisted for several years
[160,161,174,175,179,180,184,185]. The skin lesions and hypersecretion
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from meibomian glands remained unchanged for long periods in many patients
[174,184,185]; their magnitudes in 1974 appeared to be related to blood PCB 
concentrations [174], In addition, complaints of generalized fatigue, and 
symptoms referable to the peripheral nervous system and to the respiratory 
system became more prominent. In 1974 these complaints and symptoms were 
established as part of the diagnostic criteria for Yusho [161], These 
additional symptoms were not related to the PCB concentrations in the blood
[174].
Elevated serum triglyceride concentrations were found to be related 
to the concentration of PCBs in the blood serum [175], and inversely 
related to the bilirubin concentrations in the serum [179]. The average 
serum triglyceride concentrations measured annually in 14 Yusho males from 
1969 through 1974 ranged from 159 mg/100 ml in 1969, to 174 mg/100 ml in 
1972, to 160 mg/100 ml in 1974 without any significant changes from year to 
year. In 29 Yusho females, the concentrations initially (1964) averaged 
153-161 mg/100 ml, but decreased in 1973 and 1974 to 129 and 111 mg/100 ml, 
respectively [180],
The Yusho population of about 1,300 persons has been followed closely 
and records indicate that as of May 1975, 29 of them had died [162].
Deaths have been due to a variety of causes such as accidents, suicides,
cardiac problems, and cancers. Malignant neoplasms were found In at least 
nine cases [161], from which Kuratsune et al [160] concluded that there was 
a suggestion of excess deaths but that no more could be said because 
information essential for analysis was not available.
The relevance of the Yusho episode to occupational PCB exposure is
compromised because: (1) the oil was ingested; and (2) it contained large
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concentrations of dibenzofurans compared with those in the PCBs to which 
workers generally have been exposed in their occupations. Its relevance is 
further compromised because the effects observed from daily ingestion of 1- 
15 mg of PCBs [165,167] were peculiar and excessive compared to those 
observed in workers exposed by inhalation to PCBs at 1-5 mg/cu m [120,125], 
notwithstanding that the amounts absorbed may have been similar.
Nevertheless, information obtained from the Yusho episode Is relevant 
to the study of PCB toxicology and occupational exposure. The information 
establishes that PCBs can be transmitted from mother to fetus, and, in the 
milk, from mother to child. It also establishes that some PCB compounds 
are eliminated from the body relatively rapidly, and that others may 
require years for elimination.
(c) Occupational Exposures
Chloracne was among the earliest reported effects associated with 
worker exposure to PCBs [125-128], It was not clear in some early reports 
that PCBs were contributing to the chloracne because PCBs usually 
constituted 10-20% of mixtures containing 80-90% chloronaphthalenes, a 
previously known cause of chloracne [121,122], An early report that 
associated chloracne with PCBs in the absence of chloronaphthalenes was 
that of Jones and Alden [120] in 1936, The manufacturing process was 
largely an open one and the workers were also exposed to benzene, biphenyl, 
and other compounds incidental to PCB manufacture. Over the years, cases 
of chloracne associated with occupational exposure to PCBs have continued 
to appear [186-196],
Other effects associated with PCBs in early reports included 
digestive disturbances, eye Irritation, liver injury, and impotence
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[123,125], Elkins [130] reported in 1950 that the average concentrations 
of PCBs in the workroom air of several plants in Massachusetts ranged from 
0.1 to 5.8 mg/cu m. Maximum concentrations ranged from 0.2 to 10.5 mg/cu 
m. No evidence of Immediate toxic effects was observed except at PCB 
concentrations approaching 10 mg/cu m, which the workers found to be
unbearably Irritating.
Three cases of severe chloracne were described by Puccinelll [186] In 
1954. The affected employees worked in a factory that produced capacitors 
impregnated with Aroclor 1254. The workroom was 24 x 9 x 5 meters. 
Capacitors were heated to about 100 C in a 3-cu m autoclave to remove 
moisture, and then Impregnated with the Aroclor while in the autoclave. 
The temperature in the autoclave was reduced about 12 hours later. When 
the autoclave was opened, the temperature of the Aroclor was 70-80 C. The 
capacitors were removed and carried to another location for finishing. 
Originally, one autoclave was used, but eventually eight were in operation, 
and PCB emissions to the workroom air occurred almost continuously.
Concentrations of PCBs in 500-liter samples of air were found to vary from
5.2 mg/cu m in the center of the room, to 6.4 mg/cu m around the finishing
operation, to 6.8 mg/cu m near the autoclave during removal of the
capacitors. The three chloracne cases were In men, 18-24 years of age. 
They had worked in the factory for 2-4 years, and developed the first signs 
of chloracne 4-8 months after their exposures began. Other than chloracne, 
the men appeared healthy, and all findings, including liver function tests 
were reported as normal.
Eight other cases of chloracne associated with PCB exposure during 
the manufacture of radio capacitors were described by Hofmann and Meneghlnl
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[187] in 1962. In the process, PCB vapors were generated by heat. The 
cases included one man and seven women, 20-37 years of age, who were 
exposed to PCBs 2.5-4 months before onset of signs of chloracne. The face 
was involved in six cases; other involved areas varied, but included the 
arms, neck, upper torso, pubes, buttocks, and thighs. The case of a 21- 
year-old woman was described in detail. The first signs of chloracne 
appeared on her face 4 months after she began work, and she was observed by 
the authors [187] 4 months later. On the face, a dirty brown coloring 
appeared. A hyperpigmented spot with shaded areas was present on the 
forehead. Subsequently, her buttocks and pubes became Involved. Exposure 
concentrations were not mentioned.
Severe chloracne was described by Birmingham [188] in 1964 in 13 of 
15 workers exposed to an Aroclor which was a mixture of bi- and terphenyls 
(65% chlorine content). An enamel containing the Aroclor was painted onto 
glass and then baked In an oven. Faulty ventilation caused contamination 
by chlorinated hydrocarbon vapors. Exposure concentrations and duration of 
exposure were not given.
An additional case history published In 1969 Involved a 43-year-old 
man exposed to PCBs In an electrical component factory [189]. He developed 
chloracne on the forehead, face, arms, and thighs within 3 months after 
beginning work handling racks of electrical parts that had been dipped in 
hot PCBs. Exposure concentrations and actual durations of exposure were 
not stated, but It was reported that the man had put his hands In the 
mixture without skin protection for a long time, and that his clothes often 
became Impregnated with the PCBs. On examination 8 months after transfer 
to another job In the same room, papules, comedones, and pustules were
found on his forehead, scalp, face, and arms. Although the man had been 
removed from direct exposure to PCBs, their odor was present in the man's 
new work area. It was reported that this was the first case of chloracne
in the plant, where more than 100 workers had been engaged in the process
for more than 20 years.
A company that used PCBs at two manufacturing facilities provided 
testimony on employee health in 1975 (In the Matter of General Electric
Company, File No. 2833, New York State Department of Environmental
Conservation). Examination of records submitted as testimony Indicated 
that exposures were to an askarel [25] containing, by weight, about 60% of 
Aroclor 1254, 40% trlchlorobenzene, and 0.0115-0.135% dlepoxlde scavengers. 
From the records submitted, it was not possible to determine the precise 
numbers of male and female workers. The exact occupations of the workers 
could not be determined either but a substantial number of "crimpers" was 
indicated.
The records showed that employees had reported to the dispensary 
complaining of skin rashes and dermatitis on 49 occasions during the 
previous 15 years. Only the fingers and hands were involved in 21 
complaints, only the arms and hands in 5, and only the face and legs In 1. 
In 7 other complaints the face, neck, and legs were mentioned in 4, 2, and 
1 cases, respectively, in addition to the upper extremities. Associated 
with the complaints of skin rashes and dermatitis were some complaints of 
itching of the face (2), neck (1), eyes (1), arms (2), and hands (1). A 
generalized skin rash was the basis of 14 additional complaints. One 
worker developed the generalized rash on exposed parts of his body after 
only 2 days of working with the askarel.
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The company physicians attributed the rashes to allergic or contact 
dermatitis caused by exposure to the askarel. Treatment included the use 
of creams, and temporary or permanent removal from exposure. Of the 49 
complaints, 22 were second episodes, and in these cases the workers were 
removed permanently from exposure to askarels. One female employee who had 
dermatitis of the fingers was removed from exposure for 12 days. Within 2 
days of reexposure she again reacted to the askarel and was permanently 
removed from such work.
Over the same 15 years, other kinds of complaints were made by the 
workers on 16 occasions. These complaints included burning sensations of 
the eyes (7), nose (1), and face (1); dry throat (1); asthmatic bronchitis
(3); nausea (1); dizziness (1); and aggravation of acne (1). In most of 
these cases, the company physicians recommended permanent removal from 
exposure.
The health status of eight laboratory workers who routinely analyzed 
dielectric fluids containing PCBs was reported by Levy et al [197] In 1977. 
The men were 25-49 years of age and had been employed 2.5-18 years. 
Breathing zone, point source, and general work area air samples were 
collected on magnesium silicate at 50 ml/mlnute over the workday on three 
occasions. The breathing zone samples contained PCBs at 0.014-0.073 mg/cu 
m. Samples taken near an oven contained 0.042-0.264 mg/cu m, and general 
room area samples contained PCBs at 0.013-0.15 mg/cu m. The blood PCB 
concentrations In the workers were 36-286 ppb. The most common complaint 
of the workers (6 of 8) was dry or sore throat. Other complaints were skin 
rash (3 of 8), gastrointestinal disturbances (3 of 8), eye irritation and 
headache (each, 2 of 8). Findings on examination of the eight workers were
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skin rash (1), nasal Irritation (2), rales (1), and elevated blood pressure
(4). No liver, spleen or neurologic abnormalities were found by physical 
examination. There were no cases of chloracne. Serum alkaline 
phosphatase, SGOT, SGPT, and total bilirubin, measured In seven subjects, 
were all within normal limits. In addition, medical records of 40 other 
exposed employees were examined, revealing two cases of slightly Increased 
SGOT, two elevated serum triglycerides, and one case each of Increased 
serum alkaline phosphatase (SAP) activity, total serum bilirubin, and serum 
uric acid.
Epidemiologic Studies
An outbreak of dermatitis among workers In a Connnecticut chemical 
plant was described in 1954 by Meigs et al [190]. PCBs had been 
substituted for molten salt in a heat exchange unit without modification of 
the system. There were slight, but obvious, vapor leaks under certain 
conditions, and the concentration of PCBs in the workers' breathing zones 
was determined to be 0.1 mg/cu m. No employee worked regularly at points 
of leakage, and the operations, as described, continued for 19 months.
Mild to moderate chloracne on the face, forehead, and ears developed 
In 7 of 14 exposed workers; the mastoid region of one worker also was 
affected. The duration of exposure before the initial signs occurred 
ranged upward from 5 months and averaged 14 months. The average length of 
exposure was 11 months for those who did not develop chloracne, with one 
worker showing no signs after 19 months. Liver function tests were 
performed on the seven workers who had developed chloracne. Clinical tests 
Included direct and total serum bilirubins, 24- and 48-hour cephalin
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flocculations, thymol turbidity, and SAP activity. Findings were normal in 
six workers, and borderline Increases in cephalln flocculation and thymol 
turbidity were found in the seventh worker with chloracne. Thirteen months 
later, the thymol turbidity test had improved, but cephalin flocculation 
had not changed. All cases of chloracne were stated to have cleared up 
after an unspecified treatment. Control of vapor emissions by welding all 
joints in the heat exchange unit prevented recurrence [190].
Exposures of workers to PCBs in six industrial plants were discussed 
by Hasegawa et al [191] in 1972. The concentrations of PCBs found are 
summarized in Table III-7.
TABLE III-7







A PCB manufacture 6 26-163 19-37
B Capacitor manufacture 3 120-350 20-125
C Biphenyl recovery 2 13-15 4*
D Capacitor manufacture 2 350-540 48-6,270**
E !» 3 95-965 73-650
*1 sample
**6,270 due to spillage 
Adapted from reference 191
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PCBs were manufactured in one plant and used in manufacturing 
capacitors in four plants (one had discontinued use of PCBs 1 month 
earlier). Biphenyl, not chlorobiphenyls, was present in the sixth plant 
[191]. Air samples were collected in two fractions. A fraction associated 
with particles > 0 . 1 n  was collected on filter paper, and a fraction 
containing vapors and particles <0.1jt in diameter was collected In two 
serially-connected midget lmplngers containing n-hexane. Samples were 
collected only from places where high concentrations of PCBs were expected 
and not from the factory where PCB use had been discontinued,
The vapor concentration exceeded the particulate concentration in all 
except the sample taken after spillage. Particulate matter was 
characterized by GLC as containing the same chloroblphenyl composition as 
the PCB product used in the plant, whereas the vaporized material contained 
one less chlorine atom/molecule than the PCB used In the plant.
PCBs were measured in the blood of the employees of six plants, 
Including 99 exposed workers and 32 controls [191]. Concentrations of PCBs 
in the blood sera of exposed workers averaged 370 ppb, whereas those of the 
controls averaged 20 ppb. The workers exposed to PCBs in the plant that 
had discontinued PCB use had serum PCB concentrations of 90 to 730 ppb 
(average 460 ppb). Based on data from three of the plants, no relationship 
was found between duration of exposure (from <1 to 20 years) and 
concentration of PCBs in the blood [191],
Complaints of dermal ailments seemed to be unrelated to the blood PCB 
concentrations and were considered to be due more to direct contact of the 
skin with PCBs than to generalized intoxication. The principal dermal 
findings included brown chromodermatosis of the dorsal joints of the hands
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and fingers and of the nail bed, and acneiform exanthema. The latter also 
Involved the jaw, back, and thelghs In several cases. The Investigators
[191] considered that there was a definite effect of PCBs on fat
metabolism, as shown by decreases In the concentrations of total, free, and 
esterlfled cholesterols In the blood, and by trends In the same direction 
for neutral fats, total glycerides, phospholipids, and beta-lipoprotein In 
the blood. There was evidence of mild disturbances of liver function
manifested by Increased SGOT, SGPT, and SAP activities and decreased 
activity of serum chollnesterase. These enzyme activity changes were not 
considered to be clinically significant.
Studies of 38 current and 80 former employees of a capacitor factory 
In which Kanechlor 500 had been used from 1954 to about 1960 and Kanechlor 
300 had been used from about 1960 to 1972, with PCB use having been 
discontinued In April 1972, were reported by Hara et al In 1973 [192] and
again In 1974 [193]. (Presumably, this factory was the one stated by
Hasegawa et al [191] to have discontinued use of PCBs.) Current workers 
Included 17 who were engaged In the capacitor Immersion process; the 
remaining 21 workers were engaged In finishing and assembling operations. 
The study concentrated on the 17 immersion process workers. During 
exposure to PCBs In March 1972, the concentrations of PCBs in the whole 
blood of the immersion workers ranged from about 7 to 300 ppb, and were 
closely related to years of exposure. One year later, blood PCB 
concentrations had all decreased, but by varying amounts. For example, one 
of two workers who initially had PCB concentrations in their blood of about 
180 ppb had a concentration of <10 ppb 1 year later, while the other one 
had a concentration >100 ppb. The average PCB blood concentration for the
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17 workers decreased to about 75% of the original value. Based on blood 
samples collected about 6 and 12 months after use of PCBs was discontinued, 
the blood PCB half-lives for the Immersion workers were calculated. It was 
found that the greater the duration of exposure, the greater the PCB half- 
life (1 year of exposure, 3 months half-life; 10-15 years of exposure, 30 
months half-life). This indicated to the investigators that blood served 
as a PCB carrier, whereas fat served as a depot tissue [192],
While working with PCBs, many of the total group of employees had 
dermal complaints (blackheads, 45%; acnelform eruptions, 37%; skin 
irritations, 13%) [192]. A year after discontinuance of exposure to PCBs, 
these conditions had Improved noticeably and only one or two blackheads 
remained. No correlation was apparent when concentrations of PCBs and
triglycerides in the sera of a large number of workers were compared 
graphically. The workers were also studied about 18, 24, and 36 months 
after use of PCBs had been discontinued [193], During this period, blood 
PCB concentrations decreased to about 10-20 ppb In all but two workers who 
had been exposed to PCBs for 9 and 15 years. The skin disturbances were 
reduced to vestigial markings on a few Individuals. Comparisons with the 
concentrations of triglycerides and PCBs in the sera of these workers 
Indicated that the proportion of workers with significant Increases in 
triglyceride. concentrations Increased as the concentrations of PCBs 
Increased. Of nine workers with blood PCB concentrations >50 ppb, five had 
elevated triglyceride concentrations.
Examinations of 13 workers from an electrical capacitor manufacturing 
plant for clinical manifestations of PCB toxicity were reported by Kltamura 
et al [194] in 1973. Examinations were performed when the company
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discontinued the use of PCBs In June 1972, end were performed twice 
subsequently at 3-month Intervals. The average length of worker exposure 
to PCBs had been about 2.5 years. Immediately after discontinuance of PCB 
use, the average PCB concentration In the blood of workers was 820 ppb, 
ranging from 320 to 2,100 ppb [194]. The mean concentration fell to 310 
ppb after 3 months, and to 200 ppb after 6 months. From these 
observations, Kltamura et al [194] estimated the biological half-life of 
the PCBs In the blood immediately following the cessation of exposure to be 
about 90 days. No consistent correlation could be found between the 
concentration of PCBs In the blood and the duration of exposure to PCBs. 
Nall, hair, and gum color and color of the mucous membranes of the oral 
cavity all were normal. Ten of the workers had varying degrees of skin 
disorders on different parts of their bodies. The skin disorders Included 
seborrhea adlposa, acne vulgaris, and follicular papules on parts of the 
body where direct contact with the PCBs normally did not occur. The 
authors [194] concluded that PCBs probably had been an Important factor In 
the etiology of the skin disorders and that results of blood tests, hepatic 
function tests, and urinalyses were normal. Serum triglycerides were not 
determined.
A study by Inoue et al [195] of the health of workers In family-owned 
sllk-thread glossing factories In which PCBs were used was published In 
1975. The study was Initiated because PCB concentrations exceeding 100 ppb 
had been found in the blood of a 73-year-old man who had undergone surgery. 
His family operated a household thread-glossing factory. The family 
members and the hired helper were studied. Serum concentrations of PCBs 
resembling Kanechlor 500 ranged from 130 to 520 ppb. There was a close
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correlation between the PCB concentration in the blood and the degree of 
involvement in the glossing work. The head of the household had skin 
lesions and comedones on the face, back, and ears and had blood PCB 
concentrations of 190-210 ppb. The rest of the people had practically no 
skin abnormalities, and other findings (not described) were, in general, 
considered of minor significance. A study of PCB contamination of the 
premises and the air of the same factory was reported by Fujiwara et al 
[33]. At the time the samples were taken, use of PCBs had been 
discontinued. However, PCBs were found in air at 0.25 mg/cu m, in floor
boards at 80-130 ppm, in the dirt under the machinery at 10-900 ppm, and in 
the dust on steel frame beams at 110-180 ppm. The PCBs were similar to 
those in Kanechlor 500.
Subsequent to the above study, Inoue et al [195] reported on the PCB 
concentrations in samples of blood obtained from 54 other similarly 
employed people. PCB'concentrations of over 100 ppb, 50-99 ppb, 10-50 ppb, 
and 0-9 ppb were found in 2, 5, 19, and 28 persons, respectively.
Correlative comparisons with the various functions performed In the 
factories showed that those workers who had direct contact with the 
glossing machines, those who maintained and repaired the machines, and 
those who had over 20 years of work experience had the highest 
concentrations of PCBs in their blood. Skin abnormalities and other
findings In these 54 persons were described as relatively mild. One of the 
persons studied, a woman in her 10th month of pregnancy, had a serum PCB 
concentration of 24 ppb. Following birth, the mother and daughter were
described as healthy with no evidence of abnormalities. The concentration 
of PCBs in the mothers's milk was found to be 0.25 ppm, and after
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consultation, she stopped nursing her baby [195].
In 1974, Sato and Hasegawa [32] discussed their findings on PCB 
residues in the workers and in the air of pressure-sensitive ("carbonless") 
copying paper manufacturing plants 2 years after PCB use had been 
discontinued. A PCB product comparable to Kanechlor 300 was still detected 
in the workroom air of four of five factories at concentrations ranging 
from 0.13 to 4.4 jig/cu m; in one factory PCBs comparable to a mixture of 
Kanechlors 300, 400, and 500 were found at concentrations ranging from 0.15 
to 1.2 Mg/cu m. Concentrations of PCBs in the blood sera of these workers, 
as measured by GLC, ranged up to 73 ppb, compared to a maximum of about 20
ppb in controls. The authors [32] concluded that the blood PCB
concentrations in the workers were still elevated.
PCB concentrations in the blood of three groups of employees with
different PCB exposure histories were presented in 1972 by Karppanen and 
Kolho [198]. The first group of four men and five women had no known 
occupational exposure to PCBs. The six women of the second group had been 
exposed while handling PCBs in an analytical laboratory. The third group 
of eight men and four women had worked, since 1968, in a plant where 
Aroclor 1242 was impregnated into capacitors. The authors [198] stated 
that the workroom air of the capacitor factory met internationally accepted 
limits (presumably <1 mg/cu m), and that protection of the skin had been 
given special attention. PCB measurements were made by GLC, using electron 
capture detection. The unexposed group had blood PCB concentrations of 
5.6-12 ppb, the analytical laboratory workers haa concentrations of 36-63 
ppb, and the capacitor plant workers had concentrations of 74-1,900 ppb. 
Subcutaneous adipose tissue samples from two of the unexposed workers
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contained PCBs at 1.5 and 2.3 ppm; PCBs in their blood expressed as 
concentrations in fat of the blood were 6.6 and 9.9 ppm, respectively. In 
three capacitor plant workers, adipose tissue samples contained PCBs at 
160, 285, and 635 ppm; PCBs In their blood, expressed as concentrations In 
their blood fat, were 400, 305, and 700 ppm, respectively. All persons 
examined were In good health. The capacitor plant workers had been under 
special medical observation but the investigators were unable to detect any 
biologic effect from the PCBs.
An epidemiologic investigation of 37 refuse workers who were 
potentially exposed to PCBs emitted from incinerated waste was described by 
Bumgarner et al [199] in 1973. The control group consisted of 36 workers 
from a lumber yard. Paired samples of scalp hair and blood were collected. 
PCB residues in the hair and blood plasma were extracted and analyzed by 
GLC with electron capture (EC) detection; rough quantitation was by 
evaluation of five peaks associated with Aroclors 1254 and 1260. The lower 
limit of detection was 1 ppb. Hematocrit, blood cholesterol, and blood 
pressure also were determined. PCB residues in the blood plasmas of the 
controls were detected in four workers and the maximum concentration was
4.2 ppb. Measurable concentrations of PCBs were found in the blood samples 
of 32 of the 37 refuse workers; the average and maximum concentrations were 
about 4 and 14 ppb, respectively. The concentrations of PCBs In plasma 
were not related to duration of exposure, age, or race. PCBs were not 
detected in hair samples (limit of detection, 1 ppb). Hematocrit, blood 
cholesterol, and blood pressure values did not change at different PCB 
concentrations.
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A survey of the health of 34 workers exposed to Aroclor 1242 during 
manufacture of capacitors was discussed by Ouw et al [196] In 1976. The 
Aroclor was an electrlcal-grade material that contained "no Impurities." 
Breathing zone samples were collected in lmplngers containing Isopropanol. 
It Is not clear if all samples were collected from the breathing zones. 
Nineteen workers were assigned to fill capacitors with Aroclor 1242 heated 
to 70 C. These workers were exposed to PCBs at 1.08-1.44 mg/cu m. The 
other 15 workers, located in a different room, were assigned to assemble 
Aroclor-dlpped capacitor components. These workers were exposed to PCBs at 
0.32 mg/cu m. None of the 34 workers used protective clothing.
PCBs in the blood were separated by GLC and identified by their 
retention times relative to aldrln. PCBs were not detected In the blood of 
30 control subjects. For the two groups of PCB-exposed workers, averages 
of measurable blood PCB concentrations are presented In Table III-8.
TABLE III-8
AVERAGE OF DETECTABLE BLOOD PCB CONCENTRATIONS (ppb)
OF TWO GROUPS OF WORKERS
PCB Retention Time Relative to Aldrin
Exposure No.
Group Workers 0.69 1.31 1.47 1.96
Fillers 19 602(19)* 314(17) 391(13) 475(4)
Assemblers 15 140(14) 100(14) 899(5) (0)
¿Numbers In parentheses are the numbers of workers in whom more than a 
trace of the PCB peak was detected.
Adapted from reference 196
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Distribution of PCBs in the blood of workers exposed while filling 
the capacitors differed from that of workers who assembled the components. 
The higher boiling components were present more frequently and to a greater 
extent in the fillers.
Twelve of the workers (5 of 19, and 7 of 15) complained of mild 
burning and irritation of the face, eyes, and skin, and 5 of these had 
eczematous rashes on the hands and legs. One filler had chloracne. 
Although individual abnormalities were found in SGPT, SAP, and bilirubin, 
the average values for the exposed workers were within normal limits. 
Bromsulphothaleln retention tests were found to be elevated In four of the 
seven fillers whose blood PCB concentrations were >500 ppb. The 
Investigators [196] reported no evidence of significant adverse responses 
to PCB exposure in the workers with blood PCB concentrations below 200 ppb.
Subsequently, "more efficient" exhaust ventilation was installed and 
the workers were advised to wear "suitable Impervious gloves" [196], Air 
measurements, made after the ventilation change, Indicated that the fillers 
were being exposed to PCBs at 0.18-0.75 mg/cu m and the assemblers at 0.08 
mg/cu m. These were substantial reductions. However, blood PCB 
concentrations that were found in 15 workers reexamined 2 months after the 
ventilation change did not show any substantial reductions. The 
investigators [196] speculated that this might have been because the 
workers did not strictly follow the recommendation to wear protective 
clothing.
Based on a search of chart records, Bahn (HA Sinclalre, written 
communication, June 1976) reported a preliminary study of the incidence of 
cancer in a group of 51 research and development employees and 41 refinery
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plant employees at a New Jersey petrochemical facility who were considered 
likely to have been exposed to Aroclor 1254 for various periods between 
1949 and 1957. The eight cancers observed in the study population through 
December 31, 1975 were not significantly more than would be expected (5.7) 
in a similar sample of the US population [200]. However of the eight 
cancers, the three melanomas and the two cancers of the pancreas were 
significantly different from calculated expectations. Some findings of 
this preliminary investigation were described in a letter from Bahn et al 
[201] to the editor of the New England Journal of Medicine.
In this preliminary study, PCB exposure histories were based on 
recollections of two company employees. Exposures to other chemicals could 
not be ascertained. The expected cancer rates were based on US population 
data rather than on a rate for the locality of the petrochemical facility. 
To correct these deficiencies in the preliminary study, a more intensive 
investigation Is being conducted (BN Kightlinger, written communication, 
November 1976). A substantial change has occurred in the cohort since 
release of the preliminary report by Bahn and her coworkers, and it seems 
likely that the findings on this new cohort will differ significantly from 
those of the preliminary study. The final report is not yet available.
In a study of current and former employees engaged in the manufacture 
of PCBs, no cases of malignant melanoma or pancreatic cancer were found 
from a review of the case histories of more than 300 employees (G Roush, 
written communication, September 1976). Seven cases of lung cancer were 
found from the death certificates of 50 former employees compared to an 
expected number of 2.7. The data are preliminary and were not corrected 
for age or smoking habits. The final report is not yet available.
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Animal Toxicity
Although there have been a few reports of dermal and Inhalation 
experiments with animals, most of the Information on animal toxicity has 
Involved Ingestion of PCBs In the diet or by Intubation. Several animal 
experiments have Involved oral administration of PCBs for the lifetime of 
the animal. These studies have demonstrated chronic changes in the 
microscopic anatomy of the liver and other organs, effects on reproduction, 
embryonic and fetal toxicity, effects on offspring from nursing, and 
carcinogenic and teratogenic responses.
(a) Inhalation and Dermal Application Studies of PCB Mixtures 
Absorption and distribution of Inhaled PCBs were studied by Benthe et 
al [97] In 1972. Groups of 4-6 male Wlstar rats were exposed to aerosols 
of a commercial PCB mixture containing 42% chlorine, Pydraul A 200, 
commonly used In hydraulic fluids. Absorption and distribution of the PCBs 
were studied through the measurement of PCB concentrations in liver, brain, 
and adipose tissue. The aerosols were produced In an aerosol generator at 
180 C. The aerosols were cooled, the larger particles were separated out, 
and the airborne PCBs were Introduced Into a chamber at a concentration of
30.4 ±3.4 g/cu m. Groups of the rats were exposed for varying periods up
to 2 hours. It was found that 15 minutes of exposure was sufficient to
attain more than 50% of the PCB concentration of 69.7 fig/g liver wet weight 
that could be attained with 2 hours of exposure. Consequently, the
investigators used an exposure time of 30 minutes to study distribution of 
PCBs to the tissues.
immediately after 30 minutes of exposure, PCB concentrations were 
maximal, at about 52 /ig/g liver tissue, whereas they were at low
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concentrations in the other tissues at 14 f i g / g  in adipose tissue, and 9 
/ig/g in brain tissue. After 24 hours the PCB level in the brain attained a 
maximum value of about 18 ( i g / g  and within 36 hours the PCB concentration in 
the adipose tissue attained a maximum of about 250 jug/g. By 48 hours the 
concentrations of PCBs in the liver were reduced to about 3 n g / g  and in the 
brain to about 5 /ig/g, whereas the adipose tissue concentrations remained 
above 200 ¿ig/g.
Experiments were reported by Rozanova [202] in 1943 in which rats 
were exposed to a technical mixture of "tetrachlorodiphenyl" and 
"pentachlorodlphenyl." The mixture, known as Solvol, was a transparent, 
colorless, oily, very viscous liquid used for filling capacitors. The 
"tetrachlorodiphenyl" component of the mixture had a distillation range of 
220 to 245 C and the "pentachlorodlphenyl" component had a distillation 
range of 242 to 260 C. The animals were exposed in a 22-liter chamber 
through which air was 'drawn continually at a rate of 1-1.5 liters/minute, 
after first passing through a glass gooseneck containing the liquid PCBs. 
Air samples were taken from the chamber from time to time to determine the 
PCB concentrations. The analytical method was not reported.
Four rats exposed for 3 hours at about 10 mg/liter became 
uncoordinated and comatose and died within a day [202], Autopsy findings 
included liver necrosis and fatty degeneration, cloudy swelling of the 
epithelial cells of the renal tubules, congestion in the heart and spleen, 
and necrotic signs in the spleen. Three rats were exposed repeatedly to 
vapors of Solvol at 0.5 mg/llter. One rat died after eight exposures, and 
the other two were killed after 11 exposures. Five other rats were 
repeatedly exposed at 0.25 mg/llter; one was killed after 16 exposures, and
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the others, which appeared to be in satisfactory condition, were killed 
after 69 exposure*. In these chronically exposed rats, gross and 
microscopic findings were similar to, but less marked than, those found in 
the acutely exposed animals. In addition, hyperplasia of the Kupffer cells 
was found in the liver.
Treon et al [203] exposed groups of animals each comprised of 10 
rats, 10 mice, 6 guinea pigs, 4 rabbits, and a cat to Aroclor 1242 or 
Aroclor 1254 vapors 7 hours/day, 5 days/week for up to 31 weeks. Aroclor 
1242 exposures at concentrations of 8.6 jug/liter (0.83 ppm) for 3 weeks, 
6.83 Mg/liter (0.66 ppm) for 17 weeks, or 1.9 ¿¿g/liter (0.18 ppm) for 31 
weeks. Exposures to Aroclor 1254 were at 1.5 jug/liter (0.11 ppm) for 31 
weeks or at 5.40 jug/liter (0.41 ppm) for 17 weeks. No consistent changes 
in mortality, growth, pathology, organ size, liver function, or hematologic 
parameters were found in animals exposed to Aroclor 1242. The animals 
exposed to Aroclor 1254 vapors showed no changes in growth or mortality but 
microscopic evidence of apparently reversible hepatic cellular injury was 
found in all species except the cat at both exposure levels. Enlarged 
livers were found in the animals exposed at 5.40 n g / liter. An appreciable 
incidence of pneumonia was found among the exposed and control animals, a 
fact which could have confounded some of the results, but it is Important 
to note that liver changes, including fatty degeneration, were found in 
exposed animals that were free of pneumonia.
Inhalation experiments with the commercial PCB product 
"Decachlorodiphenyl" were reported by Berczy et al [98,99] in 1974. The 
oral toxicity of this PCB product was Investigated by Hunter et al [204], 
who administered it in the diet to Sprague-Dawley rats at 1,000, 2,000,
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5,000, and 10,000 ppm for 4 weeks. All animals fed Decachlorodlphenyl 
gained more weight than the controls and had greater liver to body weight 
ratios. Other effects observed at 10,000 ppm included Increased spleen, 
thyroid, and kidney weights relative to body weights, reduced hemoglobin 
concentrations, and in males reduced rbc counts and hematocrits.
In one inhalation experiment [98], five male and five female rats 
were exposed for 6 hours to particles of the PCB product at an average 
concentration of 2.54 mg/liter. Seventy-eight percent of the particles 
were in the range of 1-5 t m  in diameter, 17% in the range of 5-15 jum, and 
the remaining 5% were >15 jum. During exposure there were repeated episodes 
of blinking and sneezing. Signs of irritation disappeared after cessation 
of exposure. During the subsequent 14-day observation period, food and 
water consumption and growth of the rats were considered by the authors to 
have been similar to those of the controls. No gross pathological changes 
were seen when the rats were killed 14 days after removal from exposure 
[98],
Subsequently [99], three groups of rats, each consisting of 8 males 
and 8 females, were exposed 6 hours/day, 5 days/week for 4 weeks at average 
concentrations of 4, 80, and 777 jig/liter. A similar group of rats was
used as a control. In this experiment, where 85-90% of the particles were 
in the 1-5 ¡ m  range and 1-3% were >15 jum, no signs of irritation were seen 
during the exposures at the lower concentrations and growth rates were 
normal compared to controls. At the highest concentrations, frequent 
blinking and sneezing were noted during the exposures, and the growth rate 
of the melee was slightly retarded (final body weights of 395 g vs 435 g 
for controls). The liver weights, relative to body weight, were increased
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in males exposed at the highest concentration, and in females exposed at 
the medium and high concentrations. Microscopic findings in the livers of 
the rats exposed at the high concentration Included occasional focal 
aggregations of mononuclear cells with either parenchymal or periportal 
distribution, and minimal degrees of periportal hepatocytlc vacuolation, 
and decreased centrilobular or periportal glycogen. These findings were 
not considered by the authors [99] to be of toxicologic significance. A 
statistically significant decrease in packed cell and mean cell volumes was 
found in male rats exposed at the high concentration. In this group there 
was also a low white cell count due to a decrease in the number of 
lymphocytes, and Increased thrombocyte activity. Blood glucose, SGOT, and 
serum sodium concentrations were decreased.
Von Wedel et al [205] described In 1942 the results of an experiment 
performed to determine the systemic effects of exposure of mice, guinea 
pigs, and rabbits, by inhalation, ingestion, and dermal application to an 
unspecified Aroclor. Concentrations and durations of exposure were not 
specified for the inhalation and Ingestion experiments. However, 0.5, 1.0, 
or 1.5 ml of solutions containing 0.5 g Aroclor/ml were used for the dermal 
applications. Within 5 days after the dermal applications, small papules 
and blisters formed on the exposed skin areas and the external epidermal 
layers became desquamated. In addition, subacute yellow atrophy of the 
liver with some fatty Infiltration was observed. Similar liver lesions 
were produced in the Inhalation experiment.
In 1944, Miller [206] administered Aroclor 1242 to rats, rabbits, and 
guinea pigs by subcutaneous (sc) injection, by oral intubation, and by 
dermal and corneal application. The PCB doses ranged from single doses of
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69 mg to small drops (approximately 17 mg) applied dally to the cornea of 
rats for 25 days, to 1,380 mg Injected dally Into rabbits for 10 days. 
Fatty degeneration and atrophy of the centrilobular cells of the liver were 
the characteristic signs of toxicity. The greatest amounts of liver damage 
were seen In guinea pigs, less was seen In rabbits, and the least amount In 
rats, regardless of the dose, duration of exposure, or route of 
administration. Necrotic lesions were also seen In the skin of animals 
that received sc Injections; signs of dermal Irritation were seen after 
applications to the skin. The conjunctival tissue presented no gross 
changes when examined under magnification in the living animals. Since the 
pathologic changes in Internal organs were similar regardless of method of 
administration, this experiment indirectly demonstrated that PCBs could be 
absorbed through the skin and the eye.
The effects of Solvol applied to the ears of rabbits were reported by
Parlbok [207] in 1954. Solvol was applied for 6 hours dally in doses of 
0.7 to 3.76 g. A single application caused edema and inflammation of the 
ear, and one rabbit died 7 days after the application. With multiple 
doses, the animals died after 6-17 days. The dead animals, including the 
one that died after the single application, had fatty degeneration of the 
livers.
Vos and Beems [208] reported in 1971 on the dermal toxicity of PCBs
in adult female New Zealand rabbits. Three commercial preparations of PCBs
were used: Clophen A60, Phenoclor DP6, and Aroclor 1260. Twenty-seven 1-ml 
(118 mg) applications of each of these products (in isopropanol), 5 
times/week over 38 days, to the clipped and shaved backs of the rabbits 
resulted in various manifestations of toxicity.
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In general, the toxic signe were most pronounced in the Clophen- 
treated animals and least pronounced with Aroclor 1260. Dermal findings 
included thickening of the skin due to hyperplasia and hyperkeratosis of 
the epidermal epithelium, and dilation and plugging of hair follicles with 
keratinous material. Microscopic study of liver sections showed a 
considerable diversity of lesions, including centrilobular degeneration, 
focal hydropic degeneration, focal necrosis, atrophy of centrilobular 
parenchymal cells, cytoplasmic hyaline degeneration, pigmentation of 
Kupffer cells, and, to a lesser extent, pigmentation of parenchymal cells. 
Renal damage was found in all PCB-treated animals. The most common 
findings were hydropic degeneration of the convoluted tubules, with nuclear 
pyknosis, and bursting and lysis of the tubular epithelial cells [208]. 
Dilation of the renal tubules, filled with casts of necrotic epithelial 
cells, was found in half the rabbits. These findings indicate that the 
dermal application of PCB mixtures causes systemic lesions of the liver and 
kidneys besides the direct effect on the skin. However, In other studies 
[19,21,23], it was determined that Clophen A60, Phenoclor DP6, and Aroclors 
1248 and 1254 were contaminated, to varying degrees [21], with highly toxic 
tetra- and pentachlorodlbenzofurans.
(b) General Effects of Oral Administration of PCB Mixtures 
Single-dose oral LD50's of several PCBs reported in rats (JW Cook, 
written communication, June 1970) generally indicated that as the degree of 
chlorination increased, the acute toxicity decreased. The more highly 
chlorinated products (Aroclors 1248-1268) were of approximately equal 
toxicity (LD50's of about 10 g/kg), whereas the LD50's of the less highly 
chlorinated products (Aroclors 1221-1242) ranged from about 4 to 9 g/kg.
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The minimum lethal doses of these PCBs applied to the skin of rabbits were 
generally in the range of 1-2 g except for 1221 which was in the range of 
2-3 g and 1268 which was >2.5 g.
The immunosuppressive activity of Aroclor 1260 was described in 1972 
by Vos and de Roij [209] who fed three groups of 12 4-week-old female 
albino guinea pigs the PCB at 0, 10, or 50 ppm in their diets for 8 weeks. 
Aroclor 1260 was analyzed and found to be free of contamination with 
chlorinated dibenzofurans, although it appeared to contain a minor 
acnegenic impurity. In each group, six animals received sc injections of 
aluminum phosphate-adsorbed tetanus toxoid to stimulate the lymphoid system 
(antitoxin production). The other six animals in each group served as 
positive or negative controls. Cellulose acetate electrophoresis was used 
to determine serum proteins, including gamma-globulins. The gamma- 
globulin-containlng cells in the popliteal lymph nodes were significantly 
reduced in the stimulated animals fed PCBs. Serum gamma-globulln levels 
were significantly decreased in the guinea pigs stimulated with tetanus 
toxoid and fed 10 ppm of Aroclor 1260 In their diet. Increased serum 
alpha-globulin levels were found in the stimulated guinea pigs fed either 
10 or 50 ppm of the PCB, and significantly increased concentrations of 
albumin were found In the- sera of both the stimulated and the unstimulated 
guinea pigs fed the PCB at 10 ppm. Also, both the absolute and relative 
weights of the cervical lymph nodes in the unstimulated group fed 10 ppm of 
Aroclor 1260 were significantly reduced whereas those of the mesenteric 
lymph nodes in the stimulated guinea pigs fed 10 and 50 ppm of PCB were 
significantly increased. These findings indicate that some 
immunosuppressive effect was produced by the feeding of PCBs. However, the
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decreases of the gamma-globulln levels were not found to be dose-related. 
No evidence of any PCB-induced change was observed in microscopically 
examined stained sections of liver, kidneys, adrenals, and skin.
Vos and Van Driel-Grootenhuis [210] reported their studies of the 
effects of PCBs on the humoral and cell-mediated immunities of guinea pigs 
in 1972. Three experiments were performed with different protocols. In 
the first experiment, the authors investigated the humoral immune response 
of guinea pigs fed 0, 10, 50, or 250 ppm of Clophen A60 in their diets and 
stimulated with a single sc injection of tetanus toxoid 3 weeks after the 
feeding regimen began. Suppression of humoral immunity was observed at the 
50-ppm level. Microscopic examination of the livers revealed centrllobular 
degeneration, cellular atrophy, cellular necrosis, and nuclear enlargement. 
At the 250-ppm level, no antitoxin production was observed.
The diets of guinea pigs in a second experiment [210] contained 0, 
10, or 50 ppm of Clophen A60 or 50 ppm of Aroclor 1260. Primary and 
secondary antigenic stimulations with tetanus toxoid were given after 3 and 
5 weeks. The experiment lasted 6 weeks. Suppression of the humoral Immune 
response was observed in groups fed 50 ppm of either PCB product.
Decreases in the weights of the thymuses and Increases In liver weights
were observed at the 50-ppm Clophen A60 level and, to a lesser degree, at 
the 50-ppm Aroclor 1260 level. The residual liver concentrations of PCBs 
increased as the dose level and the duration of exposure increased.
In their third experiment, Vos and Van Driel-Grootenhuis [210] fed 30 
guinea pigs diets containing Clophen A60 at 0, 50, or 250 ppm. After 3 
weeks, the animals were challenged with 0.05 ml of Freund's complete
adjuvant followed in 47 days by an injection of 0.1 ml of avian tuberculin
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antigen. The animals were killed 2 days later. All animals of the 250-ppm 
group died during the experiment, exhibiting retarded growth, atrophy and 
depletion of the lymphoid system, and liver damage. Significantly 
decreased thymus weights and Increased liver weights also were observed, 
and total white blood cell counts were reduced significantly.
Bruckner et al [211] administered Aroclor 1242 to rats by oral 
Intubation to determine Its acute and subacute effects. Two groups of six 
rats each were given single doses of either 2.5 or 6.0 g/kg of Aroclor 
1242. The initial effects observed at both dosages were the same for the 
first 4 hours, le, diarrhea, decreased spontaneous activity and muscle 
tone, decreased response to pain stimuli and mild chromodacryorrhea. 
However, during the next 24 hours the group receiving 6.0 g/kg had profuse 
diarrhea, adlpsla, oliguria, anorexia, erythema of the limbs, lack of 
response to pain stimuli, and general weakness. Eventually, ataxia, coma, 
and death followed. The condition of the rats receiving the lower dosage 
gradually Improved after the first 24 hours and was normal at the end of 72 
hours.
Another group of rats [211] that received single oral doses of 4 g 
Aroclor 1242/kg showed weight loss, elevated packed red cell volumes, 
Increased serum polymorphonuclear leukocytes, crenated red blood cells, and 
Increased SGOT activities. All organs appeared normal except the livers 
and kidneye. The livers exhibited foci of sudanophlllc vacuolatlon. The 
kidneys showed widely scattered foci of vacuolated tubular epithelial 
cells.
In the subacute studies conducted by Bruckner et al [211], six rats 
were given 100 mg of Aroclor 1242/kg orally every other day for 3 weeks;
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three control rats.received 100 mg/kg of peanut oil on the same schedule. 
Changes observed in the treated rats Included increased liver weights, 
decreased packed red blood cell volumes, Increased SGOT activities and 
marked increases in liver microsomal hydroxylatlng and N-demethylating 
enzyme activities. Microscopic examinations of the livers and kidneys 
revealed greater Increases In generalized lipid vacuoles than had been 
found with the acute doses. When single ip doses of 100 mg Aroclor 1242/kg 
were given to rats, increased N-demethylase and aniline hydroxylase 
activities were observed after only 24 hours [211].
The effects of lower dietary levels of Aroclor 1242 on rats were 
reported by Bruckner et al [212], who fed it to groups of six male Sprague- 
Dawley rats at concentrations of 0, 5, or 25 ppm for 2, 4, or 6 months. 
Small reductions In hematocrit and hemoglobin levels similar to those found 
in other studies by Bruckner et al [211,213] were seen. Urinary excretion 
of coproporphyrln was significantly Increased and dose-dependent Increases 
in liver microsomal hydroxylase activity were measured at the time of each 
sampling. Similar dose-dependent relationships were found in other 
experiments [213,214]. Proliferation of the hepatic endoplasmic reticulum 
was seen after 2 months of ingesting a diet containing 25 ppm of Aroclor 
1242; after 4-6 months of such ingestion, lipid vacuolization of the liver 
was evident.
In 1974, Bruckner et al [213] reported reduced weight gain, hepatic 
and renal damage, and an Increase in urinary coproporphyrln excretion In 
rats Injected ip with a total of 1.6 g/kg of Aroclor 1242 during a 10-week 
period. The hydroxylatlng and N-demethylating activities of the liver were 
significantly elevated 24 hours after a single ip Injection of 100 mg/kg of
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Aroclor 1242, with hydroxylating activity showing the greater increase. 
Cytochromes P-450 and b5 and NADPH-cytochrome reductase activities of the 
liver all were significantly Increased 3 days after dosing. A single dose 
of 50 mg/kg gave similar but less marked effects, whereas 25 mg/kg produced 
significant Increases In only hydroxylating and N-demethylatlng activities.
Kimbrough et al [215] described In 1972 some effects of 
chlorobiphenyl mixtures on the livers of rats. Groups of 3- to 4-week-old 
male and female Sherman strain rats were given Aroclors 1254 and 1260 at 0, 
20, 100, 500, and 1,000 ppm in their diets. Each group consisted of 10 
males and 10 females. Food consumption was measured periodically. The 
animals were fed the PCBs for 8 months.
One female fed 100 ppm of Aroclor 1260 died after 6 months and two 
females fed 500 ppm died after 1 and 2 months. Eight females fed the 1,000 
ppm diet died In 2-6 months. The rats fed 500 and 1,000 ppm gained less 
weight than did the controls. At autopsy, livers of the male rats fed 
Aroclor 1260 weighed significantly more than did livers of control male 
rats. Livers of the females were larger than normal but the weight 
differences were not statistically significant, although at 500 ppm the 
fractions of body weight represented by the livers increased significantly 
as a result of the reduced body weight gain. Microscopic findings in the 
livers Included hepatocytlc hypertrophy, Inclusions in the cytoplasm, brown 
pigment in the Kupffer cells, lipid accumulations, and, at the higher 
dietary levels, adenofibrosis. The nodular greyish-white areas that 
repreeented extensive foci of adenofibrosls consisted of fibroblasts and 
collagen that surrounded rosettes of epithelial cells [215],
77
Aroclor 1254 produced similar results [215]. One female and two male
rats died at 500 ppm, but none died at the lower dietary levels, and the
rats fed 500 ppm gained less weight than did controls. Ultrastructural 
changes in the livers of exposed animals consisted of proliferation of the 
smooth endoplasmic reticulum (SER) and atypical mltrochondrla. Similar 
changes have been observed in other experiments with PCBs [131,212,216- 
218]. A major difference between the effects of the two products was the 
much higher Incidence of hepatic adenoflbrosls at a lower dietary level of 
Aroclor 1254 (100 ppm). In general, the effects of Aroclor 1254 on the
liver were more pronounced than those of Aroclor 1260.
In 1973, Kimbrough et al [219] reported the results of a study 
conducted to determine whether morphologic changes produced in the liver 
would regrees after Ingestion of PCBs was stopped. Fifty male SPF Sherman 
strain rats were given Aroclor 1254 at 500 ppm in their diets for 6 months, 
and then were returned to normal diets. Groups of five rats were killed 0, 
1, 2, 3, 4, 6, 8, and 10 months after ingestion of PCBs had been
discontinued. The livers and adipose tissues of the 10-month group were
analyzed for PCBs. Control animals were used in all evaluations and were
fed only laboratory chow.
The livers of exposed animals killed when exposure to Aroclor 1254
was discontinued were enlerged and most of the 40 livers studied
microscopically showed enlarged hepatocytes, increased lipid contents, and
adenoflbrosls. A brown pigment was seen in the Kupffer cells and in other
macrophages of 15 livers. Small adenoflbrotic lesions consisting of
glandular epithelial cells that formed ducts surrounded by slight amounts 
of flbrotic tissue were seen; larger lesions had more extensive fibrosis
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and contained collagen. Similar findings had been reported earlier by 
Kimbrough et al [215] and both in the areas of adenofibrosis and in 
othewise normal hepatic tissue, Kimbrough [220] later reported finding 
small clusters of glandular type cells, resembling those of pancreatic 
tissue in general appearance and staining characteristics, In 15 of 36 rat 
livers with adenofibrosis. The cells stained red with the stain used for 
esterase, and developed a blue granular appearance with the stain used for 
protein bound tryptophan. These staining reactions were suggestive of 
those of salivary gland tissue to the author. The cells may have been 
derived from either ductal or vascular epithelium, but there is no evidence 
to substantiate either suggestion [220],
Signs of regression of the adenoflbrotlc lesions were not noted 
except for the disappearances of epithelial cells from the centers of the 
lesions [219]. Liver weights did regress to normal after 10 months without 
PCB exposure, but the lipid accumulation and the hypertrophy of the hepatic 
cells remained unchanged. Analysis of adipose tissues from the final group 
of rats killed showed that the PCB levels ranged from 924 to 1688 ppm 
(mean, 1192 ppm). Liver PCB levels ranged from 17.3 ppm to 26.2 ppm (mean, 
22.7 ppm). The PCB concentrations in the adipose tissue and livers of the 
control animals were less than 1.0 ppm. The authors [219] were unable to 
decide whether contamination of Aroclor 1254 with dibenzofuran was 
responsible for the observed liver lesions [219],
Kimbrough and Linder [221] reported in 1974 the results of a PCB- 
feeding experiment which they undertook to induce adenoflbrotlc lesions in 
the livers of BALB/cJ Inbred male mice, ie, lesions similar to those 
previously observed In rats fed Aroclors 1254 and 1260. Two hundred mice,
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5-6 weeks old, were distributed randomly into 4 groups of 50 each. Two 
groups were fed a ground diet containing 300 ppm of Aroclor 1254. At the 
end of 6 months, one of these exposed groups was placed on a PCB-free diet 
while the other exposed group continued on the test diet for another 5 
months. The other two groups served as controls and were fed the plain 
ground laboratory diet for the entire 11 months. The average PCB intake 
was 49.8 mg/kg/day in the mice fed the PCB diet for the entire 11-month 
period.
Livers of 45 of the 58 surviving control mice were found to be 
normal. The other 13 had focal round-cell infiltrates and sometimes small 
areas of necrosis and fibrosis. Skin abscesses, usually near the groin, 
were identified in all 13 control mice with hepatic round-cell infiltrates. 
These skin lesions were thought to be abscesses of the preputial glands. 
In comparison, 10 hepatomas were identified in 9 of the 22 survivors in the 
group fed the PCB diet for 11 months. These tumors consisted of well-
differentiated hepatocytes, relatively uniform in size but usually smaller 
than the surrounding liver cells. They were well circumscribed and 
surrounded by compressed hepatic parenchymal cells or strands of fibrous 
tissue. In the larger tumors, there were areas in which the sinuses were 
dilated and filled with a pink-staining amorphous material. No metastases 
were seen on gross Inspection of the organs, although no detailed
screening, such as serial sectioning of the lungs, was undertaken. Only 
one small hepatoma, composed of well-differentiated hepatocytes, was 
identified among the 24 survivors fed the PCB diet for only 6 months. The
authors [221] noted that the mouse strain used in this study rarely
develops hepatomas spontaneously.
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Adenofibrosis was identified in the livers of the mice subjected to 
the 11-month PCB diet. These lesions, according to the authors [221], may 
or may not be precursors of malignant lesions. They were seen in several 
areas of each liver as fibrosis and as glandular formations of proliferated 
epithelial cells replacing parenchymal cells. They formed ducts which 
produced mucus and which were surrounded by connective tissue of varying 
abundance.
Allen and Abrahamson [216] reported on morphologic and biochemical 
changes in the livers of rats given Aroclors 1248, 1254, and 1260 at 1,000 
ppm in their diets for 6 weeks. A control group was fed unsupplemented 
chow. Each group contained 24 rats. Four rats were killed after 
1,3,7,14,21, 28, and 42 days of exposure. White blood cells, hemoglobin
(Hb), hematocrit (Hct), differential white cell count, total serum 
proteins, and blood urea nitrogen (BUN) were measured at each interval. 
Selected tissues were prepared for microscopic examination and the livers 
were homogenized and analyzed for cytoplasmic protein, DNA, and RNA. Liver 
micro8omes were examined for aryl hydrocarbon hydroxylase, nitroreductase, 
N-demethylase, and nitrophenylacetate hydroxylase activities, and for 
cholesterol content.
All of the PCB-dosed rats failed to gain weight. The most severe 
effects were noted with Aroclor 1248, followed by Aroclors 1254 and 1262. 
All blood samples showed Increases in Hb and Hct, with no changes in the 
white blood cell counts. Neutrophils were increased in the sera of all 
treatment groups. There were no changes in BUN or in total serum protein 
levels. Organ weights in all of the experimental rats constituted higher 
percentages of total body weights than in controls; the livers showed four­
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fold increases in weight in all PCB-dosed groups. The increased liver 
weights were discernible after only 1 day of exposure. Liver hypertrophy 
was attributed to proliferation of SER, development of large concentric 
arrays of membranes, and Increases in lipid droplets within the cytoplasms 
of the affected cells. Aroclor 1248 was the most, and 1262 the least, 
toxic PCB product as judged by changes in liver histology. Liver 
homogenates contained increased concentrations of protein and RNA, and 
decreased concentrations of DNA. These changes were seen within 2 weeks 
after initiation of feeding Aroclors 1248 and 1254; the protein and nucleic 
acid concentrations then either leveled off or decreased after 4-6 weeks. 
Aroclor 1262, however, did not Induce these effects until 4 weeks after the 
beginning of feeding; the initial changes were followed by reversals [216].
Liver microsomal fractions had Increased protein and phospholipid 
concentrations. These changes occurred earlier In the rats fed Aroclor 
1248 and 1254 than in the Aroclor 1262-fed animals. Microsomal 
nitroreductase activity, expressed on the basis of microsomal protein, was 
variable In the animals fed Aroclors 1248 and 1254; however, all animals 
fed Aroclor 1262 had progressive increases In nitroreductase activity. N- 
demethylase activity increased early in the experimental period and 
Increased progressively In all treatment groups as the exposures continued. 
Aryl hydrocarbon hydroxylase, glucose-6-phosphatase, and other esterase 
activities increased initially, followed by continuous declines in activity 
In the groups fed Aroclors 1248 and 1254. The rats fed Aroclor 1262 had 
similar, but less marked, changes. When enzyme activities were expressed 
as activity per total liver, all showed marked increases. After 6 weeks,
other degenerative changes in the liver occurred, such as dissolution of
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the concentric arrays of membranes, vésiculation of the endoplasmic 
reticulum, and accumulation within the cytoplasm of llpld droplets that had 
developed during the hypertrophic phase of the Intoxication [216].
Allen et al [222] administered PCBs (Aroclor 1248) and 
polychlorinated terphenyls (Aroclor 5460) to rhesus monkeys. Sixteen male 
monkeys were distributed Into three groups. Group 1 consisted of six 
animals and was fed a basal diet supplemented with 300 ppm of Aroclor 1248. 
Group 2 consisted of six animais fed a basal diet containing 5,000 ppm of 
Aroclor 5460. The remaining four monkeys constituted the control group and 
were fed the standard colony diet. Each animal had access to 400 g of diet 
dally. The physical status of the animals was evaluated dally and 
"complete" blood studies were performed biweekly. Approximately 10 g of 
liver tissue were removed from each animal during the 6th week (via 
laparotomy) and during the 12th week (at necropsy) for biochemical and 
microscopic evaluation.
Animals fed Aroclor 1248 lost an average of 26% of body weight; those 
receiving Aroclor 5460 lost an average of 19% of body weight. Gross 
chenges seen in the animals fed Aroclor 1248 Included loss of hair from 
head, neck, and back, puffy faces, edematous lips, and swollen eyelids with 
purulent exudates around the eyes. These changes were seen within 1 month; 
similar, but less marked changes were seen In the animals fed Aroclor 5460 
[222].
Hematologic changes developed gradually. After 3 months, hemoglobins 
had decreased by about 2 g/100 ml, and hematocrits had diminished from 
about 40% to 33%. Total white blood cell counts did not change; however,
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there was a shift to the left in the differential count. Total serum 
proteins decreased by about 1.5-2 g/100 ml, and there was a gradual shift 
in the albumin/globulin ratio of the serum protein. No changes were seen 
in SGOT or BUN. Both experimental groups had similar patterns of changes 
[222].
At necropsy, both groups of animals showed extensive alopecia, 
acneiform lesions of the skin, subcutaneous edema, liver hypertrophy with 
fatty infiltration, and gastric mucosal hypertrophy and hyperplasia. Liver 
hypertrophy was attributed mainly to proliferation of the hepatocytic SER. 
Gastric hypertrophy was characterized by thickened gastric mucosa, numerous 
large cystic areas filled with mucin, and hyperplasia. Ulceration was 
seen, as was Invasion of the underlying mucosa by glandular-type epithelial 
cells [222].
The authors [222] noted that, biochemically, the decreases observed 
in the DNA concentrations of the livers of both experimental groups 
reflected the hypertrophic cells observed microscopically, and the 
increases in protein and RNA were said to be compatible with the 
proliferated SER. Levels of microsomal protein per gram of protein were 
not markedly altered, but decreases in the specific activities of esterase, 
aniline hydroxylase, nitroreductase, and glucose-6-phosphatase became 
apparent within 6 weeks, and persisted. N-demethylase activity was 
Increased at each examination.
The results of a toxicity study conducted on four young male rhesus 
monkeys fed Aroclor 1242 at concentrations of 3, 10, 30, or 100 ppm were 
reported by Bell [223], McNulty [94], and in a communication written in
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March 1977 by WP McNulty. All four monkeys on these diets died within 9 
months. The monkeys had facial swelling, red and swollen eyelids, 
conversion of all secretory-type cells of the stomach to mucous cells, 
growth of mucous glands Into the muscular walls of the stomach, multiple 
ulcers in the stomach, atrophy of the thymus gland, and either 
disappearance of sebaceous glands or conversion of these glands to keratin 
cysts, particularly in the eyelids.
Allen et al [104] and Allen and Norback [224] found gastric 
hypertrophy and hyperplasia and focal ulceration of the stomach lining In 
adult male rhesus monkeys fed single doses of 1.5 or 3.0 g of Aroclor 1248.
(c) Studies Involving Individual PCB Isomers
In 1972, Vos and Notenboom-Ram [225] discussed the comparative
toxlcitle8 of dermally applied 120-mg doses of 2,2',4,4',5,5'-
hexachlorobiphenyl and Aroclor 1260. The PCBs, dissolved in isopropanol, 
were applied 20 times to the clipped and shaved backs of three groups of 
four rabbits each, 5 times/week for 4 weeks. The control group received 
only Isopropanol. The Aroclor 1260 sample was found to be "free" of 
chlorinated dlbenzofurans (limit of detection, 1 ppm), and because of the 
nature of the chemical reactions utilized in the synthesis of
2,2',4,4',5,5'-hexachlorobiphenyl. Dermal applications of these PCBs 
resulted in early macroscopic skin lesions and morbid liver changes similar 
to those found by Vos and Beems [208]. These liver lesions included
centrllobular degeneration and liver cell atrophy, focal cytoplasmic 
hyaline degeneration of the hepatocytes, enlarged nuclei, loss of glycogen 
and proliferation of SER. The authors [225] concluded that, although the
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major acnegenic action of crude PCB mixtures results from the presence of 
chlorinated dibenzofurans, PCBs have acnegenlc actions of their own.
Hansell and Ecoblchon [217] described the effects of a series of 
chemically pure chlorobiphenyls on rat liver morphology. Biphenyl and a 
series of isomerically 'pure mono-, di-, tetra-, hexa-, and 
octachloroblphenyls of known composition were administered lntraperltoneal 
(ip) injections in daily doses of 50 mg/kg to groups of seven young male 
Woodlyn strain Wlstar rats for 3 consecutive days. The rets were killed 4 
days after the final Injections had been made and sleeping times after 
phenobarbltal administration had been determined. The major microscopic 
alterations observed were proliferation of the hepatocytlc SER, changes in 
the rough endoplasmic reticulum, end Increased numbers of lipid droplets 
and mlcrobodles. However, In the rats administered isomerically pure hexa- 
and octachloroblphenyls, there were additional changes in hepatic 
morphology, including large numbers of hepatocytes with cytoplasmic 
vacuoles and small foci of necroeis involving five or six cells. Biphenyl 
and 2,2'-dichloroblphenyl appeared not to Induce extensive proliferation of 
the SER, but with the other compounds the SER proliferation appeared to be 
related to the degree of chlorination, especially to the preeence of a 
chlorine in the 4 and/or 4' positions.
The investigators [217] also injected groups of seven rats ip with 
daily doses of 100 mg/kg of either 4-mono-, 4,4'-dl-, or 2,5,2',5'- 
tetrachlorobiphenyl for 7 days; all rats from each group were killed 24 
hours after the last injections. This regimen caused more pronounced 
alterations in hepatocytlc ultrastructure than those observed after the 3- 
day experiments. Marked proliferation of SER and lncreaaed numbers of
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microbodies and lipid droplets were noted, as were a large number of 
necrotic foci, centrilobular necrosis, and proliferation of biliary 
ductules. The most severe lesions were seen in the group receiving 4,4’- 
dichlorobiphenyl. There was not the increase in hepatic weight and cell 
size noted by other authors [219,226]. Hansell and Ecobichon [217] 
observed that this apparent anomaly may have been due to the duration of 
PCB administration, only 3-7 days, and to the relatively low dosages.
Allen et al [226], in a series of experiments, studied the toxicity 
of 2,2',5,5'-tetrachlorobiphenyl in rats and rhesus monkeys. In the first 
experiment, 5-week-old rats were separated into five groups consisting of 
five males and five females each. After being fasted overnight, each of 
these groups was administered by gavage a single dose of one of the 
following amounts of the compound dissolved in corn oil: 0, 0.5, 1.0, 1.5,
or 2.0 g/kg. Each dose had a total volume of 1 ml. After the dose had 
been given, blood was taken for complete blood counts. Eighteen of the 40 
PCB-dosed rats died within 3 days. The dead animals Included all those 
given 2.0 g/kg, 7 rats from the group given 1,5 g/kg, and 1 rat from the 
1.0 g/kg group. The rats were observed for 21 days after which complete 
blood counts were performed and the surviving animals were killed and 
necropsled. The major pathologic changes observed In the animals that died 
were marked regressions of lymphocytes in the spleen and lymph nodes and of 
cortical thymocytes. With the exception of hemorrhage and atrophy of the 
thymus, which were related to the decrease in the cortical thymocytes, and 
enlargement of the liver and kidneys, all tissue samples were normal when 
compared with those from the nonexposed group.
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The second experiment was conducted to determine the effects of 
hepatic microsomal enzyme activity on the responses of male Sprague-Dawley 
rats to 2,2',5,5'-tetrachlorobiphenyl [226], The rats were separated into 
6 groups of 10 animals each. Group 1 was a positive control given four ip 
injections of 75 mg/kg of the microsomal enzyme inhibitor, SKF 525A, at 8- 
hour intervals. Group 2 was given four daily sc injections of 75 mg/kg of 
phénobarbital. Group 3 was the general control. Groups 4, 5, and 6
received 1.25 g/kg of the chloroblphenyl in 1 ml of corn oil by gastric 
intubation; group 5 was dosed with the chloroblphenyl 24 hours after 4 days 
with daily sc doses of 75 mg/kg of phénobarbital. Group 6 received 75 
mg/kg of SKF 525A Ip 2 hours prior to administration of 2,2', 5,5'- 
tetrachlorobiphenyl, and every 8 hours thereafter for 24 hours. Within 4 
days, all the rats in group 5 and 50% in group 4 had died whereas none had 
died in group 5, which was pretreated with phénobarbital. The findings 
that pretreatment with phénobarbital allowed complete survival of rats 
after an LD50 dose of the PCB, whereas pretreatment with SKF 525A caused 
100% mortality, Indicated to the Investigators that metabolic
transformation by endoplasmic reticulum enzymes resulted In deterification 
[226].
The third experiment was performed to compare the differences between 
the responses of rats to 2,2* ,5,5'-tetrachlorobiphenyl and Arodor 1248 
[226]. Twelve male rats were placed in three groups of four animals each; 
group 1 was fed 100 ppm of Aroclor 1248 in Its diet, group 2 was given 100 
ppm of the 2,2',5,5' isomer in its diet, and group 3 (control) was fed the
staple ground meal diet. After 4 weeks of these feeding regimens, the rats
were fasted for 24 hours, killed, and necropsled; blood was also collected
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at this time. There were no detectable differences In general appearance, 
food consumption, activity, growth rate, or blood chemistries between the 
two experimental groups and the control group. The only significant 
difference at autopsy was an increase in liver weight as a percentage of 
body weight of the animals fed Aroclor 1248: 4,46 ± 0.11%, compared with 
3.38 ± 0.13% for those fed 2,2',5,5'-tetrachlorobiphenyl and 3.0 ± 0.12%
for the controls. Proliferation of the endoplasmic reticulum within the 
hepatic cells was observed in the Aroclor 1248-fed animals. The N- 
demethylase activity and the cytochrome P-450 content of the microsomal 
fraction of homogenized liver from the Aroclor 1248-fed rats were increased 
whereas the activity of aniline hydroxylase and glucose-6-phosphatase in 
this fraction had decreased. There were Increases in the concentrations of 
protein and RNA and a decrease in the DNA content of the liver homogenates 
from the Aroclor-fed animals. The livers of rats fed the Isomer had 
similar but less marked changes in concentrations of protein, RNA, and DNA. 
The mean concentration of microsomal protein in liver was identical with 
that of the controls but was more variable. A significant Increase in the 
mean activity of N-demethylase was found.
The fourth experiment [226] was performed to determine the effects of 
2,2',5,5'-tetrachlorobiphenyl on non-human primates. Seven adult male 
rhesus monkeys were given 18 mg/kg of the PCB isomer dissolved in 2.5 ml of 
corn oil and three controls were given 2.5 ml of c o m  oil, all by gavage 
after a 24-hour fast. Complete blood counts had been done on each animal 
prior to intubation. Immediately after treatment, the animals were placed 
in metabolism cages and their urine and feces analyzed for 2,2',5,5'-
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tetrachlorobiphenyl by GLC. On the 14th day of the experiment the animals 
were fasted for 24 hours, killed, and necropsied. Tissues were taken for 
light and electron microscopy and GLC. No overt clinical effects were seen 
in the treated monkeys. Over 12% of the PCB was recovered unmodified in 
the feces but only minute amounts were present in the urine. Only the 
adipose tissue and adrenals had high PCB assays, and microscopically, 
except for a moderate proliferation of hepatocytic SER, all tissues were 
normal. DNA was slightly decreased in liver homogenates of exposed animals 
and hepatic microsomal cytochrome P-450 was increased.
Torok [227], in 1976, reported a study of pregnancy in NMRI mice 
treated with 2,2'-dichlorobiphenyl. The mice were separated into three 
groups, with group 1 (37 mice) serving as the control; group 2 (18 mice) 
received the PCB in oral doses of 375 mg/kg/day on days 1-3 of gestation, 
and group 3 (37 mice) received 750 mg/kg/day on the same schedule. 
Administration of the PCB at either level resulted in longer intervals from 
breeding to parturition: 18.2 days for controls, 19.4 days for mice
treated with the PCB at 375 mg/kg/day, and 21.8 days In mice treated at 750 
mg/kg/day. There also were reductions in the numbers of dams with litters 
and In the mean litter size. Reductions were greatest in group 3. The 
authors [227] concluded that the effects were due to delayed implantation,
(d) Reproductive and Teratogenic Effects of PCB Mixtures 
Curley et al [101] studied the transplacental movement of PCBs in 
rats. Three groups of 90-day-old female rats were paired with male rats of 
the same age. All were fed standard laboratory chow by the authors, who 
designated the day of insemination as day 0. Aroclor 1254 was given in
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doses of 0, 10, and 50 mg/kg In peanut oil (presumably by oral Intubation) 
once a day on days 7 through 15 of pregnancy to groups 1, 2, and 3,
respectively.
On the 20th day after Insemination, fetuses were taken by Caesarean 
section from three rats of each PCB-exposed group and from two control 
rats. The fetuses from each experimental group were divided Into two lots 
and analyzed as duplicate samples for PCBs. Ten rats from each of the 
three experimental groups were allowed to deliver spontaneously. When the 
offspring were 5 days old, six mothers from each exposed group and two from 
the control group were separated from their litters for several hours and 
then returned for 1 hour of nursing. The contents (milk) of the pups' 
stomachs were analyzed for PCBs. Litters from three rats in each 
experimental group were allowed to survive until weaning at 21 days of age. 
These baby rats then were killed and their tissues analyzed for PCBs by GLC 
with EC detection [101].
The rats subjected to Caesarean section had normal fetal complements, 
in both size and number, and in the rats allowed to deliver spontaneously 
there were no significant differences in average litter size and weight 
among the three groups. However, the three groups, with 0, 10, or 50-mg/kg 
doses of Aroclor 1254, had 0, 1, and 4 stillbirths on the average,
respectively [101],
Analyses of the tissues of the Caesarean-delivered pups showed 
measurable levels of PCB-derived components in the exposed groups only. 
The mean PCB concentrations were <0.12, 0.63 ± 0.06, and 1.38 ±  0.06 n g / g ,  
respectively, for groups 1, 2, and 3. Although the PCB dose for group 3 
was five times that of group 2 (50 vs 10 mg/kg Aroclor 1254), the average
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amount of PCB-deriyed components measured In the fetuses from these two 
groups differed by only two-fold. The authors suggested that the PCB 
distribution between the mothers and their fetuses may not have been
uniform and that a partial (unspecified) barrier may have existed [101],
Livers were increased in size and had enlarged hepatocytes In 15 of 
21, and 15 of 20 weanling rats from groups 2 and 3, respectively. Some 
rats from group 3 showed vacuolization of the hepatocytic cytoplasm (10 of 
20), and 5 of 20 exhibited bile duct proliferation. Morphologic changes in 
the liver were more pronounced at the higher dose [101],
PCB-derived components were detected in litter-pooled milk at mean 
concentrations of <0.75, 20.60 ± 1.59, and 66.3A ± 8.36 *ig/g in groups 1, 
2, and 3, respectively. The authors [101] concluded that the morphologic 
changes identified in the livers of exposed weanling rats were probably 
caused by PCBs transmitted to the pups in the milk from the dams [101].
Reproductive effects of feeding Aroclors 125A and 1260 to Sherman 
strain rats for two generations were reported by Linder et al [228] in
197A. In preliminary experiments, the two mixtures were fed to groups of
10 females at 100 and 500 ppm in the diet. Two similar groups served as 
controls. The diets, fed for 67 days before the first mating, were 
continued through gestation and lactation. After weaning of the first 
litters, the parents continued to be fed the diets. After being fed PCBs 
for a total of 186 days, they were again mated and the diets fed through 
the second gestation and lactation. Feeding Aroclor 125A at 500 ppm 
resulted in only A first litters being born (2 alive), with no survivors to 
weaning. Consequently, feeding Aroclor 125A at 500 ppm was discontinued. 
With Aroclor 125A at 100 ppm, there was little indication from either the
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first or second mating of reduced fertility, or Increased death in utero or 
during the nursing period. Aroclor 1260 fed at 100 ppm for 67 days had no 
apparent effect on reproduction, litter size, or survival of the first 
litters; however after being fed for 186 days, only 5 second litters were 
born from 9 mated females, compared to 9 out of 10 in the controls. At 500 
ppm, Aroclor 1260 resulted in more pups dead at birth in first litters, 
reduced second litter size, and fewer litters being weaned (3 of 8 first 
litters; 2 of 6 second litters).
Subsequently, Linder et al [228] fed groups of 20 female Sherman rats 
Aroclor 1254 at 1, 5, 20, and 100 ppm and Aroclor 1260 at 5, 20, and 100
ppm. Appropriate control groups with similar numbers of rats were used. 
The experimental plan was similar to that described above except that the 
FI generation pups continued to be fed the F2 generation diet until they 
reproduced the F2 generation. The first matings of the FI generation were 
after they were exposed to PCBs in utero, in milk, and in the diet for 125— 
129 days. The FI generation rats fed Aroclor 1254 at 20 and 100 ppm were 
mated a second time after a total of 274 daye of PCB exposure.
Rats exposed to Aroclor 1254 at dietary levels of 20 ppm or more had 
fewer pups in their litters than the controls [228]. There were also fewer 
F2 generation pups then controls. Second litters b o m  from rats fed 100 
ppm of Aroclor 1254 had increased mortality and markedly decreased mating 
performance. Dietary levels of 5 ppm Aroclor 1254 and 100 ppm Aroclor 1260 
had no effect on reproduction in rets exposed through two generations. 
Liver weights were increased in 21-day-old FI male weanlings at 1 ppm of 
Aroclor 1254 and in either sex of FI and F2 weanlings at 5 ppm or higher of 
both Aroclors 1254 and 1260.
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Villeneuve et al [229], in 1971, wrote about fetotoxic effects of 
Aroclors 1221 end 1254 in rabbits. Twenty-four mature female rabbits were 
divided into six groups each comprised of two control and four experimental 
does. Experimental animals were given the Aroclors orally at 1.0 and 10 
mg/kg/day beginning after mating and continuing through gestation.z They 
were killed 28 days after mating. Neither Aroclor had a fetotoxic effect 
at either dose level. Liver weights expressed as percentages of body 
weight were significantly heavier in the does fed 10 mg/kg Aroclor 1254 
than in controls (4.29 vs 2.79Z). Liver weights of the other experimental 
does and of all fetuses were not significantly different from controls.
In another experiment reported by Villeneuve et al [230], 16 mature 
female rabbits were separated into four groups and, after mating, were
dosed orally with 0, 12.5, 25, or 50 mg/kg of Aroclor 1254 daily for the
first 28 days of gestation. The 50-mg/kg group had three pregnancies.z One 
pregnant female died on the 11th day and contained nine fetuses. A second 
one died on the 17th day and contained six resorption sites. The third 
female aborted three dead fetuses on the 28th day. Two rabbits in the 25- 
mg/kg group had normal fetuses. A third rabbit aborted her litter on the 
28th day and died. The four animals in this group showed an average weight 
loss of 26 g and liver weights found at autopsy 29 days after mating 
averaged 5.11Z of their body weights. Autopsies were performed on the 
fetuses of the two rabbits which had conceived in the 12.5-mg/kg group; the 
first rabbit had two normal fetuses, with six resorption sites, while the
second aborted two fetuses on the 27th day and was found on autopsy to
contain one partially resorbed and two dead fetuses. The two dead fetuses 
obtained on autopsy showed subcutaneous cephalic hemorrhages and had
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asymmetric skulls. Average weight gain of the females during pregnancy was 
265 g, and their liver weights averaged 6,03% of their body weights. 
Controls gained 654 g during pregnancy, and their livers averaged 2.66% of 
their body weights.
In their third experiment, Villeneuve et al [230] gave each animal In
three groups of six female rabbits 25 mg/kg Aroclor 1254 in corn oil
(orally). Controls received corn oil alone. A control group and one 
exposure group were dosed from day 1 through day 28, and another control 
and an exposure group were dosed from day 7 through day 28. Administration 
of Aroclor 1254 at 25 mg/kg/day from day 1 through day 28 resulted in 
abortions in two of four rabbits. Their average weight gain was 245 g and 
liver weights averaged 6.03% of their body weights (controls, 531 g weight 
gain; liver weights, 2,65% of body weight). In the second group 
administered PCBs, one of four rabbits aborted. Average weight gain was 
156 g and the liver weights averaged 4.82% of the body weights.
PCB concentrations in various tissues of six rabbits and their 
fetuses, chosen at random from the above groups, were determined by Grant 
et al [231]. Concentrations of PCBs were higher in the livers of the 
fetuses then in their mothers: 5.4 vs 2.1 ppm at a dose of 1 mg/kg; 78.1 vs
69.5 ppm at 12.5 mg/kg; and 375.3 vs 124.2 at 25 mg/kg. In other tissues,
PCB concentrations were generally less In the fetuses than in the dems.
Allen et el [232] In 1974 presented evidence of possible fetotoxlclty 
in a short term PCB feeding experiment with 12 adult female rhesus monkeys. 
The monkeys ranged In age from 7 to 10 years and had an average weight of 
5.6 kg. Each previouely had delivered at least one Infant and the 
menstruel cycle of each had been recorded for et least 2 years. Six of the
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monkeys were fed an unspecified diet containing 25 ppm of Aroclor 1248 for
2 months. The other six monkeys were controls. After 2 months, the PCB- 
exposed animals were placed on PCB-free diets of commercial monkey chow.
The monkey which had consumed the largest amount of PCBs died on the 
128th day of the experiment [232]. At the beginning of the 5th month, ie,
3 months after the test animals had been removed from the PCB-containing 
diet, the remaining five test monkeys and the six controls were mated 
again. Three PCB-exposed monkeys were thought to have conceived since each 
showed the characteristic post-conceptual bleeding, lack of the subsequent 
menstrual period, and an enlarged uterus. Two either aborted or reabsorbed 
their fetuses during the 2nd month of pregnancy and the third monkey 
delivered a well-developed but smaller-than-normal (375 g ± 1 g vs 544 g ± 
101 g) Infant. High concentrations of PCBs were found in the adipose 
tissues and adrenals of this infant with means of 27.7 and 24.4 pg/g, 
respectively, as compared to a range from 0.01 to 0.98 jxg/g in the other 
Infant tissues analyzed. The PCB levels in the placenta averaged 0.9 ¿tg/g, 
and 50 jig/g in the mother's adipose tissue. Two additional attempts were 
made to breed the nonpregnant females during the next 5 months. Only the 
controls became pregnant and all delivered normal infants. Six of the 
monkeys were fed an unspecified diet containing 25 ppm of Aroclor 1248 for 
2 months. The other six monkeys were used as controls. After 2 months, 
the PCB-exposed animals were placed on PCB-free diets of commercial monkey 
chow.
In 1976, Barsotti et al [233] and Allen and Barsotti [234] reported 
their findings on reproductive dysfunction in female and male adult rhesus 
monkeys fed Aroclor 1248 in their diets. One test group of female monkeys
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received 2.5 ppm and the other group received 5.0 ppm of Aroclor 1248 in a 
commercial diet. The control group, containing 12 females and 6 males, was 
fed the commercial diet alone. Females received 200 g, and the males 
received 300 g of their respective diets daily. Food left in the feeding 
cups at the end of the day was removed and weighed to determine the daily 
intake. After the end of the first 6 months, the average PCB intakes were 
180 and 364 mg for females fed the 2.5- and 5.0-ppm diets, respectively 
[233].
Some of the exposed females began to exhibit the characteristic skin 
and blood chemistry signs of PCB intoxication within 2 months. At 6 
months, all exhibited these signs in varying degrees. Menstrual cycles 
were Irregular and menstrual bleeding was excessive and prolonged [233].
The conception rates for the control females and for those fed the 
2.5-ppm Aroclor diet were 12 of 12 and 8 of 8, respectively, whereas 6 of 8 
females fed the 5.0-ppm Aroclor diet conceived [233], All 12 of the 
control group pregnancies resulted in normal births, compared to 5 and 1, 
respectively, for the exposed females fed the 2.5- and 5.0-ppm diets. 
Three of the eight fetuses of monkeys fed the 2.5-ppm Aroclor diet were 
resorbed shortly after conception. Profuse uterine hemorrhaging was 
observed rather than the Implantation bleeding which usually occurred 17 
days after conception, according to the authors [233], The two females
from the group fed the 5.0-ppm diet who did not conceive initially were
bred five times without success. Of the six females of this group that did 
become pregnant, three aborted at 46, 67, and 107 days of gestation; one
fetus was resorbed, one was stillborn, and one delivered normally. The six 
live infants born to PCB-fed mothers had body weights that were less th*n
normal for the colony by one to two standard deviations. These infants 
began showing signs of PCB toxicity (acne, swollen eye lids, increased skin 
pigmentation) after nursing their mothers for less than 2 months [234]. In 
samples obtained from three of their mothers after the infants developed 
the poisoning signs, the milk contained PCBs at 0.154-0.397 ppm, and the
milk fat from a fourth mother contained 16.44 ppm. Three of the infants
died 44-112 days after birth.
The effects of Aroclor 1254 on reproductive performance and fetal 
integrity were evaluated in beagle dogs and Hormel miniature swine by FL 
Earl et al (written communication, 1976). Aroclor 1254 was administered 
orally in capsules as a solution in corn oil to 46 purebred beagle bitches 
once dally efter the 1st day of gestation. Ten bitches were given 0.25 
mg/kg/day, 16 were given 1 mg/kg/day, and 20 were given 5 mg/kg/day. 
Sixteen untreated bitches served as controls.
The data presented ehow that Aroclor 1254 at 5 mg/kg/day
significantly interfered with reproductive performance and was teratogenic 
in the beagle. When Aroclor 1254 was administered at 0.25 and 1.0
mg/kg/day, no effects on reproduction were observed but the Incidence of 
patent fontanelles in the offspring of the 1.0-mg/kg/day group was
Increased sharply. Dosage at 5.0 mg/kg/day resulted in 45.5% resorptions
(4-fold increase over the control rate) and an average of only two live
pups per litter. Patent fontanelles were present in 50% of the offspring.
Earl and his coworkers fed Aroclor 1254 to Hormel miniature swine in 
doses of 1.0 (4 sows), 10.0 (6 sows), and 30.0 (7 sows) mg/kg/day for 21 
days before breeding and throughout gestation. Five sows served as 
controls. The 1-mg/kg/day dose produced a statistically significant
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percentage of fetal resorptions (23%). Increasing the dose to 10 mg/kg/day 
lowered the fertility rate to 50% (80% in controls) and increasing the dose 
to 30 mg/kg/day lowered the fertility rate to 43%. Cleft palate and 
syndactyly in three feet were observed in one fetus from the group fed 10 
mg/kg/day. At this dose level, there was also a significant decrease in 
survivability with only 71% of the offspring alive after 5 deys. At the 
30-mg/kg/day dose, 14 of the 15 implantations were resorbed and teratogenic 
abnormalities were present in 100% of the observed fetuses. Cleft palates, 
syndactyly, and patent fontanelles were the teratogenic effects observed. 
The fact that pigs are normally born with closed fontanelles Increases the 
slgnficance of the teratogenic findings.
(e) Studies on Mutagenicity and Cytotoxicity
To evaluate the effects of PCBs on the testes of rats, Dlkshlth et al 
[235] administered, by oral intubation, 50 mg/kg/day of Aroclor 1254 
dissolved In corn oil*to a group of 18 adult male Sprague-Dawley rats for 7 
consecutive deys. A control group of 18 rats received corn oil without 
PCBs. Three rats from each group were killed 1, 7, 15, and 30 days after 
the last PCB administration. The testes and epldldymises were separated 
and weighed, as were the livers. Microscopic, hlstochemlcal (acid 
phosphatase), and cytogenetic examinations were performed. Rats used for 
cytogenetic examination were injected ip with colchicine 2 hours before 
being killed and the chromosomes in testicular tissues were examined.
No effects on weight or gross eppeerance of either the testes or 
epldldymie were noted, nor was there evidence of atrophy or hypertrophy of 
the testee. The only structural changes noted in the testes of the exposed 
group was a proliferation of interstitial tissue cells. These celle showed
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an increase in acid phosphatase activity, which, according to the authors 
[235], denoted a change from particulate enzyme localization in testicular 
interstitial cells of the controls to a disseminated, diffuse localization 
in the testes of the exposed group.
Cytogenetic analyses showed similar chromosomal configurations in 
both the control and the exposed groups. In the PCB-treated rats, some
apparently sporadic abnormal chromosomes were seen in a few of the
metaphase figures; chromosomal abnormalities also Included breaks, exchange 
figures, chromatin bridges at anaphase, and chromosome fragments. The 
significance of these findings was unclear to the authors [235].
Green et al [236] looked for mutagenic effects in the bone marrow and 
spermatogonial cells of male Osborne-Mendel rats fed various doses of PCBs. 
Rats were given Aroclor 1242 either in single oral doses of 1,250, 2,500, 
or 5,000 mg/kg or in multiple oral doses of 500 mg/kg/day for 4 days.
Aroclor 1254 was administered orally in daily doses of 75, 150, or 300
mg/kg for 5 days. The Aroclors were mixed with corn oil, except the 5,000- 
mg/kg dose of Aroclor 1242, which was given undiluted. Controls were fed 
uncontaminated corn oil. The animals were given Colecimid (a colechicine 
derivative) at 4 mg/kg 24 hours after PCB dosing was completed and they 
were killed 3 hours later.
Aroclor 1242 produced no statistically demonstrable evidence of 
chromosomal damage In bone marrow cells at doses of 1,250 or 2,500 mg/kg, 
or at the 500-mg/kg dose level [236]. At 5,000 mg/kg, there appeared to be 
an increase in the number of chromosomal abnormalities. However, since 
most of the changes occurred in one animal, the findings were not 
considered to be significant. Aroclor 1254 did not produce statistically
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significant numbers of chromosomal abnormalities In bone marrow cells at 
any dose level tested. A statistically significant number of chromosomal 
abnormalities was not identified in spermatogonlal cells from rats fed 
Aroclor 1242. Spermatogonlal cells from rats given Aroclor 1254 were not 
examined since the results with the more acutely toxic Aroclor 1242 were 
negative. All observed chromosomal lesions were single chromatids. The 
authors [236] did not exclude the possibility of point mutations since the 
procedures used in this experiment would not have detected such damage.
Green et al [237] also Investigated the possible induction of 
dominant lethality in rats given Aroclor 1242 or Aroclor 1254 by oral 
intubation. Except for the positive controls, results showed 
nonreproduclble positive effects that were not related to dose or stage 
sensitivity. The authors concluded that the two Aroclors did not appear to 
be mutagenic.
Wyndham et al [116] performed the "Ames" bacterial test for 
mutagenicity on a variety of PCBs, using Salmonella typhlmurium mutant 
strain TA1538. A comparison was made of the mutagenic potentials of 
Aroclor 1254, 2,2'.S.S'-tetrachlorobiphenyl, Aroclor 1268, Aroclor 1221, 
and 4-chlorobiphenyl. The results showed clearly that as the degree of 
chlorination decreased, the mutagenic potential increased. A concentration 
of 100 f i g  of 4-chlorobiphenyl in the test medium gave over 2,000 revertant 
colonies/plate. The more highly chlorinated biphenyls showed very little 
activity as mutagens.
Hoopingarner et al [238] studied the toxicities of various Aroclors 
at 50 ppm in the culture medium of Chinese hamster cells, and found 
Increasing toxicity (measured by cell population survival) with decreasing
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chlorination. Aroclor 1016 appeared to be disproportionately cytotoxic, on 
the basis of its chlorine content, suggesting to the authors that this 
product contained certain toxic components in higher proportions than 
either Aroclor 1232 or Aroclor 1242, which it resembled 
chromatographlcally. Aroclor 1254 at 100 ppm showed no apparent effect on 
the chromosomal integrity of human lymphocytes in vitro.
Popper et al [239] studied the effect of hepatic microsomal 
biotransformation systems from control mice and from mice treated with PCBs 
on the mutagenic potentials of the primary carcinogen N-methyl-N’-nitro-N- 
nltrosoguanldlne (MNNG), and the secondary carcinogen dlmethylnltrosamine 
(DMN). Hepatic mlcrosomes were isolated from male Swlss-Webster mice that 
had been given 500 mg/kg of Aroclor 1254 4 days earlier, and from untreated 
control mice. The mutagenicities of MNNG and DMN were assayed by a 
bacterial auxotroph reversion test using Bacillus subtllis.
Mlcrosomes prepared from the livers of the PCB-treated mice had 2-3 
times as much cytochrome P-450 activity as the controls [239]. DMN added 
directly to the cultures was not mutagenic at concentrations as high as 300 
mM. However DMN was converted to a mutagen when exposed to such mlcrosomes 
in the presence of an NADPH-generating system. When MNNG was incubated 
with isolated mlcrosomes, its mutagenic activity was reduced. The authors 
concluded that Isolated hepatic mlcrosomes can modify the biologic 
activities of mutagens and that the hepatic microsomal blotransformatlon 
system could play a key role In chemical mutagenesis.
(f) Studies on Tumorlgenesls
Kimbrough et al [218] distributed 400, 21- to 26-day-old weanling, 
Sherman strain, "COBS" female rats randomly into two equal-slze groups.
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Half of the rats were fed a plain commercial laboratory chow. The other 
200 were fed laboratory chow containing 100 ppm of Aroclor 1260. The dosed 
group of rats was fed the PCB diet until 6 weeks before they were killed at 
the age of 23 months. Autopsies were performed on these rats as well as 
those that died before the exposures ended.
Microscopic examination was completed on 184 dosed animals and 173 
controls. From a few to multiple elevated tan nodules were found on the 
liver surfaces of 170 PCB-fed rats. The nodules varied from 0.1 to several 
cm in diameter. Only one such abnormality was found in the controls. Of 
the tumors, 26 of those in exposed animals and the 1 from the control 
animal were hepatocarcinomic; the other 144 experimental animals had 
hepatocellular nodules that were described as characteristic of neoplastic 
nodules or synomously, hyperplastic nodules. The authors [218] said 
"neoplastic nodules are part of the spectrum of response to 
hepatocarcinogens and must be Included in the evaluation of tumorigenesis." 
Tumors Identified and analyzed from other organs had no unusual features; 
no apparent differences in Incidence were observed between the experimental 
and control groups [218].
Evidence of PCB-induced hepatocarcinomas was reported by a group of 
Japanese investigators in 1972 [240] and in 1973 [241]. Nine groups of 12
male dd mice were fed a commercial stock diet supplemented with 100, 250, 
or 500 ppm of Kanechlors 300, 400, or 500. A control group of eight mice 
was fed the stock diet. All mice were given water ad libitum. After 32 
weeks, the animals were starved for 18 hours, killed, and examined 
macroscopically for tumors. Seven of the 12 mice fed Kanechlor 500 at 500 
ppm developed hyperplastic liver nodules and five had well-developed
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hepatocellular carcinomas. None of the mice fed Kanechlor 500 at lower 
concentrations or Kanechlor 400 or 300 at any concentration developed 
hepatocarcinomas.
In 1973, Kimura and Baba [242] described neoplastic changes in the 
livers of rats exposed to Kanechlor 400. Thirty 10-week-old rats were 
separated into an experimental group of 10 males and 10 females and a 
control group of 5 males and 5 females. The experimental group was fed a 
diet supplemented with olive oil containing various concentrations of 
Kanechlor 400. The control group received an olive oil-supplemented diet. 
The diet of the experimental group of rats contained 38.5 ppm of Kanechlor 
400 for the first 4 weeks, followed by 77 ppm for 8 weeks, 154 ppm for 3 
weeks, 308 ppm for 3 weeks, and 616 ppm for 8 weeks. Body weights were 
checked weekly and showed rapid decreases during the 616-ppm feeding 
period; for this reason the Kanechlor 400 content of the diet was reduced 
to 462 ppm for the next 32 weeks. The total feeding period for the 
experimental and control animals was about 58 weeks (400 days).
All rats that ingested total doses of more than 700 mg of Kanechlor 
400 developed hypertrophy of the liver [242], Pale brown nodules were 
present on the parietal and cut surfaces of the livers of female rats that 
had ingested more than 1,200 mg of PCBs. However, none of the male rats 
had such hepatic nodules, despite having Ingested equal or greater amounts 
of Kanechlor 400. On microscopic examination, the livers of female rats 
were observed to have fatty degeneration and multiple adenomatous nodules 
that appeared to be benign neoplastic lesions. Males did not develop such 
neoplastic lesions; however, their livers did exhibit fatty degeneration. 
Lung abscesses, pneumonia, splenic atrophy, and intracranial abscesses were
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found frequently in the experimental group. The authors [242] thought that 
resistance to infection was lowered in the rats fed Kanechlor 400.
A formal rulemaking hearing was convened August 20, 1976 by the US 
Environmental Protection Agency on its proposed toxic pollutant water 
effluent standards for PCBs (Federal Register 42:6532-55, February 2, 
1977). Part of the testimony concerned comparative studies in which groups 
of 100 male and female Charles River rats were fed 1, 10, and 100 ppm of 
Aroclors 1242, 1254, or 1260 for 24 months. The survival of the rats was 
poor and the experiment was said to have been Inconsistently reported. A 
réévaluation of the pathology slides revealed the occurrence of liver
tumors (hepatomas and cholanglohepatomas) in the rats fed any one of the
three Aroclor products. The incidence of liver tumors in the rats dosed at 
100 ppm was 3/20 for Aroclor 1242, 6/27 for Aroclor 1254, and 7/27 for 
Aroclor 1260, compared with 0/20 for the controls. In addition to the 
tumors there was a high frequency of nodular hyperplasia. The incidence of 
nodular hyperplasia at 100 ppm was 8/20 for Aroclor 1242, 13/27 for Aroclor 
1254, and 7/27 for Aroclor 1260, compared with 1/23 for the controls.
Nodular hyperplasia In the rats dosed at 10 ppm occurred in 2/10 for
Aroclor 1242, 3/26 for Aroclor 1254, and 9/23 for Aroclor 1260, and 1/23
for the controls. The incidence of tumors of the pituitary gland also was 
elevated in each treated group.
Correlation of Exposure and Effect
(a) Absorption, Metabolism, Excretion, and Body Burdens 
It has been demonstrated in experimental animals that PCBs can be 
absorbed into the blood from inhaled air [97] and from the digestive tract
105
[50,51,95,96]. Qualitatively, the effects in experimental animals from 
absorption by either route were similar [98,99,202-206]. When PCBs were 
applied to the skin, certain effects, such as those on the liver, were 
similar to those obtained when PCBs were ingested or inhaled [205-208]. 
Thus, it appears that PCBs were also absorbed by this route.
In experimental animals, most PCB isomers were metabolized in varying 
degrees to more polar compounds such as hydroxylated derivatives 
[41,48,49,51-56,58-81,85,87]. The more highly chlorinated isomers were 
metabolized slowly and accumulate in the tissues [41,50,51,55,61-64,66,82- 
84,96,103,107-110]. The hydroxylated derivatives were excreted in the 
bile, urine, and milk [41,48,50-56,58-61,63-66,69,71-80,85]. Unmetabolized 
compounds were excreted in feces, milk, and hair [41-44,50,51,53-56,100- 
102], and traces were found in urine [42,51-55,57-62,103-105].
In man, the metabolism of PCBs has not been studied. However, 
finding that PCB Isomers that are difficult to metabolize become 
concentrated In residual PCBs of tissues from the general population, from 
persons who have ingested PCBs, and from those with occupational exposure 
suggests that man metabolizes, eliminates, and stores the compounds in ways 
similar to those of animals [7,36,136,168,171-175]. Determinations of PCBs 
or their metabolites in urine or feces of humans have not been reported. 
PCBs have been'found in human hair [102,142]. Excretion in human milk of 
PCBs with compositions similar to those in blood, has been reported in 
association with general environmental exposures and following Ingestion 
and occupational exposures [143,144,168,192]. These findings of PCBs in 
human hair and milk also suggest metabolism and excretion similar to those 
of animals.
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Because PCBs are widespread in the environment, detectable 
concentrations have been found in tissues and body fluids of a substantial 
portion of the US population [36,102,134,135,137,140,144]. Detectable 
concentrations have been found in up to 62% of blood serum samples, with 
concentrations ranging up to 30 ppb [137]. In emaciated patients, blood 
PCB concentrations as high as 100 ppb have been found [140]. PCB 
concentrations in about three-fourths of adipose tissue samples from the 
general population were <1 ppm, and the remainder were mostly in the range 
of 1-2 ppm [36,136]. Usually the PCB isomers found in blood and adipose 
tissue have been penta-, hexa-, and heptachlorobiphenyls [7,135,136], and a 
high correlation was found between the concentrations in these two tissues 
[141]. PCB isomers in cord blood were qualitatively identical to those in 
maternal blood [138]. PCB isomers excreted in human milk were similar or 
identical to those in blood [168], and the concentrations in milk were 
positively correlated* with adipose tissue concentrations [143]. In human 
milk samples from the general US population, PCB concentrations up to 13 
ppm (fat basis) have been reported (EP Savage, written communication, 
February 1977).
These concentrations of PCBs in blood, adipose tissue, and milk of 
the general US population arise from dietary intakes estimated to be of the 
order of 10-20 Mg/day [46] and from Inhalation of air that may contain up 
to 100 ng/cu m [26,38].
(b) Irritation Effects and Chloracne
The first reports of adverse effects of PCBs on workers included 
chloracne [120,123,130], digestive disturbances [123], irritation of mucous 
membranes [120,123,130], and impotence [123]. The exposures associated
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with these effectd were not well-defined either qualitatively or 
quantitatively. When PCBs were first being manufactured, (in mostly open 
systems) the exposures were to benzene and unidentified intermediates in 
addition to PCBs [120]. Jones and Alden [120] and Schwartz [123] did not 
report exposure concentrations in their studies. However, Drinker et al 
[125] indicated that average concentrations of PCBs ranged from about 0.5 
to 1.5 mg/cu m in 30 factories, which may have included the factories 
studied by Schwartz [123]. On the basis of these reports [120,123,125], it 
would appear that chloracne and some other systemic effects occurred with 
early PCB preparations when their average concentrations in workroom air 
were below 1.5 mg/cu m. Elkins [130] found that airborne PCB 
concentrations approaching 10 mg/cu m in capacitor-impregnating operations 
in Massachusetts were "unbearably" irritating to the workers, but there 
were no apparent toxic effects with concentrations that averaged up to 5.8 
mg/cu m. Elkins [130] did not describe the processes or the PCBs used.
Puccinelli [186] found that when capacitors were filled with Aroclor 
1254 heated to 70-80 C, PCB concentrations of about 5-7 mg/cu m resulted. 
The workers studied by Puccinelli [186] developed chloracne after 4-8 
months of exposure. In studying similar processes, Hofmann and Meneghinl 
[187] found that chloracne developed after 2.5-4 months of exposure. These 
investigators [187] also described the development of areas of brown skin 
on the foreheads of workers. They did not describe the PCBs used or the 
exposure concentrations. Reports of the development of chloracne In 
Americans, who worked In operations which used heated PCBs, appeared in 
1964 and 1969 [188,189], In one of the processes [188], an Aroclor with a 
chlorine content of 65% and containing both PCBs and polychlorinated
108
terphenyls was used; the PCB used in the other process [189] was not
described, but extensive skin exposure from wearing PCB-soiled clothing and
from immersion of unprotected hands into the PCB mixture was described.
A case of chloracne that developed in an Australian worker after 
exposure to Aroclor 1242 at concentrations of 1-2 mg/cu m was reported by 
Ouw et al [196]. The PCB preparation was heated during a capacitor-filling 
process. Complaints of process workers included irritation of the face, 
eyes, and skin. Eczematous rashes were also found on their hands and legs.
In the reports of chloracne development in occupations involving PCBs 
(where environmental concentrations of PCBs were measured) [125,130,186-
189,196], the sampling and analytical methods did not distinguish between 
vapor and particulate forms of the PCBs. However, a common factor in many 
of these reports [186-189,196] was the use of heat in the process which 
would tend to generate PCB vapors.
In their study of capacitor and PCB manufacturing plants In Japan, 
Hasegawa et al [191] found that concentrations of PCB vapors (or particles 
<0.1 f an in diameter) exceeded the concentrations of PCBs in particles >0.1 
i m  in diameter. The compositions of PCBs in the particulate were similar 
to those in the PCB preparations in use, but the less highly chlorinated
compounds were concentrated in the vapors. In this study, where PCB vapors
ranged from 0.026 to 0.965 mg/cu m and PCBs in the larger airborne 
particulates ranged from 0.19 to 0.650 mg/cu m (maximum total PCBs of 1.6 
mg/cu m), dermal ailments Included a brown chromodermatosis of the hands 
and chloracne. The workers had been exposed to PCBs from <1 to 20 years.
Meigs et al [190] described a process in which chloracne developed 
where the exposures had to have been to PCB vapors. The PCB which was used
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as a heat-exchange medium was not described, but PCB concentrations were 
reported to be about 0.1 mg/cu m in the workroom air where the workers were 
exposed. Under these conditions, chloracne developed after a minimum of 5 
months of exposure.
Chloracne has also been studied in connection with determinations of 
PCB concentrations in blood. Hara et al [192,193] found whole blood PCB 
concentrations of 7 to 300 ppb in Japanese workers engaged in capacitor 
filling. About 40% of these workers had chloracne and 13% had irritation 
of the skin. Kltamura et al [194] found PCBs at 320-820 ppb in blood
samples from Japanese workers engaged in capacitor manufacture. Skin 
ailments, including chloracne, were found in 10 of 13 workers studied. 
Inoue et el [195] found chloracne In a man exposed to PCBs in a silk-
glossing factory who had a concentration of about 200 ppb of PCBs in his
blood, but they [195] found what were described as relatively mild skin 
abnormalities in 28 other workers engaged in similar processes who had
blood PCB concentrations mostly under 100 ppb (2 had concentrations >100 
ppb). Ouw et al [196] concluded from their study of capacitor workers that 
no adverse effects were found in workers with blood PCB concentrations <200 
PPb.
Studies of PCB-exposed workers where chloracne has not been found
include those of Levy et al [197], Karppanen and Kolho [198], and Bumgarner 
et al [199]. In the study by Karppanen and Kolho [198], workers who had
been exposed to PCBs for 4 years in a capacitor-impregnating operation had 
PCB concentrations of 74-1,000 ppb in samples of their blood. The
environmental exposure concentrations of PCBs were reported to meet
"internationally accepted standards." Other factors of the work situation,
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such as the skin protection used, were not reported. In the study by Levy 
et al [197], workers who had been exposed to PCBs for 2.5-18 years had 
concentrations of PCBs in samples of their blood ranging from 36 to 286 
ppb. PCB exposure concentrations at the time of the study were 0.013-0.264 
mg/cu m. Although some of the workers complained of throat or eye 
irritation, and some skin rashes were found, no cases of chloracne were 
seen. From the description of the work situation, it is unlikely that skin 
exposure to liquid or solid PCBs was an Important factor in the total 
exposure of these workers. In their study of refuse workers, Bumgarner et 
al [199] found blood PCB concentrations to be 4-14 ppb. One possible 
source of exposure of these workers was airborne incinerator effluents, and 
it is unlikely that additional exposure from skin contact occurred.
Although skin exposure was unlikely in these two reports [197,199] 
where chloracne was not found, skin exposure is not necessary for chloracne 
to develop. Chloracne has been observed in Japanese people estimated to 
have ingested totel PCB doses of 0.3-4 g [146,164-167], and chloracne-like 
lesions have been produced in experimental rhesus monkeys fed PCBs at 3 ppm 
in their diets [222].
Thus, although eliminating exposure of the skin through engineering 
controls and using appropriate protective clothing and work practices will 
reduce the total absorption of PCBs, these practices will not necessarily 
eliminate chloracne. The data Indicate that chloracne may occur with 
exposures to PCB vapor concentrations as low as 0.1 mg/cu m for several 
months, and with PCB concentrations in the blood of about 200 ppb.
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(c) Effects Referable to the Liver
Some clinical and autopsy findings in Yusho, the disease that 
occurred after ingestion of PCB-contaminated rice oil by humans, were 
indicative of liver injury [155-158,179-181]. These findings included 
changes in liver cell anatomy considered consistent with microsomal enzyme 
stimulation and increased SAP activity. Effects that persisted for several 
years included decreased concentrations of iron and bilirubin in the serum 
[155,179] and Increased serum concentrations of triglycerides. The latter
were found to Increase with residual concentrations of PCBs in the serum
[180].
The maximum amounts of PCBs consumed by individuals manifesting these 
effects were estimated to have been of the order of 3-4 g total intake over 
several months [165]. For two Yusho patients a daily PCB consumption of 67 
Mg/kg for 3 months was estimated [167]. The maximum intake would have been 
of the order of 50 ppm in the diet or 0.5-1 mg/kg/day. For comparative 
purposes, absorption of PCBs from inhalation during maximum occupational 
exposures that have been reported (10 mg/cu m) probably did not exceed 0.15 
mg/kg/day.
The extent to which PCB consumption was responsible for the effects 
on the liver is not known since the contaminated oil also contained PCDFs 
[20,160] in quantities that could have resulted in a maximum PCDF 
consumption of 20-50 mg. Autopsy findings 1-3 years after the poisonings
indicated unusually high concentrations of PCDFs (0.3-2.5 #ig/g) relative to
PCBs (3.5-5.6 Mg/g) in liver fat [160].
Although most animal feeding experiments have been conducted with 
dietary levels of PCBs that are much higher than those ingested by Yusho
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patients, others have been conducted with dietary PCB levels that seem to 
confirm the Yusho findings. Experiments have been reported with various 
commercial PCB mixtures (Aroclors 1242, 1254, 1260, and Clophen A60) added 
to the diet at 1-10 ppm [101,209-212,215,228,233], These experiments 
demonstrated Increased liver weights at all concentrations, dose dependent 
stimulation of microsomal enzyme activities, detectable proliferation of 
the SER at concentrations of 10-100 ppm, and other microscopic changes 
including enlarged hepatocytes, hepatocytic vacuolization, and, with 
prolonged exposures, development of adenoflbrosls.
At high PCB concentrations (>1,5 mg/cu m), Inhalation experiments 
with animals have demonstrated increased liver weights [98,99,202,203], 
Microscopic changes similar to those seen from PCB Ingestion were found in
livers of rats after inhalation of Aroclor 1254 at 1.5 mg/cu m or more
[203], and from other commercial preparations (Decachlorodiphenyl and 
Solvol) at much higher concentrations (>4 mg/cu m) [99,202],
These data from the Yusho poisonings and from animal experiments 
Indicate that hepatic effects seen in human are similar to those seen in 
animals. They also indicate that some commercial preparations may be less 
severe liver poisons than others, but the data are not definitive in this 
regard. The ingestion experiments demonstrated Increased liver weights 
from feeding PCBs at 1 ppm, and increasing evidence of liver injury as
dietary PCB levels were increased. A dietary level of 1 ppm may be
considered roughly equivalent to a dally Intake of the order of 0.01-0.02 
mg/kg, which would be somewhat similar to the Intake from Inhaling PCBs at 
1 mg/cu m.
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Several reports of occupational exposures to PCBs have involved the 
liver in various ways [123,125,127,186,190,191,197,198,200].
In the earliest reports of PCB toxicity [123,135,127], the PCBs were 
nixed with chlorinated naphthalenes. The mixtures caused many cases of 
chloracne and, in some cases, jaundice. Liver cirrhosis with superimposed 
yellow atrophy was found in at least one fatality [125]. Similar findings 
have not been reported where exposures were to only PCBs in the absence of 
chlorinated naphthalenes.
Mention of nausea and digestive disturbances in some reports 
[123,197] may have indicated liver injury. In the study by Schwartz [123], 
neither liver function test findings nor exposure concentrations were 
reported. In the Levy et al report [197], liver function tests (SAP, SGOT, 
SGPT, total bilirubin) performed at the time of the study did not indicate 
current liver injury. The workers had been exposed to unidentified PCBs at 
0.013-0.264 mg/cu m, and blood PCB concentrations were 36-286 ppb. Even 
though there were no findings of current liver Injury, these investigators' 
[197] examination of past medical records showed occasional findings 
indicative of slight liver Injury (elevated serum enzymes, triglycerides, 
end uric acid). A report of a worker who was removed from further exposure 
after experiencing nausea on exposure to an askarel containing Aroclor 1254 
was not accompanied by liver function test results or exposure 
concentration data (In the Matter of General Electric Company, File No. 
2833, New York State Department of Environmental Conservation, 1975).
More conclusive studies of liver function were reported by Meigs et 
al [190], Hasegawa et al [191], Hara et al [192,193], and Ouw et al [196]. 
Of the workers exposed to vapors of an undefined PCB at 0.1 mg/cu m in the
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study by Meigs et al [190], liver function tests were performed on seven. 
Findings in six of the workers were normal and, in the other one, cephalin 
flocculation and thymol turbidity tests were on the borderline of 
abnormality. Hasegawa et al [191] found some changes in liver function 
tests (increased SGOT, SGPT, and SAP, and decreased serum cholinesterase 
and lipids) of 99 workers exposed to Kanechlors but the investigators 
considered that only the decreased serum lipids were significant. PCB 
exposure concentrations at the time of the study were 0.045-1,6 mg/cu m. 
The workers had exposure histories of <1 to 20 years. PCB concentrations 
in blood samples of the workers averaged 370 ppb.
Hara et al [192] did not find evidence of a correlation of serum 
triglyceride concentrations with blood PCB concentrations during the first 
year after the work with PCBs was discontinued. However, when the same
workers were studied 2 years after stopping work with PCBs, the proportion
of workers with elevated serum triglycerides Increased as residual blood 
PCB levels Increased [193]. The effect was particularly prominent in 
workers with residual blood PCB concentrations >50 ppb. In a study of 34 
workers exposed to Aroclor 1242 in capacitor manufacture, Ouw et al [196] 
found individual abnormalities in SGPT, SAP, and serum bilirubin, but 
average values for the group were normal. Bromsulphaleln retention tests 
were elevated in four workers. Ouw et al [196] considered that there were 
no adverse responses in workers with blood PCB concentrations below 200 
ppb. The PCB exposure concentrations were 0.32-1.44 mg/cu m.
No evidence of impaired liver function was found in other studies
[186,194,195,198] where PCB exposures were reported as: Aroclor 1254 at 5-7 
mg/cu m for 2-4 years [186]: Kanechlors at >0.25 mg/cu m [195]; and
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unidentified PCBs at <1 mg/cu m for 4 years [198],
Evidence relating to impaired liver function from occupational 
exposures to PCBs is generally consistent with findings in Yusho patients 
and in animal studies that Indicated some effects could be expected from 
PCB Intakes equivalent to PCB inhalation at about 1 mg/cu m. The 
occupational exposure studies show occasional evidence of liver injury in 
workers exposed at concentrations of 0.013-0.264 mg/cu m [197], 0.1 mg/cu m 
[190], 0.045-1.6 mg/cu m [191], and 0.32-1.44 mg/cu m [196], Whether the 
observed effects occurred with exposures at the lower end of all these 
ranges is not known.
The occupational exposure studies also showed delayed recovery of 
normal serum triglycerides after exposures to PCBs stopped [193]. The 
elevated serum triglycerides were related to the higher residual blood PCB 
concentrations, and these in turn were related to the years of exposure. 
Residual PCBs have repeatedly been shown to be the more highly chlorinated 
isomers and those metabolized with greater difficulty 
[7,36,51,83,103,110,135,136].
Summaries of effects of PCBs on humans and animals are presented in 
Tables III-9 and 111-10, respectively.
Careinogenc1ty. Mutagenicity, Teratogenicity, end Effects on Reproduction
(a) Carcinogenicity
There is extensive evidence for formation of arene oxide 
intermediates during the metabolism of PCBs by several species including 
rhesus monkeys [51,68,69,74,75,81,115,116,118]. Arene oxide formation was 
also proposed as a plausible intermediate in the metabolism of the slowly
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metabolized 2,2',4,A’,5,5’-hexachlorobiphenyl [70,79], Binding PCB
metabolites to nuclear components of liver cells has been demonstrated on 
administration of PCBs to monkeys [51], and to rats [81], and by in vitro 
experiments [51,82,86,116,117], This information is sufficient to arouse 
suspicions that PCBs could have carcinogenic potential In humans.
Hepatomas were produced in 170 of 184 examined female rats fed 
Aroclor 1260 at 100 ppm from 3-4 to 23 months of age [218], and in 9 of 22 
BALB/cj male mice fed Aroclor 1254 at 300 ppm for 11 months [221], The 
tumors found in the rats Included 26 hepatocarclnomas and 144 neoplastic 
nodules. Only one liver tumor, a hepatocarcinoma, was found in 173 control 
rats.
In another report (Federal Register 42;6532-55, February 2, 1977), 
dose-related incidences of liver tumors were reported in rats fed Aroclors 
1242, 1254, or 1260 at 1, 10, and 100 ppm in the diet for 24 months. No
liver tumors were reported in rats fed the diets containing PCBs at 1 ppm. 
Only one tumor, a hyperplastic nodule (neoplastic nodule), was found in 23 
controls. Neoplastic nodules were found In the livers of rats fed the diet 
containing 10 ppm of PCBs (2/10, 3/26, and 9/23 for Aroclor 1242, 1254, and 
1260, respectively). Higher tumor incidences were found when diets 
containing PCBs at 100 ppm were fed (11/20, 19/27, and 14/27 for Aroclors 
1242, 1254, and 1260, respectively) and the tumors included hepatomas and 
cholanglohepatomas (3, 6, and 7 for Aroclors 1242, 1254 and 1260,
respectively). In this experiment the incidence of pituitary tumors was 
high in PCB-fed rats.
In a study sponsored by the National Cancer Institute, Aroclor 1254 
was fed to groups of 24 rats at 25, 50, and 100 ppm In the diet. No liver
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tumors were found in the controls, in the experimental females at any dose 
level, or in experimental males fed PCBs at 25 ppm. However,
hepatocellular carcinomas were found in a male rat fed Aroclor 1254 at 50
ppm and in two males fed the PCB at 100 ppm. The data also Indicated that 
the incidence of leukemias In males was dose-related (3/24 in controls; 
8/24 In rats fed 100 ppm).
Kanechlors have also been found to produce liver tumors when fed to 
mice and rats [240,241,242]. Of 12 mice fed Kanechlor 500 at 500 ppm for 
32 weeks, 7 developed neoplastic liver nodules and 5 had well-developed 
hepatocellular carcinomas [240,241], In this experiment which had only 12 
mice/group and continued for only 32 weeks, liver tumors were not found 
with Kanechlors 300 and 400 or with lower dose levels of Kanechlor 500, 
However in another experiment [242], Kanechlor 400 fed to 10 male and 10 
female rats for 58 weeks did produce liver tumors in the females. In this
experiment the amounts fed (38-616 ppm) varied from time to time, but were
in the 308-616 ppm range for the last 43 weeks.
These findings from animal studies indicated to NIOSH that PCBs have 
potential carcinogenic activity in humans. They Indicate, but do not 
conclusively demonstrate, with the dietary levels used, that the less 
highly chlorinated mixtures (Aroclor 1242 and Kanechlors 300 and 400) have 
less carcinogenic potential than the more highly chlorinated mixtures 
(Aroclors 1254 and 1260 and Kanechlor 500). However, all PCB mixtures 
adequately tested In rats and mice have shown carcinogenic activity. The 
Intakes of PCBs at the lowest dietary level that has produced tumors in 
rats (10 ppm) would be somewhat comparable to intakes from occupational 
exposures at 5-10 mg/cu m. However PCBs are slowly eliminated from the
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body and the higher chlorinated compounds may accumulate in the body for 
years. Thus animal experiments that are limited to 2 years by the life 
span of the animals may not be informative relative to workers exposed for 
up to 45 years.
In humans, there are no adequate studies to confirm or deny 
carcinogenicity although preliminary data suggest that among Yusho 
patients, deaths due to cancers exceed expectations [160,161] and 
preliminary studies of two occupationally exposed groups in the US indicate 
that the occurrence of certain cancers may be excessive (HA Slnclaire, 
written communication, June 1976; G Roush, written communication, September 
1976). However, the two reports are not consistent as to the types of 
cancers found to occur more frequently than expected.
(b) Mutagenicity
Several PCBs and PCB mixtures, Including the 4- and the 2,2',5,5'- 
lsomers and Aroclors 1221, 1254, and 1260, were subjected to the "Ames" 
test for mutagenicity [116], Although 4-chlorobiphenyl had mutagenic 
activity in this test, the more highly chlorinated PCBs showed very little 
activity. Aroclor 1254 did not cause significant chromosomal changes in 
the testes of rats after it was administered for 7 days at 50 mg/kg/day 
[235], In another experiment [236], neither Aroclor 1254 administered at 
300 mg/kg/day for 5 days nor Aroclor 1242 administered at 500 mg/kg/day for 
4 days produced chromosomal aberrations in spermatagonlal or bone marrow 
cells of rats. These mixtures also did not produce any evidence of 
dominant lethal mutations in rats [237]. Although PCBs have little 
mutagenic potential, they may alter the mutagenicity and carcinogenicity of 
other compounds by stimulating microsomal enzyme activities [239],
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(c) Teratogenicity
PCBs have been found in embryonic and fetal tissues of humans
[139,168] and experimental animals [101] after introduction of PCBs into 
the maternal body, demonstrating that the potential for direct teratogenic 
effects exists. Several experiments have been conducted with rats
[101,228], rabbits [229], monkeys [232], and dogs and pigs (FL Earl et al, 
written communication, 1976) that are relevent to a discussion of PCB 
teratogenicity. In some of these experiments, the PCBs were administered 
by gavage and doses were reported in mg/kg; in other experiments, the PCBs 
were reported as ppm fed in the diet. For purposes of relative comparison, 
50 ppm in the diet can be equated to 1 mg/kg/day. This is the order of 
magnitude of the maximum rate of PCB intake by Yusho patients. Animal 
experiments have used PCBs in dietary-equivalent amounts of 1-2,500 ppm. 
In most experiments with PCBs administered In amounts equivalent to dietary 
levels of 100 ppm or more, fetotoxicity (resorptions, absortlons) has been 
such that teratogenic effects may have been masked [101,228,229], In the 
two-generation feeding study of rats by Linder et al [228], no terata were 
reported. This study covered Aroclor 1254 in the concentration range of 1- 
100 ppm and Aroclor 1260 in the range of 5-100 ppm. Although terata were 
not reported, Aroclor 1254 concentrations of 20-100 ppm resulted in reduced 
litter sizes. In rhesus monkeys [232], feeding Aroclor 1248 at 2.5 and 5 
ppm caused abortions In some cases and lower than normal birth weights, but 
no terata were reported. In dogs, terata were not found in pups born from 
dams fed the equivalent of 12 ppm in the diet, but were present when 48- or 
200-ppm equivalents were fed. Sows fed the equivalent of 50 ppm in the 
same experiment had high rates of resorptions and, at 10-30 times this
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level, terata were definitely present in the piglets (FL Earl et al, 
written communication, 1976).
Although there were retarded intrauterine growth and signs of PCB 
toxicity in Yusho babies at birth, no terata were reported
[149,159,176,182,183]. A normal baby was b o m  to a woman exposed to PCBs 
in her work. The PCB exposure concentrations were not reported but the PCB 
concentration in her blood was 25 ppb at the time the baby was born.
These studies indicate that PCBs have teratogenic potential for 
humans. However, the terata observed In animals occurred at levels at or 
above doses equivalent to the maximum doses of the Yusho patients and at 
Intake rates 3-4 times greater than Intakes expected from inhalation at 
maximum reported occupational exposures.
(d) Other Effects on Reproduction
Feeding rats Aroclor 1254 at 5 ppm or Aroclor 1260 at 100 ppm had no 
effects on reproduction over two generations [228]. At higher dietary 
levels, reproductive effects Included poor mating performances, fewer 
litters, reduced litter size, and high postnatal death rates in the 
litters. In rabbits, Aroclors 1221 and 1254 were not fetotoxlc when 
administered only during gestation in amounts equivalent to dietary levels 
of about 50-500 ppm [229]. However, when administered during gestation at 
higher levels /600-2,500 ppm dietary equivalent), Aroclor 1254 caused 
resorptions, abortions, maternal death, and, in two fetuses, asymmetric 
skulls [230]. Delaying administration of PCBs until after the first week 
of pregnancy did not eliminate the effects.
Feeding rhesus monkeys Aroclor 1248 at 25 ppm for 2 months resulted 
In a high degree of Infertility that persisted for at least 8 months after
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the last ingestion of PCBs [232], In another experiment, rhesus monkeys 
fed Aroclor 1248 at 2.5 and 5 ppm for 6 months had irregular menstrual 
cycles with excessive and prolonged bleeding [233], Even though these 
monkeys conceived well on mating, resorptions and abortions were frequent, 
and Infertility was common in subsequent matings [233]. Nursing Infants 
developed chloracne-like signs within 2 months and Infants frequently died 
during the nursing period. The milk contained PCBs at 0.154-0.397 ppm 
[234].
There are no reports of infertility or abortions attributed to human 
PCB consumption or exposure. There are reports of undesirable effects In 
children born to mothers exposed to PCBs In the diet and of undesirable 
effects developing from nursing such mothers.
Babies born from mothers with Yusho were often dark colored and 
developed signs of Yusho after nursing [176,182,183], In at least one 
case, Yusho developed In a baby who was only exposed to PCBs by nursing 
[182], Concentrations of PCBs In milk were not determined at the time of 
the Yusho poisoning. A milk sample obtained after birth of a normal baby 
from a woman exposed to PCBs at work contained PCBs at 0.25 ppm, and 
nursing was discontinued [195]. The woman's exposure history and time of 
last exposure were not given, but PCBs were present in her blood at 24 ppb.




EFFECTS OF PCBs ON HUMANS
PCB Intake Exposure Index





Up to 8 mon 0.3-4g
Kanechlor 400
Not knovn 10 mg/cu m
4-8 mon 5-7 mg/cu m 
Aroclor 1254
2.5-4 mon Not reported
<1-20 yr 0 . 2- 1.6  
mg/cu m 
Kanechlors
2.5 yr ave. Not reported 
Kanechlors
Not reported >0.25 mg/cu m 
Not reported
2.5-18 yr 0.013-0.27 
mg/cu m 
Not reported








































EFFECTS OF PCBs ON HUMANS
PCB Intake Exposure Index











I f 1-23 yr 0.32-1.44 
mg/cu m 
Aroclor 1242
<200 No effects 196















I I 4 year8 (>1 mg/cu m) 
Aroclor 1242
74-1,900 No effects 198
General
environment
Continuous Air, 1-100 
Food, 10-20 
Mg/d




EFFECTS OF PCB INHALATION ON ANIMALS
Exposure Conditions 
Material mg/cu m Duration Species Effects Ref.




































Rats PCB in liver, 70 ppm 97
" 100% mortality, 202
liver necrosis
" Liver necrosis, hyper- 202































IV. ENVIRONMENTAL DATA AND BIOLOGIC EVALUATION
Environmental Concentration«
Two reports of workroom air concentrations of PCBs appeared in 1954 
[186,190], Puccinelli [186] studied the concentrations in air of a 
capacitor factory in Italy, using the methods of Elkins [130], and found 
concentrations in 500-liter air samples of 5.2-6.4 mg/cu m. Mlegs et al 
[190] did not report on the analytical methods they used to determine 
concentrations of PCBs in the breathing zones of workers exposed when a 
heat exchange unit in a Connecticut factory leaked. From the description 
of the factory, it is likely that the exposures were largely to vapors; the 
concentration found was 0.1 mg/cu m.
In 1959, Elkins [130] reported that over a number of years, PCBs In 
some Massachusetts plants ranged up to 10.5 mg/cu m of air (Table IV-1).
TABLE IV-1
PCB CONCENTRATIONS MEASURED IN MASSACHUSETTS FACTORIES




Capacitor impregnating 10.5 5.8
It 5.5 4.5
t l 0.3 0.2
Capacitor soldering 0.9 0.8
011 nixing 1.1 0.6
Regulator filling 0.2 0.1
Adapted from reference 130
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Of 21 air samples collected in capacitor impregnating operations, 
Elkins considered that hazardous concentrations (>1 ppm for Aroclor 1242; 
>0.5 ppm for Aroclor 1254) existed in 15. While the sampling and 
analytical methods used were not documented, Elkins [130] recommended 
sampling with either a fritted bubbler or two impingers in series, both 
containing amyl acetate, and analyzing by the sulfur lamp method.
Occupational environmental studies were conducted in five Japanese 
plants by Hasegawa et al [191]. Kanechlors 200 (predominantly 
dichloroblphenyls), 300 (mostly trichlorobiphenyls), and 400 (mostly
tetrachloroblphenyls) were used or manufactured in the plants. Air samples 
were drawn through filter paper to collect particulate matter and normal 
hexane to collect vapors and analyzed by GLC. The data are summarized in 
Table III-7. In the paired samples, the vapor concentrations exceeded the 
particulate concentrations. One of the plants was a biphenyl recovery 
plant where PCBs were not used. In this plant, PCB concentrations were 
<0.02 mg/cu m. In the PCB manufacturing plant, PCB vapor concentrations 
were 0.026-0.163 mg/cu m, and particulate PCB concentrations were 0.019- 
0.037 mg/cu m. Higher PCB concentrations were found in the capacitor 
plants: 0.095-0.965 mg/cu m of vapors, and 0.20-0.65 mg/cu m of
particulates. In one particulate sample collected in a capacitor plant 
after a spill, the PCB concentration was 6.2 mg/cu m.
Stalff et al [243] in a 1974 report were concerned about emissions 
from burned-out PCB-containing ballasts in fluorescent fixtures in their 
laboratory. The investigators collected samples In two midget Impingers, 
containing ethylene glycol and connected in series. The samples were 
analyzed by GLC. PCB concentrations in the air ranged from 0.012 to 0.166
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mg/cu o when the ballasts burned out and were 0.002 mg/cu m 3 days later.
In a 1976 report of a survey of Australian workers exposed to Aroclor 
1242, Ouw et al [196] listed breathing zone concentrations ranging from 
0.32 to 2.22 mg/cu m before corrective measures were taken, and from 0.08 
to 0.75 mg/cu m after installing improved ventilation. Breathing zone 
samples were collected at 30 liters/minute using Greenburg-Smith impingers 
containing 75 ml of isopropanol. The concentrations found are shown in 
Table IV-2.
TABLE IV-2
PCB CONCENTRATIONS IN THE AIR INSIDE A CAPACITOR PLANT BEFORE 
AND AFTER IMPROVEMENT OF EXHAUST VENTILATION SYSTEM




Area In the unloading tank In front 
of exhaust register from operator's 
breathing zone
1.44 0.75
Area in the unloading tank not In 
front of exhaust register
2.22 0.7
General atmosphere near tank 1.08 0.18
Soldering area 0.32 0.08
Adapted from reference 196
Exposures of electrical and materials technicians during 1976 to PCBs 
contained in materials they tested were evaluated by Levy et al [197]. Air 
samples were collected on magnesium silicate "Florlsil" at 50 ml/mlnute for
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4-8 hours and analyzed by GLC utilizing electron capture detection. 
Breathing zone samples were collected on a single day from nine employees 
for 8 hours. The concentrations in the nine breathing zone samples, which 
would represent TWA exposure concentrations for the day, ranged from 0.014 
to 0.073 mg/cu m. Concentrations of PCBs in nine point source samples 
collected over 4-8 hours on each of 3 days ranged from 0.013 to 0.264 mg/cu 
m, and in 19 room air samples collected over 4 hours on each of 3 days, 
from 0.08 to 0.16 mg/cu m.
A plant manufacturing PCBs in the US was surveyed for worker exposure 
in July 1976 [244], Three Aroclors (1016, 1242, and 1254) were made in the 
PCB production area. To begin the process, biphenyl and chlorine were 
piped into a chlorinator with a catalyst and allowed to react. Two 
separate groups of chlorinators were used for Aroclors 1242 and 1254. The 
product resulting from the reaction passed through a purifying operation, 
or to a distillation column as in the case of converting Aroclor 1242 to 
Aroclor 1016, and then on to the storage tanks. Mixing tanks were used to 
give the desired properties to the final product.
Although the operation was outdoors and theoretically a closed 
system, potential for employee exposure existed when samples were drawn or 
leaks occurred. Local exhaust ventilation was used in two operations: (1)
while filling 55-gallon drums, hoses were placed near the openings, and (2) 
when employees tested samples drawn from the chlorinators, their work 
station was equipped with an exhaust fan and hood.
Eleven personal and seven area air samples were taken in the PCB 
production area for 6-8 hours at a flow rate of 200 cc/minute [244]. PCBs 
were collected on Florlsil, desorbed with hexane, and analyzed by GLC with
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EC detection. Aroclor 1016 was the FCB produced on the sampling dates, and 
It was used as the standard for quantitating airborne PCBs. Personal air 
sample concentrations of PCBs reported as Aroclor 1016 ranged from 20 to 86 
Aig/cu m, while PCBs In area samples ranged from 16 to 55 /¿g/cu m. The data 
are presented In Table IV-3.
TABLE IV-3
PCB CONCENTRATIONS POUND IN A PLANT MANUFACTURING PCBs 
ON 2 CONSECUTIVE DAYS (¿ig/cu m)*
Personal Air Samples 
Job Title 7/21/76 7/22/76
Premium operator 47 20
Second operator 46 43
Column operator 64 51
Still operator 40 86
Standard operator - 61




Temperature testing 25 52
Chlorlnators 55 36
Incinerator burner 16 -
¿Total sampling time varied from A09 to 455 minutes and sample volumes 
varied from 67.6 to 201.6 liters.
Adapted from reference 244
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Sato and Hasegava [32] studied concentrations of PCBs In factories 
that had discontinued their use in production of pressure-sensitive copying 
paper 2 years earlier. PCB concentrations in the factories had not been 
determined when PCBs were being used, but were considered [3] to have been 
similar to those found by Hasagawa et al [196] in capacitor manufacturing 
plants. The concentrations found by Sato and Haswgawa [32] at the time of 
sampling ranged from 0.13 to 4.4 u g / c u  m. The PCB concentrations In the 
outdoor air around the factories were 0.043-0.09 ¿ig/cu m [3],
Another study of contamination In factories after PCB use had been
discontinued was reported by Fujlwara et al [33]. These Investigators 
found 0.25 mg/cu m in air of a factory that had previously used PCBs in 
silk glossing. In addition to air contamination, PCBs were found in the 
dust around machinery and In the floor boards.
PCB concentrations found in the air of some other factories and their
surrounding environments In Japan were summarized In 1976 by Tatsukawa
[245]. Concentrations found before 1957 in a factory producing
transformers and capacitors ranged from 0.39 to 4.5 mg/cu m. The factory 
was said to have been old-fashioned with bad ventilation [245]. 
Concentrations found In warehouses for carbonless copying paper in 1972 
ranged from 2 to 70 Mg/cu m. In the same year, concentrations of 0.04-0.05 
Mg/cu m were found in a university laboratory where PCBs were used, and 
concentrations of 0.006-0.12 n g / c u  m were found in areas of mills that 
recycled paper. Background concentrations found In urban areas of Tokyo, 
Osaka, and Matsuyama City were <0.002-0.04 jug/cu m.
Background concentrations of PCBs in ambient air over the US have 
been reported in ng/cu m quantities [26,38]. Average concentrations of
131
about 100 ng/cu m were found in Florida and Colorado in 1975 [38],
Control of Exposure
The present primary use of PCBs is as dielectric or insulating fluids 
for electrical capacitors and transformers. Potential hazards of PCBs in 
these industries result from inhalation and dermal exposures. It Is here 
that engineering controls, such as local exhaust systems, are necessary.
Local exhaust systems should be designed and operated in conformance 
with American National Standard Z9.2-1971 Fundamentals Governing the Design 
and Operation of Local Exhaust Systems [246]. Guidelines for handling 
capacitor and transformer askarels Include the following recommendations 
from the American National Standards Institute (ANSI) [4]: (1) Enclosed
systems of sealed piping, properly gasketed joints, valves, containers, and 
processing chambers should be used for any portion of the operation where 
askarel temperatures may exceed 55 C; (2) Enclosure should preferably 
extend to all other portions of the system Insofar as practicable; (3) 
Operations utilizing PCBs should be isolated from other manufacturing areas 
to avoid cross contamination; (4) Provision should be made for adequate 
ventilation and regulation of manufacturing operations to avoid open 
exposure to askarels; (5) When askarels are used at elevated temperatures 
(especially 55 C or higher), engineering controls must be applied, either 
by the use of closed systems or by effective local exhaust ventilation with 
general workroom exhaust.
Durfee et al [247] cited the following potential sources of air 
emissions of PCBs in transformer and capacitor manufacturing operations: 
(1) vapor exhaust from stream jet ejectors; (2) evaporation from accidental
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spills; (3) evaporation from hot surfaces as part of flood-filling, 
inspection, or holding operations; (4) vacuum pump exhausts; (5) 
evaporation from plant waste water.
There are currently no commercially available fluids which can be 
considered as totally acceptable substitutes for PCBs in the broad range of 
AC capacitors, nor are there substitute dielectric systems which would 
satisfy reliability and safety requirements In most applications [28]. 
Transformers containing PCBs represent only about 5% of the US transformer 
market, and are used only where safety and reliability are of prime 
importance. For new Installations, building and installation design 
provisions could be made to accommodate the use of filled, open dry-type, 
or sealed dry-type transformers. Major construction changes would be 
required to compensate for the fire resistance of askarel-filled units If 
existing askarel-filled transformers are to be replaced with oil-filled 
units of equivalent electrical ratings [4].
Environmental Sampling and Analytical Methods
(a) Air Sampling
Before discussing the various methods available for sampling airborne 
PCBs, it is pertinent to discuss the criteria for an Ideal sampling device. 
NIOSH evaluated an Industrial worker's exposure and found that sampling in 
the breathing zone gives a truer picture of actual exposure than does area 
sampling. The first criterion for an ideal air sampling device then is 
that it be amenable to personal sampling. In addition, It should be light, 
compact, and small enough so that workers can pursue their daily activities 
without being aware of its presence. The second criterion is that the
133
sampling device have a sufficient capacity for PCBs to enable the 
collection of an air sample representative of a typical workday. Thirdly, 
recovery of PCBs from the sampling device should be quantitative or, at the 
least, reproducible. Finally, the sample must be stable in or on the 
sampling device between the time of sampling and the time of analysis. 
This latter criterion is hardly of concern here due to the general 
stability of PCBs.
An air sampling procedure using fritted bubblers or lmplngers filled 
with toluene was published by ANSI in 1974 [4]. Neither the sampler
capacity nor the sampling efficiency had been experimentally evaluated. 
Where high sampling flow rates or high capacities were required, additional 
bubblers or lmplngers In series were recommended.
Bldleman and Olney [248] used porous polyurethane foam for collecting 
samples of atmospheric PCBs. They found that the polyurethane foam showed 
excellent collection efficiency (99% or better) for tri-, tetra-, and 
pentachloroblphenyls. The authors [248] did not address the matter of 
sample recovery from the sorbent.
In an environment where carbonless copy paper was being used, 
Nlshiyama et al [249] collected PCBs by drawing the air through a cooled 
column filled with Shlmalite, a gas chromatographic solid support similar 
to Chromosorb W. The collection efficiency of the device was 95% and the 
PCBs were eluted from the column with hexane. Other investigators used 5% 
glycerol-coated Florlsil for collecting organochlorlne pesticides and PCBs 
from air [250], Collection efficiencies were 90-100% for PCBs.
Harvey and Stelnhauer [251] collected ambient air samples of PCBs 
using 0.25% 0V-17 silicone oil coated on ceramic saddles (distillation
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column packing). The collection efficiency of this device was 70%. More 
recently, Glam et al [252] found that sorbent tubes packed with deactivated 
Florisll could be used for collecting PCBs and phthalates from air [252]. 
These compounds were found to be effectively retained by Florisll. The 
authors did not discuss efficiency of recovery.
In 1976, Laveskog and Llndskog [253] described a stack sampling 
device for chlorinated hydrocarbons which they used for PCB collection. 
This device utilized glass wool for the collection of particulates followed 
by a sorbent, 25-40% Apiezon M on Chromosorb W, to collect vapors. The 
collection efficiency of the column was 99%, and desorption efficiency with 
absolute ethanol was 87%. The authors investigated charcoal as a sorbent, 
but found it unsuitable for their purposes since the PCBs could only be 
recovered by extraction in a soxhlet apparatus with chloroform which in 
turn could not be used with electron capture detection.
Occupational Safety and Health Administration (OSHA) workers have 
used charcoal tubes for personal air sampling for PCBs (RG Kupel, written 
communication, 1976). While the sampling device would be expected to have 
good capacity for PCBs, recovery from charcoal is not quantitative. Little 
other information is known about this method.
A NIOSH Standards Completion Program Report [254] indicated that PCBs 
with 54% chlorine content were effectively trapped on a fibrous glass 
filter. However, the presence of PCB vapor either apparently was not 
addressed or was assumed to be negligible. This may not be a valid 
assumption, particularly since another report from the same program [255] 
showed that PCBs with 42% chlorine content have appreciable vapor pressure.
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NIOSH has also investigated the method of Giam et al [252], using 
Florisil as a sampling medium, in industrial environments. Florisil (30/48 
mesh) was placed in a tube similar to that used in the charcoal tube method 
for solvents, 100 mg in the front section and 50 mg in the back. The
retention capacity of this sampling device for PCBs was evaluated under
laboratory and field conditions, using various vapor generation techniques. 
In laboratory experiments, PCBs at 10 ¿¿g/llter and 75% relative humidity 
were sampled through a 100-mg Florisil bed at 0.2 liter/mlnute with no 
evidence of breakthrough after 4 hours (48 liters). Of 21 samples
collected on Florisil in a capacitor plant, only 6 had PCBs on the backup
section and all 6 backup sections contained 1% or less of the total PCBs In
the tube. The volumes of air sampled ranged up to 61 liters, and PCB 
concentrations In air as high as 1.5 jug/liter were measured. Other
laboratory experiments showed that PCBs could be desorbed quantitatively 
from Florisil with hexane. Results from Florisil tube and lmpinger samples 
taken side by side in the capacitor plant and analyzed with a single
commercial PCB product as a standard were statistically similar.
Impingers are not suitable for personal sampling and are inconvenient 
to use because they must be recharged with the sampling solvent frequently 
and must be used in series. The handling of absorber solutions is
difficult because of the potential for spillage and leakage of the solvent 
and samples during transport to and from the sampling site. Solid sorbent 
sampling devices are well suited for personal sampling since they are 
relatively small, and personnel wearing the devices quickly become unaware 
of their presence, enabling more representative sampling. Shipment of 
these devices is relatively simple.
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Of the solid sorbent sampling devices discussed, Florisil-filled 
tubes are deemed the most advantageous because Florlsll has a high capacity 
for PCBs and can be quantitatively desorbed; field evaluations have shown 
that Florisil-filled tubes are easier to handle and more convenient than 
lmpingers. Therefore, the Florisil-filled tube method is recommended for 
collection of PCBs from air, as detailed in Appendix I.
(b) Analytical
The chemistry of PCBs was extensively reviewed by Hutzlnger et al
[1], and PCB analytical chemistry has been reviewed by several authors 
[256-264] but only references pertinent to selection of an analytical 
method for determination of PCBs in industrial air samples will be 
discussed here. Of the analytical techniques available, the one most 
widely used for determining PCBs is GLC with EC detection. This technique 
is rapid, precise, and very sensitive. The far greater sensitivity of EC 
detection compared with that of the flame ionization detector (FID) is 
demonstrated by comparison of their relative responses to various PCB 
isomers, shown in Table IV-4 [1],
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TABLE IV-A
RELATIVE MOLAR RESPONSES OF ELECTRON-CAPTURE AND FLAME-IONIZATION
DETECTORS TO SOME PCBs
Relative Molar Response






















Adapted from reference 1
During the GLC-EC detection analysis of PCBs, multicomponent mixtures 
of various PCBs are almost always encountered. The samples analyzed may or 
may not resemble a commercial PCB mixture. If so, the appropriate 
commercial PCB mixture can be used as a standard for quantitation; if not, 
a commercial mixture should not be used. Quantitation cannot be accurate 
since it is based on incomplete resolution of PCB isomers. Even if 
complete resolution were possible, all PCB Isomers are not available for 
standards and the specific EC detection response of each Isomer would need
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to be known.
Many different methods have been used to "quantitate" or estimate 
PCBs. Heights or areas of one [263], two [264], three [265], or more 
[266,267], or of all chromatographic peaks [268-270] of a given sample have 
been used for comparison with standard commercial PCB mixtures. The chief
disadvantage of such methods is that when the chromatogram of the sample
does not closely resemble that of the standard the estimates are neither 
precise nor accurate. An Improvement upon these methods Is the use of 
mixed PCB standards, as described by Beezhold and Stout [271]. This 
procedure involves mixing various proportions of different PCB commercial 
mixtures, such as Aroclor 1242 and Aroclor 1254, and obtaining sets of 
chromatograms. The chromatogram most closely resembling the sample Is 
selected and the corresponding mixture Is used as the standard.
Sawyer [269], in a collaborative study, evaluated the quantitation of
PCBs in chicken fat. He found that the use of the total peak area or the 
sum total of all peak heights gave better results than did the use of 
selected peaks. The use of mixed standards gave good results when the 
composition which best duplicated the response pattern of the sample was 
used. This was adopted as an official method by the Association of 
Official Analytical Chemists [272].
Using a different approach to standardization, Rote and Murphy [273] 
produced a standard response curve using Aroclors 1232, 1242, 1248, 1254,
1260, and 1262. This plot was of the total area responses on the GLC 
trace divided by the weights of the Aroclors injected versus the average 
number of chlorine atoms in the molecule. The peaks in each chromatogram 
were Identified as to chlorine content per chlorobiphenyl molecule, and
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each sample could then be quantitated using the response curve. The 
accuracy of this method is not greater than that of the methods previously 
mentioned, since it has been shown that the response of EC detection varies 
greatly with the degree of chlorine substitution and also with the relative 
position of the chlorine substitution [1],
Rlsebrough et al [274] and Collins et al [268] used dichlorodiphenyl- 
dichloroethylene (p,p'-DDE) as a standard and assumed that the response of 
each chlorobiphenyl isomer was equal to that of p,p’-DDE. This method can 
only be grossly approximate, since the response of EC detection to 
individual PCB isomers varies greatly [1],
Rlsebrough et al [274] also reported the use of microcoulometric 
detection to determine total chlorine content, using a commercial PCB 
mixture as a standard. Sawyer [269] compared the EC detection with the 
microcoulmetric and electrolytic conductivity detectors and found that the 
latter two detectors are subject to more operational problems than is the 
EC detection.
An analytical method utilizing a computer for the quantitation of 
PCBs was described by Zobel [275], This method would not be of value for 
routine sample analysis In industrial hygiene laboratories because of the 
expense or unavailability of a computer.
The method of Webb and McCall [276] Involves standardization of an 
Aroclor mixture whose peak-by-peak composition has been determined as 
weight percentages of the total. Since the response-to-weight factor is 
known for each peak, the actual weight equivalent of each peak in the 
sample can be calculated despite vast differences of overall GLC patterns. 
To utilize this method as a standard procedure, It is necessary that some
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agency serve as a central repository for distribution of the reference 
materials. Presently, standards for Aroclors 1242, 1254, and 1260 as
dilute solutions in iso-octane are available from Webb and McCall [276], 
However, a fully characterized standard for the widely used Aroclor 1016 is 
not available. Potential future sources for these types of standards may 
be either the Association of Official Analytical Chemists or the US Food 
and Drug Administration. These organizations currently are interested in 
this method [277] and are planning to test it collaboratively.
The US Environmental Protection Agency has adopted the method of Webb 
and McCall [276] as a recommended procedure for quantitation of PCBs in 
industrial effluents [278]. Other investigators have also concluded that 
this method is the best available method of quantitation [279].
Berg et al [280] investigated the quantitation of PCBs in terms of 
derivatives. PCBs could be quantitatively converted by catalytic 
dechlorination to bicyclohexyl. However the authors [280] found that the 
relatively low level of sensitivity, because bicyclohexyl had to be 
determined by GLC with FID, was a marked disadvantage. They [280] found 
that treatment of PCBs with anltmony pentachloride under elevated 
temperatures and anhydrous conditions gave good yields (85%) of 
decachlorobiphenyl which could be determined by GLC with EC detection.
Armour [281] evaluated the perchlorlnation procedure of Berg et al
[280] to determine Its utility as a routine method for the confirmatory 
quantitation of PCBs. It was found necessary to modify that procedure 
because of observed inconsistencies in the efficiency of conversion of 
Aroclors 1254 (90-100%) and 1242 (30-70%) to decachlorobiphenyl. Armour
[281] attributed this to volatilization of the lower molecular weight PCB
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components during solvent evaporation before their reaction with antimony 
pentachlorlde. The remedy selected was to end evaporation while a small 
amount (0.1 ml) of solvent still remained, but this rendered the choice of 
solvents a more critical matter because of possible interferences during 
the perchlorinatlon step. Chloroform was the solvent chosen because It 
minimized volatility and reacted favorably at the selected conditions. The 
increased pressure produced as a result of this substitution of chloroform 
required discontinuing use of flame-sealed Carlus tubes as recommended by 
Berg et al [280] for containing the elevated temperature-pressure 
perchlorinatlon reaction. The recommended substitute was a vacuum 
hydrolysis tube having the same volume specifications (10 inn O.D. X 150 
mm), a tight Teflon sealing valve, and a side venting arm [281].
Other modifications devised by Armour [281] included the addition of 
methanol to the reaction mixture's extract to produce an azeotrope with the 
residual chloroform which could then be evaporated to a small volume before 
dilution, preparatory to determination of decachloroblphenyl. To determine 
the feasibility of a shortened reaction time, Armour et al tested iron as a 
catalyst, but decided that although a reaction time of 6 hours with iron 
catalyst resulted in quantitative (99% average conversion for six Aroclors) 
and reproducible (83-110%) conversions, the catalytic modification offered 
little advantage over the overnight procedure.
Perchlorinatlon has been used for the quantitation of PCBs by others 
[282,283]. While the sole perchlorinatlon product was usually 
decachloroblphenyl, there have been reports of undesired byproducts 
resulting from contamination of the antimony pentachlorlde with bromide 
ions [284,285]. Results of NIOSH investigations indicate that this
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contamination problem can be eliminated by vacuum distillation of the 
antimony pentachlorlde. Factors for converting decachloroblphenyl to 
Aroclors are presented in Table IV-5.
TABLE IV-5













¿Calculated by dividing the average molecular weight by 499, the molecular 
weight of decachloroblphenyl
Adapted from reference 281
From a review of the literature, NIOSH concludes that the simplest 
method of PCB quantitation Involves standardization of samples with single 
commercial mixtures of PCBs. Should the composition of a sample not 
closely resemble that of a single commercial PCB mixture, the most accurate 
and precise method of quantitation available would be that of
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perchlorination, which seems to offer the best approach for determining 
total PCB content in samples when the initial concentrations of individual 
PCBs are of little or no concern.
NIOSH recommends desorption of PCBs from Florisil with hexane, 
analysis by GLC, and quantitation of the sample by comparison with a 
standard PCB mixture of similar composition (Appendix II). If a PCB 
mixture with a composition similar to that of the sample is not available 
as a standard, NIOSH recommends converting the sample PCBs to 
decachloroblphenyl for quantitation.
The methodology presented in Appendices I and II has been tested with 
Aroclor 1016 In the laboratory and in practice. Operating parameters found 
by NIOSH are presented in the Appendices.
Biologic Evaluation
While there is presently no adequate method for biologically
monitoring industrial workers for exposure to PCBs, additional research may 
make feasible the routine measurement of residues of these compounds In 
blood or other body fluids.
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V. WORK PRACTICES
The employment of good work practices is required if hazardous 
occupational exposures to PCBs are to be prevented. The carcinogenic, 
teratogenic, dermatologic, and fetotoxic effects of PCBs largely determine 
the nature of necessary work practices.
(a) All locations where occupational exposure to PCBs occurs
should be established as regulated areas and posted with signs warning 
persons of the procedures necessary upon entering or leaving.
When an otherwise closed PCB system is opened, eg, during the loading 
and unloading of storage tanks,.the following work practices are desirable:
(1) Only authorized personnel should be permitted in the area;
(2) Adequate ventilation should be provided and the exhaust air 
should not be discharged into any environment until it has been adequately 
decontaminated;
(3) To prevent skin contact with PCBs, workers should be required 
to wear and use PCB-resistant protective clothing and equipment, including 
respirators.
(4) Upon leaving regulated areas, workers should be required to
remove such protective clothing and equipment and place it in impervious 
containers pending either decontamination or disposal;
(5) After removing such protective clothing and equipment, workers 
should be required to wash their hands, forearms, and faces, and to shower 
after the last exposure of the day.
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Whenever a worker must come into direct contact with PCBs, eg, during 
cleanup of spills or maintenance of vessels, PCB-resistant protective 
clothing and an appropriate respirator must be worn.
(b) Leakage and Spill Procedures
PCB spills are to be cleaned up promptly, either by the use of 
sorbent materials, such as sawdust, or by trapping and removal through 
pumping or other suitable means. In case of spillage of PCBs on clothing, 
the contaminated clothing should be removed as soon as practical, the skin 
should be thoroughly washed, and the clothing should be laundered or 
disposed of properly. Facilities and procedures for such cleanup must be 
provided at manufacturing facilities producing capacitors and transformers, 
because spills of PCBs are quite likely to occur during the filling and 
handling of such devices. Users of PCB-fllled transformers should Inspect 
them periodically for leakage. If leakage Is found, the cause should be 
corrected and the spillage should be soaked up with sawdust or other 
absorbent material. The leak area should be cleaned finally with rags 
soaked with an appropriate safe solvent. Leaky transformer gaskets can be 
sealed temporarily by painting over the leaky area with epoxy cement. 
Refer to Transformer Askarel Inspection and Maintenance Guide [25], and 
Guidelines for Handling and- Disposal of Capacitor and Transformer Grade 
Askarels Containing Polychlorinated Biphenyls [4] for further maintenance 
procedures.
(c) Emergencies
In emergencies, immediate measures must be taken to eliminate 
hazardous conditions. Non-essential workers must be evacuated until the 
emergency no longer exists. Any worker having visible contamination of the
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skin with PCB8 must shower immediately unless other action is warranted.
(d) Respiratory Protection
To ensure against inadvertent exposure to PCBs, workers' respirators 
must be properly selected, fitted, and maintained. A guide to industrial 
respiratory protection [286] has been developed which contains sufficient 
information to enable the establishment and maintenance of a respirator 
program that meets the requirements outlined in 29 CFR 1910.134. The guide 
[286] Includes Information on respirator selection, use, maintenance, and 
inspection, as well as a complete description of various types of 
respirators and their advantages and limitations, respirator fitting 
procedures, wearer training instructions, and physiologic and psychologic 
constraints on respirator use.
Several NIOSH studies [287-289] have shown that respiratory 
protection may be inadequate in many occupational situations, eg, abrasive 
blasting, coal mining, and paint spraying. For this reason, respirators 
are generally regarded by NIOSH as a type of control to be used only where 
engineering controls cannot be used, made adequate, or provided.
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VI. DEVELOPMENT OF STANDARD
Basis for Previous Standards
In 1942, the Subcommittee on Threshold Limits of the National 
Conference of Governmental Industrial Hygienists compiled a list of maximum 
permissible concentrations of atmospheric contaminants recommended by 
various state industrial hygiene units [290], The eight states that made 
recommendations for PCBs (chlorodlphenyls) were unanimous in recommending 1 
mg/cu m. No basis for the recommendations was given.
.Cook [291], in his 1945 listing of Maximum Allowable Concentrations 
of Industrial Atmospheric Contaminants, cited PCB standards for California 
and Utah of 1 mg/cu m and Oregon of 0.3 mg/cu m. He [291] also cited 
unofficial guidelines for Massachusetts of 5 mg/cu m and for New York of 1 
mg/cu m and he recommended 1 mg/cu m, based on the report of Drinker [132].
The American Conference of Governmental Industrial Hygienists (ACGIH) 
began listing PCBs (chloro di phenyl) with "toxic dusts, fumes and mists" 
In its recommendations of maximum allowable concentrations of air 
contaminants for 1946 [292]. It compiled its 1946 list from its 1942 list 
[290] and from Cook's [291] list, and continued to recommend 1 mg/cu m for 
PCBs.
The ACGIH continued to recommend 1 mg/cu m for PCBs (chlorodiphenyl) 
until 1956 when it specified 1 mg/cu m as the limit for PCBs with 42% 
chlorine and proposed a limit of 0.5 mg/cu m for PCBs with 54% chlorine 
[293], Each recommendation was clearly defined as a threshold limit value 
(TLV) for an 8-hour TWA concentration to which it was "felt" workers could 
be repeatedly exposed without adverse effect on their health.
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In 1961, the ACGIH added the notation "skin" to the TLV of those 
substances, including PCBs, which in liquid form can penetrate the skin to 
cause systemic effects [294,295],
In 1962, the ACGIH published documentation of its TLV recommendations 
[296]. Based on information in the reports of Schwartz [123], Drinker et 
al [125], Meigs et al [190], and Treon et al [203], the ACGIH [296]
concluded that for PCBs chlorinated to 42%, 1 mg/cu m would seem to offer 
reasonably good protection against severe systemic toxicity but may not 
guarantee complete freedom from chloracne. They also cited the Information 
[207] that PCBs could be absorbed through the skin, causing fatty 
degeneration of the liver. In documenting its recommendation for PCBs 
containing 54% chlorine, the ACGIH [296] cited Drinker et al [125], Drinker 
[132], and Treon et al [203], and on the basis of these reports it [296] 
considered that 0.5 mg/cu m appeared to be reasonable for repeated
occupational exposures.
The American Industrial Hygiene Association's Hygienic Guide 
"Chlorodlphenyls (containing 42% and 54% chlorine)" [297], published in 
1965, adopted the ACGIH recommendations for time-weighted average exposures 
and suggested a short-exposure tolerance for PCBs of 10 mg/cu m to prevent
unbearable irritation, based on the report of Elkins [130], The Hygienic
Guide [297] provided Information that minimum lethal doses applied to the 
skin of rabbits for 24 hours were 1 g/kg for PCBs containing 42% and 1.5
g/kg for PCBs containing 54% chlorine. It also recommended avoiding
prolonged or repeated skin contact, and it recommended laundering of
contaminated clothing before reuse, protecting the eyes from liquid 
splashes, treatment of the eyes if PCBs were splashed Into them, and
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periodic examinations to detect early evidence of skin irritation or liver 
damage.
In 1970, the International Labour Office published permissible levels 
of toxic substances for several nations [298]. The PCB standards for six 
nations are given in Table VI-1.
TABLE VI-1






42% Chlorine 1.0 MAC
54% Chlorine 0.5 II
Finland
42% Chlorine 1.0 MAC 8-hour
54% Chlorine 0.5 tl
Poland 0.1 MAC
Romania
42% Chlorine 1.0 II
54% Chlorine 0.5 ft
USSR 1.0 ft
Yugoslavia
42% Chlorine 0.5 fl
54% Chlorine 0.5 Vf
Adapted from reference 298
In 1975, Wine11 [299] compiled a list of international occupational 
hygienic standards for chemicals, including "chiorodiphenyl." She listed 
values for Sweden of 0.5 mg/cu m and for the German Democratic Republic of
1.0 mg/cu m. In both countries the standards were the same for PCBs 
containing 42% and 54% chlorine. The standards listed for the Federal 
Republic of Germany were 1.0 mg/cu m for PCBs containing 42% chlorine and
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0.5 mg/cu m for those with 54% chlorine, respectively.
The TLV documentations for PCBs published by the ACGIH in 1976 [300] 
did not differ significantly from the original documentations [296], 
However, the ACGIH [300] recalled, citing von Wedel et al [205], that 
several deaths due to liver atrophy occurred among workers exposed to fumes 
of chlorobiphenyls and chloronaphthalenes, but pointed out that relatively 
few, if any reports had appeared of sytemic poisoning of workers exposed 
only to fumes of PCBs.
The ACGIH has retained a TWA of 1 mg/cu m as the TLV for PCBs with 
42X chlorine content and a TWA of 0.5 mg/cu m as the TLV for those with 54% 
chlorine content (through 1976) [301]. However, a tentative short-term
exposure limit (TLV-STEL) was added to the recommendations in 1976. STEL 
is defined by ACGIH [299] as the maximum concentration to which workers can 
be exposed for up to 15 minutes continuously without suffering from 
irritation, chronic or irreversible tissue change, or narcosis of 
sufficient degree to increase accident proneness, impair self-rescue, or 
materially reduce work efficiency. According to the ACGIH [301], the STEL 
is to be considered a maximum allowable concentration, or absolute ceiling 
not to be exceeded at any time during the 15-minute excursion period; such 
excursions are not to occur more than 4 times a day and there must be at 
least 60 minutes between them. The STEL recommended for PCBs was 1 mg/cu m 
regardless of the degree of chlorination. This recommendation was made on 
the basis that the TLV documentation for PCBs [300] suggested that the 
values should be ceilings never to be exceeded, rather than TWA values for 
8 hours of exposure [301],
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The 1968 ACGIH recommendations [3021, adopted as the federal
standards for PCBs (29 CFR 1910.1000, Table G-l) are TWA 8-hour exposure
concentrations of 1.0 mg/cu m for mixtures containing 42% chlorine and 0.5
mg/cu m for mixtures containing 54% chlorine.
Basis for the Recommended Standard
(a) Permissible Environmental Limit
The major effects that have been found in workers exposed to PCBs are 
chloracne [186-191,195,196], liver injury [190-193,196], and irritation of 
skin and mucous membranes [192,196,197], Exposures at peak PCB 
concentrations of 5-10 mg/cu m have been reported as "unbearably" 
irritating [130],
Chloracne has been reported after occupational exposure to Aroclors 
1242 [196] and 1254 [186], and to various Kanechlors [191,192,194,195], as 
well as after ingestion of Kanechlor 400 [146,153], Chloracne has
frequently been associated with processes where the PCBs were heated [186—
189,196], The methodology in most of the exposure studies did not
differentiate between vapor and particulate forms of the PCBs 
[186,190,196], In one study of Kanechlors In capacitor manufacturing 
plants where chloracne was common, vapor (or small particulate) 
concentrations (0.095-0,95 mg/cu m) exceeded particulate concentrations 
(0,02-0.65 mg/cu m) [191], In another capacitor plant where heated Aroclor 
1254 was used, exposure concentrations were 5-7 mg/cu m, but the vapor 
components were not seperately determined [186]. In this plant, chloracne 
developed among workers after 4-8 months of exposure. A study of workers, 
in a plant where the work situation Indicated the exposures were to PCB
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vapors, showed that chloracne developed after a minimum of 5 months and an 
average of 14 months of exposure [190], In this study, exposure 
concentrations of an undefined PCB were reported as 0.1 mg/cu m. In other 
studies where PCB concentrations were not measured, chloracne developed 
after 3-8 months of exposure [187,189],
These data show that chloracne can develop after prolonged exposures 
to PCBs in concentrations as low as 0.1 mg/cu m, and that as the PCB 
exposure concentrations increase, the duration of exposure required for the 
development of chloracne decreases. The data also indicate that PCBs in 
the vapor phase may contribute substantially to development of chloracne. 
However, they do not prove that only PCB vapors cause chloracne. 
Particulate PCBs have been shown to be absorbed from Inhaled air by 
experimental animals [97], and Ingested PCBs have caused chloracne 
[146,153]. Occupational exposure to a variety of PCB mixtures (Aroclors 
1242, and 1254, various Kanechlors, and others) has caused chloracne, and 
no commercial PCB mixture has been shown to have more or less 
chloracnegenic properties than others.
There are some studies of PCB workers in which chloracne was not 
found [197-199], In one of these studies, the Aroclor 1242 concentrations 
were Imprecisely reported [198] and in the others the PCB mixtures were 
undefined [199], The report by Levy et al [197] gave possible PCB exposure 
concentrations of 0.013-0.264 mg/cu m and breathing zone concentrations of 
0.014-0.073 mg/cu m. Thus the data Indicate that chloracne may be 
prevented by keeping PCB exposures below 0.1 mg/cu m (100 n g / c u  m).
In some of the studies where chloracne developed, signs of liver 
injury were not found [186,194,195], but in the majority of studies where
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chloracne was found, there were also Indications of liver injury [190-
193,196]. Evidence of impaired liver function was found by other 
investigators [197] in a study where workers had not developed chloracne. 
Meigs et al [190] found evidence of slight liver injury in workers exposed 
to PCBs at 0.1 mg/cu m, and Levy et al [197] found historical evidence of 
liver injury in the medical records of workers in the plant where they 
found exposures were <0.25 mg/cu m. Among the findings in these medical 
records were elevated serum triglycerides [197], Abnormal serum 
triglycerides have been found in exposed workers by others [191-193], and 
in the Japanese people who accidentally consumed PCBs [155,157,158,175,179- 
181]. The effect on serum triglycerides in workers was related to duration
of exposure [193] and, in the workers and in the Yusho patients, to
residual PCBs in the blood [175,180,193]. In the Japanese workers who were 
removed from exposure, the effect remained for at least 2 years [193].
Other indications of liver injury in exposed workers included 
occasional findings of elevated serum enzyme activities, and abnormalities 
in various other liver function tests [190,191,196,197], A level of 
exposure at which liver injury will not occur is not indicated by the
occupational exposure studies, since evidence of liver injury has been
found in the occupational studies with the lowest PCB concentrations. It 
is not possible to determine whether liver injury occurred with exposures 
at the lower levels of all the occupational exposure ranges reported, but 
to protect workers from any liver injury it seems that exposures should be 
maintained below 0.01 mg/cu m (10 pg/cu m).
Animal experiments do not demonstrate a safe exposure level either. 
Although Treon et al [203] found no evidence of liver injury in
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experimental animals (rabbits, guinea pigs, cats, rats, and mice) exposed 
to Aroclor 1242 at concentrations of 1.9-8.6 mg/cu m for up to 31 weeks, 
Ouw et al [196] found evidence of liver injury in workers exposed to 
Aroclor 1242 at 0.32-1.44 mg/cu m. In their experiments with Aroclor 1254, 
Treon et al [203] found microscopic evidence of liver injury in animals 
exposed at 1.5 mg/cu for 31 weeks. Linder et al [228] found increased 
liver weights in rats fed Aroclor 1254 at 1 ppm for two generations. The 
intake of PCBs at this dietary level can be compared to the Intake from 
inhalation exposure at about 0.1-0.2 mg/cu m; thus, the animal experiments 
appear to confirm indications of liver injury in workers exposed to PCBs in 
this range. The combined studies of Levy et al [197], Meigs et al [190], 
Hasegawa et al [191], and Ouw et al [196], and the animal studies
[203,228], provide further support to the conclusion that PCB exposures 
must be maintained at lower levels to prevent liver injury than to prevent 
chloracne.
Since indications of liver injury can be found in reports of both 
occupational studies [190,191,196] and animal experiments [203,228] with 
the lowest PCB exposure, there is no proof of an exposure level that is 
adequately low to prevent liver injury.
The prevention of liver injury is of particular concern because there 
is substantial evidence that arene oxides are formed during the metabolism 
of PCBs by animals [51,68,69,74,75,81,115,116,118], and the data offer no 
reason to suspect that humans metabolize PCBs differently from animals. 
PCB metabolites have been demonstrated to bind to nuclear components of 
hepatic cells of rhesus monkeys [51] and rats [81] and this Is sufficient 
evidence to arouse suspicions that PCBs could be potential carcinogens in
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the workplace. Commercial PCB preparations that have been adequately 
tested in rats [218,242] (Federal Register 42:6532-55, February 2, 1977)
and mice [221,240,241] have been demonstrated to cause liver tumors. No 
liver tumors were found in rats fed Aroclors 1242, 1254, and 1260 at 1 ppm 
in the diet, but each of these mixtures produced tumors at 10 ppm (Federal 
Register 42:6532-55, February 2, 1977). In this same experiment a high 
Incidence of pituitary tumors was found in PCB-fed rats. In Yusho patients 
[160,161], and In American workers (written communications, HA Slnclaire, 
June 1976; G Rousch, September 1976), preliminary studies only Indicate
that the occurrence of certain cancers may be excessive. However, the 
findings in rats and mice demonstrate reproducible production of liver 
tumors after ingestion of various PCB mixtures, and NIOSH concludes that 
PCBs in workplace air are potential carcinogens.
Additional concerns for the health of workers and their families are 
adverse reproductive effects [228,230,232,233], including terata in animals 
fed various PCBs (FL Earl et al, written communication, 1976), and adverse 
effects in human and animal infants nursed by PCB-exposed mothers
[101,182,233]. PCBs resembling those in maternal blood both qualitatively 
and quantitatively have been found in human cord blood and In tissues of 
newborn humans and animals [101,138,139,168]. Fetal resorptions were 
common, and dose related Incidences of terata were found in pups and 
piglets when bitches and sows were fed Aroclor 1254 at 1 mg/kg/day or more.
Terata were not found in babies of Yusho patients (maximum consumption of
PCBs of about 0.15 mg/kg/day); however, many undesirable effects including 
low birth weights and chloracne-like lesions at birth and after nursing 
were found [176,182,183].
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Based on the findings of adverse reproductive effects, on its 
conclusion that PCBs are potential carcinogens in humans and on its 
conclusion that occupational and animal studies have not demonstrated a 
level of exposure that will not subject the worker to possible liver 
injury, NIOSH recommends that the TWA concentrations of PCBs in the 
breathing zone of workers be maintained at or below the minimally 
detectable TWA concentration for up to a 10-hour workday, 40-hour workweek. 
NIOSH considers the minimally detectable concentration of PCBs for the 
monitoring of occupational exposures to be 1 jug/cu m, based on its review 
of the literature and the methodology presented in Appendices I and II.
Maintenance of exposures to PCBs at or below this concentration 
should reduce risks of reproductive and carcinogenic effects, and protect 
the employees from metabolic dysfunction, hepatic injury, and dermal 
effects due to PCB exposures during their working lifetimes.
It is recognized that employees handling PCBs may have skin contact 
with these substances, potentially resulting in dermatologic and systemic 
effects. Consequently, appropriate work practices, training programs, and 
other measures should be required, regardless of the concentrations of 
airborne PCBs. Therefore, occupational exposure to PCBs has been defined 
as working with PCBs or with equipment containing PCBs that can become 
airborne or that can spill or splash on the skin or into the eyes, or the 
handling of any solid products that may result in exposure to PCBs by skin 
contact or by inhalation.
(b) Sampling and Analysis
Based on an evaluation of the literature and on its own studies, 
NIOSH recommends sampling and analysis for PCBs as detailed in Appendices I
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and II. Florisil has been selected as the solid sorbent for PCBs because 
it will collect vapors as well as particulates and PCBs can be 
quantitatively recovered from it. The recommended Florisil sampling tubes 
have been shown to have an adequate sorption capacity (at least 100 n g )  for 
monitoring occupational exposures at the recommended limit for up to a 10- 
hour workday. NIOSH has used the sampling method for monitoring TWA 
occupational exposures at 10-250 ^g/cu m [197,244] by sampling at about 200 
ml/minute for the entire workday. Total sample volumes of up to 100 liters 
were collected. At 1 n g / c u  m, 100 liters of air would contain 100 ng of 
PCBs. The lower limit of PCB detection by GLC with EC detection was found 
to be 32 pg/4-jzl injection. Since the contents of the Florisil tubes are 
dissolved In 5 ml of solvent, this represents a total of 40 ng of adsorbed 
PCBs. Although NIOSH recommends sampling at 200 ml/minute, it may be 
feasible to use pumps that sample at faster rates if there are analytical 
difficulties with samples of about 100 liters due to low concentrations of 
PCBs.
(c) Medical Surveillance
Occupational exposure to PCBs has been shown to cause signs of liver 
injury and impaired liver function. Ouw et al [196], Hasegawa et al [191], 
and Levy et al [197] all found occasional incidents of elevated serum 
enzymes: exposure conditions under which these will not occur are not 
known. Therefore, NIOSH recommends determination of SGOT and SGPT 
initially and at annual intervals. The responsible physician may also wish 
to determine serum triglyceride concentrations since these have been found 
to be abnormal in some workers chronically exposed to PCBs [191-193,197]. 
Especially, elevated serum triglyceride concentrations have been found to
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be related to duration of exposure and to the concentration of residual 
PCBs in the blood [193].
Although the data indicate that the recommended standard will prevent 
chloracne, it is not known that it will prevent other skin ailments. NIOSH 
recommends that in comprehensive physical examinations, special emphasis be 
given to the condition of the skin.
PCBs fed to bitches and sows have been found to be teratogenic (FL 
Earl et al, written communication, 1976). Although terata have not been 
observed in human babies whose mothers had been exposed to PCBs
[176,182,183], PCBs have been found in human embryos and fetuses
[138,139,168], and undesirable effects (abnormal skin color and low birth
weights) have been observed in neonates [176,182,183] born after their 
mothers had Ingested PCBs. A woman who was occupationally exposed to PCBs 
had a blood PCB concentration of 25 ppb when her normal baby was born
[195], NIOSH considers that its recommended standard will protect unborn
babies but recommends that women exposed to PCBs at work be advised of the 
potential hazards of PCB exposure to unborn children.
PCBs have been found In milk of women who have been exposed to PCBs 
[168,195] and babies have been adversely affected after being nursed by 
PCB-exposed mothers [182], A safe level of PCBs in the milk of mothers 
occupationally exposed to PCBs is not known. Human milk samples in the 
general US population usually contain detectable amounts of PCBs, and about 
one-third of the whole milk samples have been found to contain >50 ppb and 
up to about 350 ppb (EP Savage, written communication, February 1977). It 
is not known if all the mothers from whom these samples were taken nursed 
their babies without effect. Infant monkeys who were nursed by mothers
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in their milk at 150-350 ppb became sick and developed chloracne [234]. 
After consultation, the woman who was occupationally exposed to PCBs and 
who had PCBs in her milk at about 250 ppb, stopped nursing her baby out of 
concern for its health [195], Based on these considerations, NIOSH 
recommends that women working with PCBs be counseled concerning the 
advisability of nursing their babies.
(d) Personal Protective Equipment and Clothing
PCBs applied to the skin or cornea of experimental animals have been 
shown to cause local lesions and liver and kidney injuries [205-208,225]. 
One worker who developed chloracne after 3 months of exposure to PCBs was 
described as having frequently immersed his hands in the PCB mixture and 
his clothes were described as often being impregnated with PCBs [189], 
Employees working with an askarel containing 60% Aroclor 1254 frequently 
developed skin rashes which were considered by the company physician to be 
allergic or contact dermatitis from the askarel (In the Matter of General 
Electric Company, File No. 2833, New York State Department of Environmental 
Conservation, 1975). Other complaints of these workers that were ascribed 
to the askarel included irritation of the eyes, nose and throat. Levy et 
al [197] and Ouw et al [196] found that employees exposed to PCBs at 0.013-
0.264 mg/cu m and 0.32-1.44 mg/cu m, respectively, complained of similar 
irritations and, on examination, there were findings of skin rashes and 
nasal irritation. Ouw et al [196] considered that one reason the blood PCB 
concentrations in workers they studied did not decline (after improvements 
in the ventilation system had reduced the environmental concentrations of 
PCBs) was because the workers did not comply with the recommendations for 
protecting their skin from PCB contact.
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Based on these reports [189,196,197,205-208,225], NIOSH recommends 
that employees working in situations where skin contact may occur be 
provided with clothing that is impervious to PCBs and that will cover all 
body surfaces where contact may occur. To prevent splashing PCBs into the 
eyes, NIOSH recommends that employees wear appropriate goggles or safety 
glasses in accordance with 29 CFR 1910.133 and ANSI Z87,1-1968. Since 
NIOSH has found PCBs to be potential carcinogens and recommends that 
exposures be maintained at or below 1 jug/cu m, it considers that only a 
self-contained breathing apparatus with a full facepiece operated in the 
positive-pressure mode will provide adequate protection when workers are in 
areas where higher concentrations exist. Based on NIOSH studies [287-289], 
other respiratory protective devices are not considered adequate to provide 
the needed protection.
(e) Other Considerations
Engineering controls are recommended to maintain PCBs in closed 
systems to reduce exposures to the extent feasible. Such a recommendation 
is consistent with the Toxic Substances Control Act (Public Law 94-469) and 
with the need to protect employees from exposure to PCBs. However, there 
are situations, such as in accidental leakage from closed systems and in 
repair of equipment, when PCBs may not be confined. The recommended 
standard prescribes general work practices for PCBs as well as emergency 
work practices. Employees should be informed of the hazards of working 
with PCBs, and trained in the recommended general work practices and the 
procedures to follow in emergencies. The advantages to their health of 
complying with the work practices and medical monitoring requirements of 
the recommended standard should be explained to the employees. As Ouw et
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al [196] pointed out, improving air quality does not go far in alleviating 
the workers' body burdens of PCBs without their cooperation in implementing 
the recommendations for protecting their skin from PCB contact.
NIOSH also recommends certain sanitation practices to minimize intake 
of PCBs by employees. Among these practices is the requirement that 
employees be provided with clean work clothing daily and that they change 
clothing before leaving work. The importance of this measure to the 
employee and the employee’s family is exemplified in finding up to 180 ppm 
of PCBs in the dust of PCB-workers* homes [36], PCBs may remain in
contaminated premises for years [33]. Partly for the same reason, and 
because PCBs in contact with the skin can be irritating [196,197] and also 
because they have caused systemic effects in experimental animals [205- 
208,225], NIOSH recommends that workers shower before leaving work.
Toxic effects from Ingestion of PCBs have been well documented in 
humans [145-185] and experimental animals [101,209-224,226-237,240-248]. 
Workers may have an intake of PCBs from their normal diet of 10-20 ¿tg/day 
[46], and the maximum additional Intake expected from NIOSH's recommended 
allowable work exposures might be of the order of 10 n g .  NIOSH recommends 
that workers wash their hands before eating and that food, drinks, and 
smoking materials not be permitted in PCB work areas. The Importance of 
this recomme’ndation may be evaluated by considering that one drop of PCBs 
spilled on food, in drinks, or otherwise conveyed into the mouth may 
contain about 50 n g  of PCBs, compared to a total intake of 20-30 jig from 
-other sources, including allowable occupational exposures.
Because the consequences of working with PCBs may be substantial, 
NIOSH recommends that entry into PCB work areas be restricted to authorized
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employees whose entry Is logged daily, and whose exposures are monitored at 




There is a clear need for information in the following areas:
(a) The effects of chronic exposure of animals and humans to PCBs 
at low concentrations require investigation. Epidemiologic studies of 
occupational groups and information on concentrations of PCBs in workroom 
air and any related clinical findings would be useful.
(b) Chronic exposures of animals to PCBs at concentrations in the 
range of the recommended environmental limit.
<c) Studies of the reproductive histories of women who have been
exposed to PCBs in their occupational environments, including studies of 
status and development of Infants born to these women.
(d) The absorption efficiencies of various PCB mixtures by the 
dermal and respiratory routes.
(e) The method of transport of PCBs In the blood and the partition 
between blood on the one hand, and fat stores and milk on the other.
(f) A problem that confounds our understanding of the toxicity of 
PCBs is that of the toxic activity of contaminants associated with PCBs. 
The contaminants found In commercially Important PCB products should be 
identified, prepared In pure form and studied toxlcologlcally both as 
individual substances and as mixtures with other, related compounds,
(g) Studies regarding methods of removing PCBs from the skin 
(cleansing).
(h) Studies on the us« of various barrier cr«am« «• « means of 
minimizing dermal exposure to PCBs.
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(1) There Is uncertainty regarding baseline values for PCBs In the 
blood of humans; research should be conducted to determine baseline values 
for the general population and for non-exposed Industrial populations.
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IX. APPENDIX I
SAMPLING PROCEDURE FOR 
COLLECTION OF POLYCHLORINATED BIPHENYLS
General Requirement«
(a) Air samples representative of the breathing zones of workers 
must be collected to determine the exposure from each job or from the 
specific operation in each work area.
(b) Suggested records:
(1) Date and time of sample collection;
(2) Pump model and serial number;
(3) Sample tube type and number;
(4) Sampling duration;
(5) Total sample volume;
(6) Location of sampling;
(7) Temperature, pressure, and relative humidity at time of
sampling;
(8) Other pertinent Information.
Calibration
Since the accuracy of environmental sampling can be no greater than 
the accuracy of the air volume measurement, the accurate calibration of the
sampling pump is essential to the correct estimation of the volume of the
sample that is collected. The required frequency of calibration is
dependent on the use, care, and handling to which the pump is subjected. 
Pumps should be calibrated initially and recalibrated if misused or
191
repaired. If pumps receive hard usage, more frequent calibration may be
necessary. Regardless of use, maintenance and calibration should be 
performed on a regular schedule and records of these should be kept.
The accuracy of calibration depends on the type of instrument used as 
a reference. The choice of calibration instrument will depend largely upon 
where the calibration is to be performed. Ordinarily, pumps should be 
calibrated in the laboratory. For laboratory testing, primary standards, 
such as a spirometer or a soapbubble meter, are recommended, although other 
standard calibration Instruments, such as a wet-test meter or dry gas 
meter, can be used. The calibration setups will be similar for all
instruments.
Instructions for calibration with the soapbubble meter follow. If 
another calibration device is selected, equivalent procedures should be 
used. Since thezflowrate of a pump depends on the pressure drop across the 
sampling device, in this case a "Florisil" tube, the pump must be 
calibrated while operating with a representative tube in line. The 
calibration system should be assembled in series following this order: 
soapbubble meter, water manometer, Florisil tube, and pump.
(a) Check the voltage of the pump battery with a voltmeter to
ensure adequate voltage for calibration, and change or charge the battery 
if necessary.
(b) Turn on the pump and moisten the inside of the soapbubble 
meter by immersing the buret in the soap solution and drawing bubbles up 
the inside until they travel the entire buret length without bursting.
(c) Adjust the pump rotameter to provide the desired flowrate.
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(d) Check the water manometer to ensure that the pressure drop 
across the sampling train does not exceed 2.5 inches of water at 0.2 
liter/minute.
(e) Start a soapbubble up the buret and measure with a stopwatch 
the time required for it to move between calibration marks.
(f) Repeat procedure (e) at least twice, average the results, and
calculate the flowrate from the volume between the preselected marks 
divided by the time required for the soapbubble to traverse the distance.
(g) Record the volume measured, elapsed time, pressure drop, air 
temperature, atmospheric pressure, serial number of pump, date, time, and 
name of person performing the calibration.
(h) The rotameter reading should be corrected for temperature and 
pressure, if necessary.
Sampling
(a) Samples should be collected as near as practicable to the
faces of workers without Interfering with freedom of movement.
(b) Samples should be collected to permit determination of TWA
exposures for every job involving exposure to PCBs and in sufficient 
numbers to express the variability of the exposures in the work situation.
(c) Apparatus for Breathing Zone Sampling
(1) Pump, battery-operated, with clip for attachment to the 
worker's clothing. Airflow through the pump should be controlled within 5% 
of the desired rate during the entire sampling period.
(2) Sorbent Tubes
Glass tubes at least 7 cm long with A mm I.D. and containing
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two sections of 30/48 mesh deactivated Florisil« (Florisil, 30/60 mesh, Is 
sieved to the proper mesh size.) The front section, preceded by a glass 
wool plug, contains 100 mg adsorbent, and the backup section contains 50 
mg. A urethane foam plug is placed between these sections and also behind 
the backup section. The ends of the tube are flame-sealed to prevent 
contamination before use.
Deactivate the Florisil before packing the tubes by drying a weighed 
amount at 105 C for 45 minutes. After cooling to room temperature, add the
Florisil to a round bottom flask which can be attached to a rotary
evaporator. Add water at 3 ml/100 g of Florisil (ie, 3% W/W water) and
turn the mixture in the rotary evaporator for 1 hour or until it is
uniformly mixed (free-flowing).
(d) Collection and Shipping of Samples
(1) Immediately before sampling, break each end of the
sorbent tube to provide an opening at least one-half the internal diameter
of the tube (2 mm).
(2) The smaller, or backup, section of Florisil should be
positioned nearest the sampling pump.
(3) The sorbent tube must be vertical during sampling.
Tubes should not be placed in a horizontal position since this may lead to
"channeling" of the sorbent bed.
(4) Do not pass air being sampled through any hose or
tubing before it enters the tube.
(5) Collect the air sample at a flow rate of 200 cc/minute
or less to obtain the total sample volume required. The recommended
maximum sampling volume for this method is 50 liters.
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(6) Cap the sorbent tubes with Inert plastic caps 
lamedlately after sampling. Under no circumstances are rubber caps to be 
used. Label tubes and note precise location assignments.
(7) Handle one additional tube In the same manner as the 
sample tubes except that no air Is to be drawn through it. Label this tube 
as a blank.
(8) If the tubes are to be shipped, pack them tightly to 
minimize breakage in transit.
(9) Do not subject the tubes to extremes of temperatures or 
to low pressures.
(10) Provide bulk samples of the PCB preparation whose 
presence in the environment is suspected to the analytical laboratory. Do 
not transport these bulk materials in the (same container as the samples or 




Principle of the Method
A known volume of air is drawn through a tube containing Florisil to 
adsorb the PCBs present in the air sample. The collected PCBs are desorbed 
with hexane, and the resulting solutions are analyzed using gas-liquid 
chromatography with electron capture detection. The concentration of PCBs 
relative to a standard PCB preparation is read from a standard curve. If 
the air sample is found to differ significantly In composition from 
available PCB standards, then use the alternate procedure of 
perchlorination described in paragraph (b)7 of Procedure.
Range and Sensitivity of the Standard Analysis
NIOSH has found with Aroclor 1016, that the minimum detectable amount 
of PCB is 32 pg/4 ¿il. With a total desorption volume were 5 ml, this would 
represent a total sample of 40 ng of Aroclor 1016. Thus the method is 
capable of detecting a concentration of 40 ng in a 1 cu m air sample, or a 
concentration of about 1 jug/cu m in an air sample of 50 liters. The upper 
range of the analytical method is apparently limitless depending only upon 
the degree of dilution needed to maintain the concentration of the sample 
within the linear range of the electron capture detector (32 pg to 3 
ng/injection). In practice, concentrations in workplace air have been 
found to be as high as 1.5 mg/cu m.
ANALYTICAL METHOD FOR POLYCHLORINATED BIPHENYLS
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Interferences
(a) Strict measures to avoid contamination are required when using 
the electron capture detector. Foremost, the syringe must be thoroughly 
cleaned after each injection. Hexane to be used in the analytical 
procedure should be periodically analyzed by GLC for purity. It should 
show no chromatographic peaks later than 45 seconds, if less than 5 jul have 
been Injected.
(b) Any compound which has nearly the same retention time on the 
GLC column as one of the PCBs is an interferent. This type of interference 
can often be overcome by changing the GLC operating conditions or by 
selecting another column. Retention time data on a single column, or even 
on a number of columns, cannot be considered as proof of chemical identity. 
It is important, therefore, that a sample of the bulk mixture of PCBs be 
analyzed at the same time as the contents of the sample tubes so that 
chemical Identification of possible Interferences can be made.
(c) The interferences which have been reported in the literature 
in the GLC analysis of PCBs are not expected to be Important for this 
method. Chlorinated pesticides, such as DDT, DDE, etc, have been reported 
as Interferences due to coextraction with PCBs during workup of samples 
such as water, tissue, soil, or biologic fluids. In the case of personal 
air sampling in an industrial environment, these interferences would not be 
present In amounts that would significantly Interfere unless they were 
manufactured in the same area. Thus, unless these chlorinated pesticides 
are specifically known as potential lnterferents, extra cleanup or 
separation steps for these materials are not necessary.
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(d) Sulfur-containing compounds in petroleum products have been
reported as Interferences.
(e) If present in the PCB mixture, biphenyl will be an
Interference when samples are analyzed by perchlorination; however, PCBs
for the purpose of this recommended standard include biphenyl.
(f) Brominated impurities in antimony pentachloride have also been 
found to lead to Interferences in perchlorination procedures. Results from 
NIOSH laboratories indicate, however, that these brominated Impurities may 
be removed by¿vacuum distillation of the antimony pentachloride.
Precision and Accuracy
The performance characteristics of the method as found by NIOSH are 
presented below.
(a) The volume of air sampled can be measured to ±1Z if a pump
with a calibrated volume indicator is used. Volumes calculated from 
initial flow rate settings may be less accurate (±5Z) because of changes in 
flow rate during sampling.
(b) At airborne PCB concentrations of up to 10 mg/cu m, the front 
section of the Slorlsll tube has a 100Z collection efficiency for 50-liter 
air samples.
(c) Recovery of known amounts of PCBs adsorbed on Florlsil is 
quantitative (100Z).
(d) Sealed tubes or desorbed sample solutions can be stored for 2 
months without PCB loss.
(e) The precision of the analysis is dependent upon the precision 
and sensitivity of the technique used to quantitate the GLC peaks of the
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samples and standards. The precision of the standard analytical procedure 
has a relative standard deviation of 4.4%.
(f) The average conversion of PCBs to decachlorobiphenyl Is about 
100% with a relative standard deviation of about 2%.
(g) Recovery of decachlorobiphenyl subjected to the 
decachlorlnation procedure is >99% with a relative standard deviation of 
1 . 8%.
(h) The accuracy of these procedures is not known; accuracy 
depends on the ability to separate and identify each compound In the PCB 
mixture and to compare each with a known standard. Many of the isomers in 
commercial PCB mixtures have not been separated or Identified, and 
standards for many of the isomers are not available.
Advantages of the Sampling and Analytical Methods
(a) The sampling device Is small, portable, and Involves no 
liquids.
(b) The capacity of the solid sorbent sampling device for PCBs Is 
large and recovery of PCBs from the sorbent is quantitative.
(c) The contents of the sample collection tubes are analyzed by 
means of a rapid Instrumental method.
(d) Interferences are minimal, and most of those which do occur 
can be eliminated by altering chromatographic conditions.
(e) The perchlorinatlon procedure provides qualitative 
confirmation and quantitative measure of PCBs, since it Is based on 
measurement of the single GLC-EC detection response of decachlorobiphenyl.
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Disadvantages of the Sampling and Analytical Methods
(a) The precision of the sampling method is limited by the
reproducibility of the pressure drop across the tubes. Pressure drop 
changes will result in variability in the flow rate and cause the sampling 
volume to be imprecisely known because the pump is usually calibrated for 
only one tube.
(b) A substantial difference between the composition of PCBs in
the air sample and that of the commercial PCB mixture being used as a 
standard will result in a large error in accuracy when the standard 
analytical procedure is used, since estimation of the PCB content of the 
sample is based on comparison with such a PCB mixture.
Apparatus
(a) Gas liquid chromatograph equipped with an electron capture
detector capable of maintaining a detector temperature of 350 C.
(b) Glass column (6 feet x 2 mm I.D.) packed with 1.5% OV-17/1.95%
QF-1 on 80/100 mesh Supelcoport.
(O Vials (20-ml), with aluminum-lined caps.
(d) Microliter syringe (10-jul).
(e) Volumetric flasks (10-ml for standards) with glass stoppers.
(f) Method for determining peak areas.
(8) Culture tubes, 13 x 100 mm, with unlined screw top caps.





(a) Hexane, pesticide-grade quality.
(b) Nitrogen carrier gas, prepurified.
(c) PCB mixture under study.
(d) Antimony pentachloride, distilled under vacuum.
(e) Decachlorobiphenyl.
(f) Sodium sulfate, anhydrous.
(g) Hydrochloric acid, 20% aqueous.
Calibration and Standards
(a) Standardization Procedure
Use the particular PCB mixture as the standard that was being used in 
the work area in which air samples were taken. Prepare standards in hexane 
at concentrations ranging from 8 to 500 ng/ml. Calibration curves should 
be established daily since the electron capture detector response may vary 
from day to day. Plot the standard curve in terms of concentration (ng/ml) 
versus area. Since the injection volumes of the standard and the sample 
are identical, the . concentration of the sample can be read directly from 
the standard curve.
(b) Alternate Standardization Procedure (Perchlorination)
The product of the perchlorination of the PCB mixture with antimony 
pentachloride is decachlorobiphenyl. Standards of decachlorobiphenyl are 
prepared in hexane at concentrations ranging from 70 to 440'ng/fil. 
Calibration curves are established daily since the electron capture 
detector response may vary from day t d  day. The standard curve is plotted 
in terms of concentration (ng/ml) versus peak area. Since the injection
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volume of the standard and the sample are Identical, the concentration of 
the sample can be read directly from this curve.
Procedure
(a) Cleaning of Equipment
All glassware used for the laboratory analysis should be washed with 
a detergent, throughly rinsed with tap water, distilled water, pesticide- 
grade acetone, and finally pesticide-grade hexane and then dried.
(b) Analysis of Samples
(1) Preparation of Samples
Score each tube with a file and place the glass wool and front
section in a clean, dry vial. Place the separating urethane foam plug, the
back section of the sorbent, and the retaining urethane foam plug In a
second clean, dry vial. The front and back sections are analyzed
separately.
(2) Desorption of Samples
Prior to analysis, plpet 5.0 ml of hexane into each vial. 
Florlsll particles should not be allowed to cling to the glass above the 
solvent. A minimum desorption time of 10 minutes is required before 
analysis.
(3) Gas-liquld chromatographic conditions for PCB 
determination by this procedure are:
(A) Nitrogen carrier gas flow rate, 60 ml/minute.
(B) Injector temperature, 300 C.
(C) Interface and detector temperatures, both 325 C.
(D) Column temperature, 180 C.
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(4) Sample Injection
The solvent-flush technique Is recommended for injection of 
materials Into the GLC apparatus. With this method, the following
procedure would be used to Inject 4 u l  of sample. Three mlcrollters of
hexane would be drawn into the syringe, followed by 1 jul of air, followed 
by 4 n l  of sample solution. After the needle is removed from the sample 
solution, 1 additional jul of air is drawn into the syringe to minimize 
evaporation at the tip of the needle. The plunger now rests at the 9-jil 
mark. Inject at least 7 n l  of the syringe contents into the gas 
chromatogram. Not less than 1 ¿zl of flush-solvent should be used. Larger 
volumes of flush may give a solvent peak which Interferes with sample
component peaks. The syringe must be cleaned with hexane after each
injection.
(5) Preliminary Analysis
Using the solvent-flush method of subsection b(4), Inject 1 n l  
of sample and 1 n l  of flush-solvent at the conditions specified under 
subsection b(3). If the sample is too concentrated, further dilutions will 
be necessary to bring the concentration of the sample solution Into the 
linear range of the electron capture detector. Once the concentration of 
the sample is appropriately adjusted, its chromatogram should be compared 
to that of a standard to determine if the air sample Is qualitatively 
different in composition from the standard. If there is little difference 
between the two chromatograms, then proceed with the standard analysis 
using the PCB mixture for standardization, subsection b(6). On the other 
hand, should there be a significant difference between the two 
chromatograms (such that comparison with the PCB mixture could result In
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gross error), then use the alternate procedure for standardization, 
subsection b(7).
(6) Standard Analysis
Select at least five prominent peaks In the sample chromatogram and compare 
their heights or areas with those of the standard. Calculate the 
concentration of PCBs by comparing the heights or areas of the selected 
peaks In the sample chromatogram of those In the standard chromatograms of 
known amounts of material.
(7) Alternate Standardization Procedure
A 200-iil aliquot of the sample is placed in a 13-mm x 100-mm culture 
tube and the hexane is slowly evaporated with dry nitrogen until 10 n l  or 
less remain. Do not allow hexane to climb the tube during evaporation and 
do not allow the sample to evaporate to dryness. Immediately add 0.2-0.5 
ml of distilled antimony pentachloride with a disposable plpet as rapidly 
as possible (antimony pentachloride decomposes rapidly in air) and cap the 
tube. The sample should remain light yellow after this addition, but if 
the sample turns dark brown or black, it must be discarded and another 
aliquot of that sample must be used. All samples are placed together In a 
sand bath. There should be no liner in the cap of the tube, since most 
liners are attacked by antimony pentachloride. A sample of
decachlorobiphenyl is treated in a manner similar to the samples. The sand 
bath containing all of the treated samples is placed in a preheated oven at 
160 C for at least 3 hours. Samples may also be treated overnight. After 
perchlorination, the sand bath is removed from the oven and the samples are 
removed from the sand and allowed to cool to room temperature. To each 
sample is added dropwlse 0.5 ml of 20% hydrochloric acid. This mixture is
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then extracted four tines with 1-2 ml of hexane each time. Each extract is 
passed through a funnel containing approximately 0.5 g of anhydrous sodium 
sulfate (retained by a glass wool plug) into a 10-ml volumetric flask. The 
volume of the sample is brought to 10 ml by rinsing the plpet, sodium 
sulfate, and funnel tip with hexane. The funnel should not rest on thezllp 
of the flask during filtration. The glass wool plug and sodium sulfate In 
the funnel are replaced after each sample. An aliquot of the sample 
solution is Injected under the GLC conditions described above. The 
solvents flush technique is recommended using 2 n l  of solvent back flush 
and 6 n l  of standard or sample solution. The syringe must be cleaned with 
hexane after each injection. The height or area of the decachlorobiphenyl 
peak is compared to that of the decachlorobiphenyl standard and the weight 
of decachlorobiphenyl present is calculated.
(8) Gas-liquid chromatographic conditions for
decachlorobiphenyl determination:
(A) Nitrogen carrier gas flow rate, 90 ml/mlnute.
(B) Injector temperature, 300 C.
(C) Interface and detector temperature, 325 C.
(D) Column temperature, 220 C.
(c) Determination of Desorption Efficiency
NIOSH has found average desorption efficiency is >99.3%, thus, 
results of sample analyses need not be corrected for desorption efficiency.
Calculations
(a) Standard Analytical Procedure
The following are the steps in the calculation of concentrations of
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PCBs in air when determined with a PCB mixture as the standard.
(1) Add the heights or areas of several selected prominent
peaks (at least five) in the chromatogram, compare with the total heights 
or areas of those same peaks in the standard, and read the concentration of 
the sample solution (ng/ml) from the standard curve.
(2) Multiply the concentration, in ng/ml, of the sample 
solution by the total volume, in ml, of the sample solution and calculate 
the weight of PCBs in the sample. Make corrections for the blanks if 
necessary.
(3) Add the weights found on the front and the back 
sections of the tube to find the total weight of PCBs in the air sample.
(A) Divide the total weight of the PCBs in the air sample
by the volume, in liters, of air sampled and report the PCB concentration 
in ng/llter or its equivalent in n g / c u  m.
(b) Alternate Standardization Procedure
The following are the steps in the calculation of concentrations of 
PCBs in air using the perchlot. cion method.
(1) The height or area of the decachloroblphenyl peak in
the chromatogram of the sample aliquot is compared to the height or area of
the decachloroblphenyl peak in the chromatograms of the standard. The 
concentration of decachloroblphenyl in the sample aliquot is read from the 
standard curve.
(2) The concentration of decachloroblphenyl in this aliquot 
(ng/ml) is multiplied by the total volume (ml) of the sample solution to 
give the total weight of PCBs In the sample as decachloroblphenyl.
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(3) The weights of PCBs, as decachloroblphenyl, found on 
the front and back sections of the tube are summed, corrections for blanks 
are made, and the total weight of PCB, as decachloroblphenyl, In the air 
sample is calculated.
(4) The total weight of PCB is divided by the volume of air 
sampled and the air concentration is reported in ng/llter or its equivalent 
in Mg/cu m.
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XI. APPENDIX III 
MATERIAL SAFETY DATA SHEET
General Instructions for preparing a Material Safety Data Sheet 
(MSDS) are presented in this chapter. The examples used in the text are 
for illustrative purposes and are not intended to apply to any specific 
compound or product. Applicable information about a specific product or 
material shall be supplied in the appropriate block of the MSDS.
The product designation is Inserted in the block In the upper left
corner of the first page to facilitate filing and retrieval. Print in 
upper case letters as large as possible. It should be printed to read
upright with the sheet turned sideways. The product designation Is that 
name or code designation which appears on the label, or by which the 
product is sold or known by employees. The relative numerical hazard 
ratings and key statements are those determined by the guidelines in
Chapter V, Part B, of the NIOSH publication, An Identification System for 
Occupationally Hazardous Materials. The company identification may be 
printed in the upper right corner if desired.
(a) Section I. Product Identification
The manufacturer's name, address, and regular and emergency telephone 
numbers (including area code) are inserted in the appropriate blocks of
Section I. The company listed should be a source of detailed backup
information on the hazards of the material(s) covered by the MSDS. The
listing of suppliers or wholesale distributors is discouraged. The trade 
name should be the product designation or common name associated with the 
material. The synonyms are those commonly used for the product, especially
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formal chemical nomenclature. Every known chemical designation or 
competitor's trade name need not be listed.
(b) Section II. Hazardous Ingredients
The "materials" listed In Section II shall bp those substances which 
are part of the hazardous product covered by the MSDS and Individually meet 
any of the criteria defining a hazardous material. Thus, one component of 
a multicomponent product might be listed because of its toxicity, another 
component because of Its flammability, while a third component could be 
included both for its toxicity and its reactivity. Note that a MSDS for a
single component product must have the name of the material repeated In
this section to avoid giving the Impression that there are no hazardous 
Ingredients.
Chemical substances should be listed according to their complete name 
derived from a recognized system of nomenclature. Where possible, avoid 
using common names and general class names such as "aromatic amine," 
"safety solvent," or "aliphatic hydrocarbon" when the specific name is 
known.
The "%" may be the approximate percentage by weight or volume 
(Indicate basis) which each hazardous Ingredient of the -mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, le, 
"10-40% vol" or "10% max wt" to avoid disclosure of trade secrets.
Toxic hazard data shall be stated in terms of concentration, mode of 
exposure or test, and animal used, eg, "100 ppm LC50-rat," "25 mg/kg LD50-
skin-rabbit," "75 ppm LC man," or "permissible exposure from 29 CFR
1910.1000," or, if not available, from other sources of publications such 
as the American Conference of Governmental Industrial Hygienists or the
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American National Standards Institute Inc. Flashpoint, shock sensitivity 
or similar descriptive data may be used to Indicate flammablllty, 
reactivity, or similar hazardous properties of the material.
(c) Section III. Physical Data
The data In Section III should be for the total mixture and should 
Include the boiling point and melting point In degrees Fahrenheit (Celsius 
In parentheses); vapor pressure, In conventional millimeters of mercury (mm 
Hg); vapor density of gas or vapor (air ■ 1); solubility In water, In
parts/hundred parts of water by weight; specific gravity (water ■ 1);
percent volatiles (Indicate If by weight or volume) at 70 degrees 
Fahrenheit (21.1 degrees Celsius); evaporation rate for liquids or 
subllmable solids, relative to butyl acetate; and appearance and odor.
These data are useful for the control of toxic substances. Bolling point, 
vapor density, percent volatiles, vapor pressure, and evaporation are 
useful for designing proper ventilation equipment. This information is 
also useful for design and deployment of adequate fire and spill 
containment equipment. The appearance and odor may facilitate 
identification of substances stored in Improperly marked containers, or 
when spilled.
(d) Section IV. Fire and Explosion Data
Section IV should contain complete fire and explosion data for the 
product, Including flashpoint and autolgnltlon temperature in degrees 
Fahrenheit (Celsius in parentheses); flammable limits, in percent by volume 
in air; suitable extinguishing media or materials; special firefighting 
procedures; and unusual fire and explosion hazard information, If the 
product presents no fire hazard, insert "NO FIRE HAZARD" on the line
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labeled "Extinguishing Media."
(e) Section V. Health Hazard Information
The "Health Hazard Data" should be a combined estimate of the hazard 
of the total product. This can be expressed as a TWA concentration, as a 
permissible exposure, or by some other indication of an acceptable limit. 
Other data are acceptable, such as lowest LD50, if multiple components are 
involved.
Under "Routes of Exposure," comments in each category should reflect 
the potential hazard from absorption by the route in question. Comments 
should Indicate the severity of the effect and the basis for the statement, 
If possible. The basis might be animal studies, analogy with similar 
products, or human experiences. Comments such as "yes" or "possible" are 
not helpful. Typical comments might be:
Skin Contact— single short contact, no adverse effects likely;
prolonged or repeated contact, irritation, and cracking.
Readily absorbed through the skin with severe systemic effects.
Eye Contact— some pain and mild transient irritation; no corneal
scarring.
"Emergency and First Aid Procedures" should be written in lay 
language and should primarily represent first-aid treatment that could be 
provided by paramedical personnel or individuals trained in first aid.
Information in the "Notes to Physician" section should include any 
special medical information which would be of assistance to an attending 
physician including required or recommended preplacement and periodic 
medical examinations, diagnostic procedures, and medical management of 
overexposed workers.
211
(f) Section VI. Reactivity Data
The comments in Section VI relate to safe storage and handling of 
hazardous, unstable substances. It is particularly important to highlight 
instability or incompatibility to common substances or circumstances such 
as water, direct sunlight, steel or copper piping, acids, alkalies, etc. 
"Hazardous Decomposition Products" shall Include those products released 
under fire conditions. It must also include dangerous products produced by 
aging, such as peroxides in the case of some ethers. Where applicable, 
shelf life should also be indicated.
(g) Section VII. Spill or Leak Procedures
Detailed procedures for cleanup and disposal should be listed with 
emphasis on precautions to be taken to protect workers assigned to cleanup 
detail. Specific neutralizing chemicals or procedures should be described 
In detail. Disposal methods should be explicit including proper labeling 
of containers holding residues and ultimate disposal methods such as 
"sanitary landfill," or "incineration." Warnings such as "comply with 
local, state, and federal antipollution ordinances" are proper but not 
sufficient. Specific procedures should be identified.
(h) Section VIII. Special Protection Information
Section VIII requires specific Information. Statements such as
"Yes," "No," or "If Necessary" are not informative. Ventilation 
requirements should be specific as to type and preferred methods. Specify 
respirators as to type and NIOSH or US Bureau of Mines approval class, ie, 
"Supplied air," "Organic vapor canister," "Suitable for dusts not more 
toxic than lead," etc. Protective equipment must be specified as to type 
and materials of construction.
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(i) Section IX. Special Precautions
"Precautionary Statements" shall consist of the label statements 
selected for use on the container or placard. Additional Information on
any aspect of safety or health not covered in other sections should be
Inserted in Section IX. The lover block can contain references to 
published guides or in-house procedures for handling and storage. 
Department of Transportation markings and classifications and other 
freight, handling, or storage requirements and environmental controls can 
be noted.
(j) Signature and Filing
Finally, the name and address of the responsible person who completed 
the MSDS and the date of completion are entered. This will facilitate 
correction of errors and Identify a source of additional Information.
The MSDS shall be filed in a location readily accessible to workers 
potentially exposed to the hazardous material. The MSDS can be used as a 
training aid and basis for discussion during safety meetings and training 
of new employees. It should assist management by directing attention to 
the need for specific control engineering, work practices, and protective 
measures to ensure safe handling and use of the material. It will aid the 
safety and health staff in planning a safe and healthful work environment 
and in suggesting appropriate emergency procedures and sources of help in 
the event of harmful exposure of employees.
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IX SPECIAL PRECAUTIONS
PR ECA UT ION A RY
STA TEM EN TS
OTHER HANOLING ANO 
STORAGE REQUIREMENTS
P R tP A R E O a v
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TABLE XII-1
















1221 20.5-21.5 275-320 1.18 286-302 349 Clear, mobile oil
1232 31.4-32.5 290-325 1.26 305-310 460 IV
1242 42 325-366 1.38 384-356 none** vv
1248 48 340-375 1.44 379-384 VV vv
1254 54 365-390 1.54 none** I I Light-yellow visous liquid
1260 60 385-420 1.62 »1 tf Light-yellow soft, sticky resin
1262 62 390-425 1.64 1» • 1 Light-yellow sticky, viscous resin
1268 68 435-450 1.82 • • White to off-white powder
¿Cleveland Open Cup 
**None to boiling point
Adapted from reference 1
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TABLE XII-2
QUALITATIVE AND PER CEN T CHLOROBIPHENYL AND B IPHENYL COM POSITIONS OF COMMERCIAL PCB PREPARATIONS 
(Q u a lita tiv e ly  m a jo r p e ak s  = M, m in o r p e ak s  = m, am b igu ou s id e n tit ie s  = ?; q u a n tita tiv e ly , p e rc en tag es  ro u n d ed )
C L -S ubstitu ted  P o sitio n s  C om m erc ial P re p a ra tio n  D esig n a tio n s  ( tra d e  n am es o m itted )
1221 1221 1221 1221 1232 1116 1242 1242 1242 124« 1241 12S4 1254 1254 RM 12M 12«a
0 13 16 ID 16 m 0.5 m m m m
2 28 32 m 35 m 1 m 0.8 m m m m
3 3 m 3
4 19 19 m 20 in 2 m m
2.3 0.4
2.4 4 3 2 1 <0.7 m <0.1 m m
2.5 0.2 tr m m
2.6 0.3 0.4 tr m
2.2- 9 5 m 5 m 7 m <1.0 M in m m
2.3' 3 m 2 m 1 m m M m m m
2.4' 14 10 m 11 m 11 m <5 « in 0.5 m m
M 1 m m
3.5 tr
3.3-
3,4' 1 m <3




2.T.3 m 5 * «? m




tXA 0.3 m in m 4 m 11 M m 8 m m
2,3',4 m m 4 m <15 M m <13 m m
2.4.4' 02 in m 4 m 7 M7 HI 3
2.2'.5 06 06 m 12 m 2 M m 0.1 m m
2.3V5 0.2 9 m M in <13
2.4'.5 0.2 m m 10 m m m HI m
2.2' .6 m 1 m m m m m
2.3'.6 0.3 M7
2.4',6 2 M m m
3.4.5





QUALITATIVE AND PERCENT CHLOROBIPHENYL AND BIPHENYL COMPOSITIONS OF COMMERICAL PCB PREPARATIONS
(Qualitatively m ajor peaks = M, m inor peaks •  m, ambiguous identities = ?; quantitatively, percentages rounded)
C L -S ubstitu ted  P o sitio ns  C om m erc ial P re p a ra tio n  D esig n a tion s  ( tra d e  n am es o m itted )







2.r,3.4 3 1 0.7
2.3.3' .4 0.4 M 7 m






















2.2'.4.4' m 1 m m
2.2’.4.5' 3 m 12 M7 m 16 m 1
2.2\4.«' 0.1
2.3" .4.4’ tr m m m
2.3' .4.5'
2.3'.5.5’ M7













































1242 1 2 «  1 2 «  12*4 1254 1254 KM 12M 12(0 1210 MO MO DK




II) 2 23.7 M m m 1
m M 4 <4
5
M 2 ni 1
m rti m M 3 0.3
m 17
M? m 14 M 4 2 M 3
m m m
m m M 8 ID 3
m m M 1 m
m m 2 m M 2 ID tr
m 1 m m M 7 M 6
m 1 m 14 M 5 <16 m 2
M?
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CL'Svbatitated Positivas Commercial Preparation Designations (trade names omitted)
















2 .7 .I4 .W










2,2',3,5,5',6 m 1 3
2,7.3,5,S,6'
2,?,3,3\4,4' 2 m 1 M 2
2,?.3,3,.4.5' <1 2
î . r . l M '. ï  m 12 M 5 M m 11 m m
2.3.3'.4.4',5’ m
2.7.3,31.4.6’ m M 2 M 3
2.7.3.4,4',6'
TABLE XII-J (Continued)
QUALITATIVE AND PERCENT CHLOROBIPHENYL AND BIPHENYL COMPOSITIONS OF COMMERCIAL PCB PREPARATIONS
(Q ualitatively m ajor peaks = M, m inor peaks = m, am biguous identities = ?; quantitatively, percentages rounded)
N>■h»U>











































































1 <4 M m 4 m m
0.2 <9 m 09
0.3 m 4 m ffl





0.2 <20 M 2
759-103/10929
TABI,E XII-2 (C on tinued)
QUALITATIVE AND PERCENT CHLOROBIPHENYL AND BIPHENYL COMPOSITIONS OF COMMERCIAL PCB PREPARATIONS
(Quali ta t ive ly  m a jo r  pe ak s  -  M, m in o r  pe a k s  = m, am biguous ide n t i t ie s  -  ?; quanti ta t ive ly ,  p e rc en tag e s  ro un d ed )
CI.-KubütUutcd Positions ( C o m m e r c i a l  P r e p a r a t i o n  D e s i g n a t i o n s  ( t r a d e  n a m e s  o m i t t e d )
N>N>
1221 1221 1221 1221 ¡232 1016 1242 1242 1242 1248 1241 1254 1254 1254 ASO 1260 1260 1260 W0
2,3.3’.4,4\5.5’.6
2.2',3.3',4.4',5.5’ 04 2 m 07
2,2'.3,3'.4.4'.5.6' m m








17 * 16 * 16 * 16 * 14 16 * 16 * 14 7 * 14 8 7Reference No
* PW Albro, written commimicition. November 1976
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